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Abstract
This thesis examines young women’s decision-making regarding Human
Papillomavirus (HPV) vaccination. Using a narrative approach, five young women were
asked to share their stories of how they came to be or not be vaccinated. Two in-depth
interviews were used to elicit participants’ stories, and an overall narrative for each
young woman was constructed. The five individual narratives reveal a number of
themes that capture the diversity of young women’s decision-making experiences and
point to the complex ways in which young women are negotiating decisions regarding
vaccination. Within this thesis, I take a critical stance on the topic of HPV vaccine
decision-making in order to illuminate how young women’s decisions are embedded
within broader social and discursive contexts. This critical approach to understanding
participant narratives was informed by a strong sensitivity to conceptual frames of
medicalization, healthism, and neo-medicalization and dominant discourses related to
health risk and individual responsibility.
Keywords: Human Papillomavirus (HPV), narrative inquiry, qualitative,
decision-making, young women
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Y oung W om en’s Narratives 1

Chapter One: Introduction
This thesis presents the results of a qualitative, narrative study that explored young
women’s decision-making related to vaccination against Human Papillomavirus (HPV), a virus
that has been linked with the development of genital warts and cervical cancer. As a young
female whose studies are focused in health, this topic was of particular interest because I am part
of the cohort of young women to which this vaccine has been recently marketed. After hearing of
the vaccine’s approval for women in Canada in 2006,1 became interested in its incorporation
into provincial health care programs. To explore this interest, I conducted an independent study
in the fall of 2007, under the supervision of Brian Innes, which examined some of the questions
and controversies surrounding the vaccine and its introduction into Ontario elementary schools.
As a result, I became familiar with various arguments and perspectives regarding the
effectiveness of the vaccine for women and its potential benefits and risks. During the course of
my independent study, I became critical of current pressures on young women to get vaccinated
and came to realize that, while research on decision-making was being conducted with parents
and young girls, examinations of how university-aged women were making decisions about the
vaccine were absent from the literature.
The aim of this Master’s research project was therefore to explore how a sample of young
women between the ages of 18 and 26 conveyed their personal stories regarding HPV
vaccination and described their decision-making experiences within the context of their daily
lives. A review of the research literature regarding HPV vaccination shows that the majority of
studies to date have been quantitative in design and have focused largely on parental
acceptability of HPV vaccines or attitudes toward hypothetical HPV vaccines. This project is
unique in that it took a narrative approach and focused on the experiences of young women over
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the age of 18 whose stories have been excluded from previous studies. This focus is important
given that university-aged women are making decisions about vaccination under a different set
of circumstances than are younger girls. Unlike girls in elementary school who are able to
receive the HPV vaccine at no cost through provincial vaccination programs, university-aged
women must pay for the vaccine if they wish to be vaccinated. Furthermore, unlike younger girls
whose vaccination decisions may be guided primarily by their parents’ wishes, university-aged
women are likely living away from home and making decisions about their health more
independently.
The narrative methodological approach used in this study was chosen in order to allow
participants to describe their experiences in their own ways and to overcome the limitations of
other structured data collection methods. Study participants’ stories related to HPV vaccination
were collected using a two-stage in-depth narrative interview process which began, in the first
interview, with a general request for one’s story of how they came to be (or not be) vaccinated.
In the second interview, a semi-structured approach was used to elicit further details regarding
participants’ experiences.
In using a narrative approach, one of the major goals of this study was to uncover new
understandings about not only what influences young women’s decision-making, but also how
these influences ultimately lead young women to be or not be vaccinated. Within this thesis, I
take a critical stance on the topic of HPV vaccine decision-making in order to illuminate how
young women’s decisions are embedded within broader social and discursive contexts. This
critical approach to understanding participant narratives was informed by a strong sensitivity to
conceptual frames of medicalization, healthism, and neo-medicalization and dominant discourses
related to risk and individual responsibility for health. To begin, details regarding HPV and HPV
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vaccination are reviewed in order to provide the reader with important background information
regarding the topic under study.
Human Papillomavirus
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI)
in Canada, affecting up to 80% of women at some point in their lives (McAliser, 2006).
Although HPV infections can happen at any age and can affect both men and women, the highest
rate of infection has been found in women under the age of 25 (Sellors et.al., 2000). Epithelial
cells of the skin and mucous membranes of the body can be infected by any of the over 100
strains of this double stranded DNA virus (Steben & Duarte-Franco, 2007). Although the vast
majority of HPV infections are transient and are cleared by the body’s own immune system,
clinical studies have confirmed that HPV has a number of potential disease outcomes. In
particular, strains of the virus that have been categorized as “low risk” have been associated with
genital warts or minor cervical cell changes while those categorized as “high-risk” have been
associated with cervical cancer in women (Fey & Beal, 2004). HPV has also been implicated, to
varying degrees, as an underlying cause of several other types of cancers including anal, vulvar,
vaginal, penile, oral, and pharyngeal (Markowitz et.al., 2007).
For men and women of reproductive age, HPV infections are often detected soon after
the initiation of sexual activity (Franco, Duarte-Franco, & Ferenczy, 2001; Ho, Bierman,
Beardsley, Chang, & Burk, 1998; Winer et.al., 2003). Infection rates are especially high among
university-aged women, even those who do not consider themselves to be sexually active. In a
study by Winer et.al (2003), almost 10% of participants who identified themselves as virgins
tested positive for HPV. Although these women had not been engaging in vaginal penetration,
they reported having engaged in non-penetrative sexual activity. Given that different strains of

Young W om en’s Narratives 4

HPV can be transmitted either sexually or through skin-to-skin contact, abstinence from all
forms of sexual activity is the only definitive way to prevent infection. While male condoms are
widely used for STI prevention in other contexts, research has shown that they do not provide
complete protection against HPV transmission (Manhart & Koutsky, 2002). This is because
condoms do not cover many areas (e.g. scrotum, penile base, and anus) which can be involved in
the skin-to-skin transmission of the virus.
As noted previously, most HPV infections are transient and asymptomatic and are cleared
by the body’s own immune system. In fact, current research indicates that 70% of women will
clear an HPV infection within one year, and 90% will clear it within two years (Lippman,
Melnychuk, Shimmin, & Boscoe, 2007). In order for the virus to lead to cervical cancer, an
infection must persist and remain undetected for an extended period of time. According to
Friedman and Shepeard (2007), the time it takes for cervical cell abnormalities caused by HPV to
develop into progressive cervical cancer is about 10 to 15 years. Because the time from infection
to cancer may take years or even decades, most cases of cervical cancer are diagnosed in patients
45-50 years of age (Markowitz et.al., 2007).
Given the significant amount of time it takes for an HPV infection to progress to cervical
cancer, incidence and mortality rates related to cervical cancer have remained relatively low in
Canada. In 2008, for example, an estimated 1,300 women were diagnosed with cervical cancer
and approximately 380 died of the disease (Canadian Cancer Society, 2008). These relatively
low incidence and mortality rates are often attributed to Canadian women’s access to public
health care and, in particular, screening tests. Historically, the Papanicolaou, or Pap smear has
proven to be an effective screening test for cervical cell changes caused by HPV. Since the
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introduction of the Pap smear in Canada more than 50 years ago, cervical cancer incidence and
mortality rates have declined by more than 70 percent (Public Health Agency of Canada, 2003).
HPV Vaccines
Recently, a new method of preventing cervical cancer has emerged in the form of two
prophylactic vaccines. Unlike Pap smears that detect cervical cell changes caused by HPV, the
vaccines aim to prevent infection from certain strains of HPV from the outset. Currently, there
are two HPV vaccines on the market- Gardasil and Cervarix . Both vaccines protect against
rr w

-rw

two strains of the virus (HPV-16 and HPV-18) that cause 70% of cervical cancers (Bosch & de
Sanjose, 2003; Centers for Disease Control and Prevention [CDC], 2008), and Gardasil™ also
protects against two other strains (HPV-6 and HPV-11) that cause 90% of genital warts (CDC,
2008; Dunne & Markowitz, 2006; Kahn, 2005). In addition, Gardasil™ has been shown to
prevent potential precursors to other cancers such as anal, vulvar, vaginal, and penile (Cortez &
Pettypiece, 2008; U.S. Food and Drug Administration [USFDA], 2008).
It is important to note that, while both Gardasil and Cervarix prevent against certain
strains of HPV that have the potential to lead to cervical cancer, for ethical reasons the study
period for these vaccines was not long enough for cervical cancer to develop. Thus, the
preventative benefit of these vaccines has been extrapolated from their proven ability to prevent
what are considered cervical pre-cancerous lesions or dysplasias (UFDA, 2006). Although the
vaccines may offer limited protection against other HPV types that are closely related to HPV 16
and 18, many other high-risk strains of HPV are not affected by the vaccines (Castle & Scarinci,
2009). For this reason, and because the duration of protection from the vaccines is unknown,
experts recommend that women continue to be screened regularly with Pap smears, even if they
have been vaccinated (Cutts et.al., 2007; USFDA, 2006). Continued Pap screening is also
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important given that there is no evidence to suggest that either vaccine exerts a preventive or
therapeutic effect against HPV infections contracted prior to vaccination (Denny, Bhatla, &
Wittet, 2010).
HPV Vaccination in Canada
Before 2006, the public was largely unaware of HPV and its potential consequences. In
2006, Merck Pharmaceuticals launched its “Make the Connection” and “Tell Someone”
campaigns in order to raise public awareness of the link between HPV and cervical cancer
(Herskovits, 2007). These campaigns consisted of both television and print advertisements that
encouraged young women to become informed about HPV and its connection to cervical cancer
and to pass this information on to their family and friends. Shortly after these campaigns were
introduced, Merck released the first ever HPV vaccine, known as Gardasil™.
In July of 2006, Health Canada approved Gardasil™ for use in girls and young women
aged 9 to 26 (Kahn, 2005). Later that year, following recommendations from Canada’s National
Advisory Committee on Immunization (NACI), the Canadian government approved 300 million
dollars in funding to the provinces to provide free vaccination to girls aged 9 to 13 for a period of
three years (Torgerson & MacAdam, 2007). By June 2008, five provinces had adopted free
vaccination programs and now the vaccine is being provided free of charge to school-aged girls
in all ten provinces and the Yukon Territory. In Ontario, for example, a voluntary school-based
program offers free Gardasil™ vaccinations to all girls in grade eight. Those who are not in
grade eight must purchase the vaccine at a cost of approximately $400- $450 if they wish to be
vaccinated (Comeau, 2007).
In the US, Gardasil™ has been marketed directly to consumers, first to teenage girls and
their mothers as health care decision makers, and more recently, to university aged women.
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Marketing efforts, such as Merck’s “One Less” campaign have focussed heavily on the vaccine’s
potential to prevent cancer (“Become one less life affected by cervical cancer”) but have
neglected to draw attention to other preventative measures such as safer sexual practices and the
importance of routine Pap tests (Petersen, 2006). Although direct-to-consumer drug advertising
is not legal in Canada, these advertisements have reached many Canadians through American
television stations that are broadcast across the border. Despite aggressive marketing from Merck
and recommendations from both Health Canada and NACI, all girls and young women eligible
for vaccination have not uniformly accepted Gardasil .
One reason why some people are refusing vaccination may be related to the intense
controversy surrounding the Gardasil™ vaccine since its introduction more than four years ago.
One article in particular was a catalyst in generating public debate about the vaccine in Canada.
The article, entitled “Our Girls Are Not Guinea Pigs” (Gulli, 2007), was published in Maclean’s
magazine shortly after the Ontario HPV vaccination program was announced. It highlights many
concerns about the safety of the Gardasil™ vaccine and calls into question the potential
implications of testing the vaccine on an entire generation of young women. Since its release,
public response to Gardasil™ has been mixed, with varying opinions being expressed by health
officials, politicians, women’s health groups, and others (Comeau, 2007; Downton, 2007).
In general, two points of view can be identified at each end of the spectrum in the
ongoing debate about Gardasil™. At one end, there are those who are vehemently in favour of
the vaccine and believe that it represents a new and exciting development in cancer prevention
and women’s health (Hanna & Bachmann, 2006). At the other end, there are those who believe
that the vaccine poses many potential risks to young women that cannot be ignored (Lippman
et.al, 2007). Those who are cautious about these risks believe that more research needs to be
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done before young women are encouraged to be vaccinated. For example, in Canada, concerns
about the speed at which Gardasil™ was approved and questions about its long term safety and
efficacy have been the focus of many debates. As Lippman et.al (2007) point out, the lack of
research regarding the long-term side effects of the vaccine, and the potential for the vaccine to
encourage premature sexual activity among young women are growing concerns among parents
and others. They also note that many health researchers remain sceptical about the need for a
publicly funded vaccine since most cases of HPV are cleared by the body’s own immune system.
The introduction of the Gardasil™ vaccine in Canada has also spurred debate on
university campuses. For example, in 2008, a group of nursing students lobbied to have the HPV
vaccine paid for through the student health plan at the University of Western Ontario (UWO).
Despite their efforts, concerns about the cost of the vaccine led the request to go unanswered
(Bemstien, 2008). At UWO, and in other universities, advertisements for Gardasil™ could be
found not only in student health centres, but also across campus in women’s washrooms,
cafeterias, and residences. In January 2008, student questions and concerns about the vaccine at
UWO stimulated the organization of a Town Hall gathering on campus that featured speakers
from the university and from the local public health unit (Berman, 2008). It was here that
attendees learned more about varying opinions on the vaccine and were encouraged to ask
questions and/or express their concerns.
Organization of the Thesis
In the next chapter, previous research related to HPV vaccine decision-making is
reviewed in order to draw attention to the significant gap in research related to university-aged
women’s experiences and decision-making concerning currently available HPV vaccines. In
Chapter Two, I also review four health behaviour theories that are commonly used in the field of
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health promotion, explore the limitations and assumptions of these theories, and describe
medicalization and related concepts which, I argue, are important to consider when examining
young women’s experiences of decision-making about HPV vaccination. In Chapter Three, the
narrative methodology and specific methods used in this study are reviewed and the ethical
considerations for narrative research are described. Results from the first level of analysis are
presented in Chapter Four in the form of an overall narrative for each participant. Cross-narrative
themes are explored in Chapter Five along with a discussion regarding how these themes relate
to previous research. Furthermore, Chapter Five examines participants’ narratives in light of
concepts such as medicalization, healthism and neo-medicalization and explores how dominant
discourses related to risk and individual responsibility for health are manifested in different ways
in participant narratives. To conclude, I discuss the limitations and significance of this work and
suggest directions for future research.
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Chapter Two: Literature Review
The purpose of this chapter is to provide the reader with an overview of existing
literature related to HPV decision-making and to draw attention to some of its inherent
assumptions and limitations. In the first part of the chapter, I review previous research conducted
with both parents and young women regarding acceptance of either a hypothetical or an actual
HPV vaccine. Particular attention is then paid to those studies that were explicitly based on
constructs from dominant theories of health behaviour such as the Health Belief Model, Social
Cognitive Theory, Theory of Reasoned Action, or the Theory of Planned Behaviour. At the end
of the chapter, I turn my attention to concepts such as medicalization and neo-medicalization in
order to explore the broader context in which HPV has been constructed as a health risk. Related
discourses of health risk and individual responsibility for health are also highlighted given their
particular relevance in discussions of HPV vaccination as a preventative measure.
Parental Acceptance of the HPV Vaccine
A review of the literature related to HPV vaccination shows that the majority of studies to
date have focused on parental acceptance of the vaccine rather than on personal decision-making
by young women. This focus on parental acceptance is understandable given that Gardasil was
first developed and recommended for girls before sexual onset at an age when parental consent
for vaccination is usually required. A recent review of quantitative literature related to HPV
vaccine acceptability in the United States found that more than 20 studies were specifically
concerned with parents’ responses to HPV vaccination for their young daughters (Allen et.al,
2010). It is important to note that, of these studies, many were done prior to vaccine licensure
and were thus based on the presentation of a hypothetical HPV vaccine. Overall, parental
acceptance of an HPV vaccine was found to be related to factors such as perceived benefits to
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society, benefits to own child, influence of peer groups, influence of physicians, personal
experience with genital warts or cancer, and perceptions of risk and disease severity (Constantine
& Jerman, 2007; Dempsey, Zimet, Koutsky & Davis, 2006; Waller, Marlow, & Wardle, 2006;
Zimet, Perkins, & Sturm, 2005).
In one study conducted after vaccine licensure, researchers approached mothers with
daughters aged 11 to 17 years and asked them to complete a questionnaire regarding HPV
vaccination for their daughters. Mothers who were enrolled in the pilot portion of the study
completed the questionnaire and were later interviewed to obtain feedback. Results of this study
indicated that those mothers who had less than a high school degree, had a history of sexually
transmitted infections, and whose daughter(s) would not mind three needles, were more likely to
report favourable attitudes toward having their daughter(s) vaccinated (Rosenthal et.al., 2008).
Overall, these authors concluded that mothers' decisions about the HPV vaccine were not related
to their sexual values or their daughters' sexual behaviour, but rather their parenting, sense of
vulnerability, and general vaccine attitudes. Rosenthal et.al (2008) also noted that, although
many mothers did not appear to feel an urgency to vaccinate their daughters given the newness
of the vaccine, many planned to have their daughters vaccinated eventually.
To date, most research related to parental acceptance of the HPV vaccine has been
quantitative in design, asking parents to answer researcher-defined questions according to pre
established scales or multiple-choice options. Because these methods have a tendency to limit
participants’ ability to introduce new topics, two groups of researchers have also explored
parental acceptability of the vaccine using qualitative methods. In their 2009 study, Dempsey,
Abraham, Dalton, and Ruffin interviewed 52 mothers who had either declined or accepted
vaccination for their daughters and found that, while nearly all the mothers expressed concerns
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regarding vaccine safety, factors such as a lack of knowledge about HPV, age-related concerns,
and low perceived risk of infection were commonly cited reasons for declining vaccination. In
terms of motivating factors, those most commonly cited were related to a desire to prevent
illness, physician recommendation, and high perceived risk of infection (Dempsey, Abraham,
Dalton, & Ruffin, 2009). In an earlier study in which participants were shown television
vignettes of typical pro- and anti-vaccination claims, Leask, Chapman, Hawe, and Burgess
(2006) reported similar results from their focus groups with mothers. In this study, researchers
reported that mothers often spoke of personal experiences, value systems, and levels of trust in
health professionals as fundamental influences on their decision-making about vaccination. In
particular, Leask et.al (2006) noted that although some mothers expressed surprise and concern
about alleged vaccine risks, many often reinstated their support for vaccination by drawing on
notions of good parenting, social responsibility, and anticipatory regret (anticipation of regret if
their child was unvaccinated and developed cervical cancer).
Although research regarding parental acceptance of HPV vaccination is useful in its
ability to provide some insights into the decision-making experiences of parents, these studies do
not lend understanding to how university-aged women themselves are making decisions about
the vaccine. This is especially important because the contexts in which young women are making
decisions about vaccination may differ greatly from that of young girls and their parents.
Hypothetical HPV Vaccine Acceptance Among Young Women
Of those studies exploring HPV vaccine acceptability among young adults and
university-aged women, the majority were conducted prior to the development of an approved
vaccine. Once again, these studies were based on the presentation of a hypothetical HPV vaccine
(Boehner, Howe, Bernstein, & Rosenthal, 2003; Friedman & Shepeard, 2007; Hoover, Carfioli,
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& Moench, 2000; Kahn, Rosenthal, Hamannn, & Bernstein, 2003; McClelland & Liamputtong,
2006; Zimet, Mays, Winston, Kee, Dickes, and Su, 2000). Overall, results from these studies
indicated that most women held positive attitudes toward vaccination and stated high intentions
to receive the vaccine. Generally, intention to receive the vaccine was related to knowledge
about HPV, a higher number of sexual partners, personal beliefs about vaccination, and approval
from physicians and others (Kahn et.al., 2003; Zimet et.al., 2000). Common motivating factors,
particularly among African American women, included receiving information about the vaccine,
affordable prices, good results in clinical trials, and knowing others who had already been
vaccinated (Scarinci, Garcés-Palacio, & Partridge, 2007). Scarinci et.al (2007) also found that,
although Latina immigrants reported positive intentions to be vaccinated, multiple credible
sources of information (e.g. educational talks, doctors, television, churches, and other women)
were seen as necessary to promote the vaccine before the Latino community at large would
accept it.
In one study conducted prior to vaccine licensure, focus groups with men and women
aged 25 to 45 years were used to explore participants’ knowledge, attitudes, and beliefs
about HPV and a hypothetical HPV vaccine (Friedman & Shepeard, 2007). This research
indicated that, in order to make a decision regarding HPV vaccination, participants needed more
information about the prevalence, transmission, and consequences of HPV; the vaccine’s safety,
side effects, degree of protection, and schedule of delivery; and their own level of HPV risk and
susceptibility. Friedman and Shepeard (2007) found that a desire to protect one’s health was
often noted as a factor in hypothetical vaccine acceptance, while a lack of perceived
susceptibility to HPV served as a barrier to vaccine acceptance. Other barriers expressed by
participants in this study included the cost of the vaccine and fear that others might think that

Y oung W om en’s Narratives 14

they were promiscuous if they received a vaccine against a sexually transmitted disease
(Friedman & Shepeard, 2007). Cost was also noted as a barrier to hypothetical vaccine
acceptance in a later study by Sauvageau, Duval, Gilca, Lavoie, and Ouakki (2007). In this
study, researchers found that young women under the age of 25 were especially concerned about
the cost of the vaccine. These researchers noted that although respondents indicated positive
intentions to be vaccinated, vaccine acceptability declined when the issue of cost was introduced
(Sauvageau et.al., 2007). Among young women under the age of twenty-five, 91% indicated that
they would agree to receive the vaccine if it was publicly funded, but only 72% would agree to
pay $100 per dose (Sauvageau et.al., 2007).
Although many early studies showed favourable acceptability of a hypothetical HPV
vaccine, findings from these studies may not be congruent with actual acceptance of an HPV
vaccine. According to Allen et.al (2010), there is evidence to suggest that under circumstances
where benefits and potential harms are unknown- such as in the case of a hypothetical vaccinereported intention is not necessarily related to actual uptake. In this case, information about cost,
vaccine delivery, and potential side effects would not have been available and participants would
not have been exposed to any controversy about the vaccine in the mass media. Although these
studies provide some insight into how women think they would make decisions about an HPV
vaccine, very few studies to date have explored how women actually do make decisions in the
context of currently available vaccines.
Actual HPV Vaccine Decision-Making Among Young Women
Although an actual HPV vaccine has been available for more than four years, only a
small body of primarily quantitative research exists that explores how young women are making
decisions about vaccination. In terms of factors associated with intentions to receive the HPV
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vaccine, Kahn et.al (2008) found that, in their sample of sexually experienced females between
the ages of 13 and 26, the following factors were independently associated with intention to
vaccinate: (a) the belief that influential people would approve of vaccination; (b) higher
perceived severity of cervical cancer or genital warts; and (c) pregnancy history (having been
pregnant).
In terms of age, previous research suggests that younger women are more likely to be
vaccinated or to consider vaccination than those who are older. In one study, researchers
examined knowledge and early adoption of the Gardasil™ vaccine among girls and young
women aged 13 to 26 years and found that vaccine uptake was more likely among 13 to 17 year
olds, particularly among those who reported a recent healthcare visit (Caskey, Lindau, &
Alexander, 2009). In a similar study in which young women between the ages of 18 and 26 were
surveyed, researchers found that the 18 year old women in their sample were approximately 4
times more likely to report uptake of the Gardasil™ vaccine compared to respondents over the
age of 19 (Licht et.al., 2010). In terms of studies conducted prior to vaccine licensure, a
telephone survey of adults aged 18 to 69 years in Quebec also found that younger respondents
were more receptive to the idea of an HPV vaccine than older respondents (Sauvageau et.al.,
2007). Finally, in their study of Dutch men and women aged 18 to 25, Lenselink et.al (2008) also
found that, despite low levels of knowledge regarding HPV and cervical cancer, younger
participants in their sample were significantly more likely than their older counterparts to
indicate future acceptance of an HPV vaccine.
Recently, researchers interested in HPV vaccination decision-making have begun to
focus specifically on university-aged women. For example, in a survey study by Gerend and
Magloire (2008), researchers found that being sexually active is a strong motivating factor for
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vaccination in this population. According to the results of their study, university-aged women in
committed relationships or who were casually dating were more likely to express interest in
vaccination than those who were single. In addition, factors such as being sexually active and
having a greater number of lifetime sexual partners were found to be predictive of both higher
perceptions of risk for HPV and greater vaccination intentions (Gerend & Magloire, 2008). In
another survey study conducted in the United States, researchers found that in their sample of
1,401 female university students, the factor most strongly associated with young women’s
intentions to be vaccinated was the perception that peers were planning to be vaccinated or had
already been vaccinated (Allen, Mohllajee, Shelton, Othus, Fontenot and Hanna, 2009). Most
recently, Roberts, Gerrard, Reimer, and Gibbons (2010) asked a sample of 972 female
undergraduate students aged 18 to 25 to complete a questionnaire regarding HPV vaccination.
These researchers found that, although many of the young women were old enough to receive the
vaccine without parental consent, perception of their mother’s approval and mother-daughter
communication about sex were significant predictors of vaccination in this age group.
Many of the studies conducted with university-aged women have examined knowledge or
awareness of HPV and HPV vaccination as potential predictors of vaccine acceptance. For
example, in the study by Licht et.al (2010), respondents who knew that HPV caused genital
warts were more likely to have received at least one dose of the vaccine. Interestingly, a similar
study conducted with Dutch men and women in this age group reported very different results. In
their study, Lenselink et.al (2008) found that a medical education, knowledge of HPV,
knowledge of cervical cancer, and knowledge of a cervical screening programme, were not
significantly associated with intentions to be vaccinated. Instead, these researchers found that in
their sample, women and younger participants were significantly more willing to accept HPV
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vaccination regardless of their knowledge of HPV or cervical cancer (Lenselink et.al, 2008).
Finally, in another study which assessed knowledge as a predictor of vaccination, Caskey et.al
(2009) found that respondents who reported family members as sources of information about
HPV were more likely to be vaccinated, while vaccine receipt was lower among those who
reported school as a common source of HPV information. Although these studies provide some
insight into the relationships between HPV awareness and uptake of the vaccine, it is important
to note that assessments of knowledge and/or awareness are often based on assumptions
regarding how much and what kind of knowledge is necessary for decision-making. The
problematic nature of these kinds of assumptions is a topic I return to later in this literature
review.
In summary, studies with university-aged women have suggested that HPV vaccine
acceptance may be influenced by a number of factors including HPV-related knowledge, age,
and sexual history. Although these factors have been identified as possible predictors of vaccine
acceptance, more research needs to be conducted to explore other unidentified influences, not
only in terms of acceptance, but in terms of the decision-making process in general. This
exploration should go beyond merely identifying factors that influence HPV vaccine decision
making, to examining the complex ways in which these factors influence how young women
make decisions about vaccination in the context of their daily lives. Within the last two years,
some researchers have begun to turn to qualitative research approaches in their efforts to gain a
deeper understanding of young women’s decision-making experiences.
Qualitative Research Regarding Currently Available HPV Vaccines
To date, only three qualitative studies have been published in English regarding the
uptake of currently available HPV vaccines by young women. One study, conducted in Malaysia,
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used focus groups to learn more about young multi-ethnic women’s attitudes toward the vaccine.
In her sample of young women aged 13 to 27 years, Wong (2008) found that poor knowledge of
HPV did not influence vaccine acceptability. Furthermore, although participants were generally
in favour of the vaccine, the majority of young women in her study preferred to delay
vaccination for three main reasons; (a) because it was newly introduced; (b) because they did not
perceive themselves to be at risk of HPV infection; and (c) because of cost factors (Wong, 2008).
Concerns were also raised regarding the safety of the vaccine and its potential to be an indicator
for promiscuity and sexual activity (Wong, 2008). Although this study was based on the
introduction of an actual HPV vaccine in Malaysia, its focus was on exploring what women
thought about the vaccine and what their attitudes were toward possibly being vaccinated in the
future. As a result, this study did not provide any further insights into the actual decision-making
experiences of young women who had already accepted or declined vaccination. As well, and
similar to the critique by Allen et.al (2010) about studies of intentions to get a hypothetical
vaccine, the extent to which attitudes and intentions are related to actual experiences is unknown.
A second mixed-method study conducted in Denmark investigated young women’s
acceptance or rejection of the HPV vaccine (Mortensen, 2010). In addition to conducting
telephone surveys with young women aged 16 to 26, researchers used focus groups to leam more
about participants’ vaccination decisions. Researchers found that prevention of cervical cancer
was the main driver behind women’s decisions to accept the vaccine, followed by parental
encouragement and financial support, personal experience of knowing someone with cancer, and
recommendation by health care professionals (Mortensen, 2010). The greatest barrier to
vaccination, according to this study, was cost. Additionally, a lack of information about the
benefits of vaccination for sexually active young women was seen as a barrier to vaccination,
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particularly among older participants (Mortensen, 2010). Overall, Mortensen (2010) found that
many women in her sample did not wish to be vaccinated and that the difference between
intention to be vaccinated and starting vaccination was considerable; while more than half of the
women in her sample said they wanted to be vaccinated, only half of these had actually started or
completed the vaccination series at the time the focus groups were conducted. Although
Mortensen (2010) chose focus groups as a way to gain insight into social constructions of
meaning around HPV vaccination, she drew attention to one important limitation of this method.
As she notes, “the social control that characterizes group interviews means that focus groups are
less suitable for producing data about individual lives or narratives” (Mortensen, 2010, p.l 1). As
a result, individual understandings and unique experiences may be under-reported in focus
groups.
While both of the studies described above represent a much-needed shift toward
qualitative approaches to understanding decision-making, they remain limited. Like other
quantitative studies that are based on pre-selected survey questions, these researchers made
assumptions regarding possible influences on decision-making by designing focus group
interactions around a set of pre-determined topics. Furthermore, although Mortensen (2010) was
interested in how young women came to refuse or accept vaccination, she excluded young
women who were undecided about the vaccine. The inclusion of young women who are
undecided is important since ambivalence towards vaccination is often overlooked in studies that
oversimplify the process of decision-making and focus exclusively on factors that influence
acceptance or barriers to acceptance. These studies tend to assume that acceptance is the
desirable choice, and do not consider how and why young women make the decisions they do in
the context of their everyday lives.
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Most recently, a narrative study conducted in the U.S. used in-depth interviews to
identify implicit and explicit values underlying HPV vaccine decision-making among collegeaged women (Hopfer & Clippard, 2010). The authors of this study examined narratives of
vaccine acceptance and rejection and noted specific themes for each type of narrative. The
narratives of vaccine acceptance, for example, consisted of four themes: (a) supportive family
messages; (b) explicit health care provider endorsement; (c) the influence of peers in normalizing
vaccination; and (d) disease framing (e.g. cervical cancer and genital warts) as a means to
shaping perceptions of vaccine benefit. Conversely, vaccine resistance narratives consisted of
five themes including: (a) scepticism of vaccine safety; (b) invoking alternative prevention
strategies (e.g. condoms); (c) articulating stigmatizing HPV messages (i.e. those related to
promiscuity); (d) overcoming self-efficacy barriers (e.g. cost, availability, time, and fear of
parental disclosure); and (e) delay strategies (i.e. waiting until later to decide about vaccination).
Although Hopfer and Clippard's (2010) research allowed for the exploration of collegeaged women’s experiences related to HPV vaccine decision-making, one important limitation
must be noted in terms of the study’s overall objective. As Hopfer and Clippard (2010) describe,
their personal bias rests on the belief that, “it is in the interest of women’s long-term health to
adopt the HPV vaccine” (p.3). Given this assertion, Hopfer and Clippard (2010) approach their
research from a highly instrumental standpoint that assesses knowledge levels in order to
develop new ways of increasing college-aged women’s awareness about HPV and uptake of the
HPV vaccine. This instrumental approach was evident in the design of their study in which pre
defined questionnaire items and interview questions shaped participant narratives by centering
primarily on what participants knew about HPV and HPV vaccination, and where they obtained
this information.
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There continues to be a need for more interpretive qualitative research in the area of HPV
vaccination in order to allow for new insights regarding the complexities of decision-making to
be explored. Although HPV related knowledge might be an important factor influencing young
women’s decision-making, it is likely only one of many factors that influence and shape young
women’s experiences. As well, because the qualitative research published to date has only been
conducted in Malaysia, Denmark, and the United States, additional studies looking at Canadian
populations specifically would provide insight into how young women are making decisions
about HPV vaccination in the Canadian context.
Health Behaviour Theories and HPV Research
As demonstrated in the preceding sections of this literature review, many studies related
to HPV vaccine decision-making have focused on examining respondents’ knowledge, beliefs,
and/or attitudes toward either a hypothetical HPV vaccine or an actual HPV vaccine. Although
most authors do not clearly articulate their rationale for choosing to examine knowledge, beliefs,
and/or attitudes as explanatory variables for vaccination intentions or decisions, it is likely that
these variables were chosen based on health behaviour theories that dominate instrumental forms
of health promotion research, theories that privilege a particular view of individual decision
making. Only three of the studies presented in this review of the literature explicitly describe
how established theories of health behaviour were used to guide data collection and analysis
processes (Boehner et.al, 2003; Kahn et.al., 2008; Sauvageau et.al., 2007). These studies each
drew on one or more of the following models or theories: (a) Health Belief Model, (b) Social
Cognitive Theory, (c) Theory of Reasoned Action, or (d) Theory of Planned Behaviour. These
theories are among the most widely used theories in the field of health promotion and represent
commonly used frameworks in studies of health-related decision-making (Munro, Lewin, Swart,
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& Volmink, 2007). Although these theories emphasize different aspects of decision-making, they
are similar in the way that they assume that decision-making occurs primarily at the individual
level. While other perspectives on health behaviour change do exist within the field of health
promotion which examine program planning at group and community levels (Best et.al., 2003), it
is these individual-level theories which appear to have been applied, implicitly or explicitly, in
recent research in the area of HPV vaccination. In what follows, brief descriptions of each of the
four theories of health behaviour noted above are provided. Particular attention is then drawn to
research studies on HPV vaccination that have used these theories explicitly.
Health Belief Model (HBM)
The basic premise of the Health Belief Model (HBM) is that decisions about health
behaviour are made when three conditions are met. First, the person must believe they are
susceptible to a particular health risk, and that this risk is severe. Second, the potential benefits of
a particular risk-reducing action must outweigh any potential costs. Third, environmental cues
(e.g. media publicity) must prompt the individual to decide to reduce health risks (Langer &
Warheit, 1992). The major proposition that the model puts forth is that if an individual perceives
a disease or negative health outcome to be a threat, then they will be motivated to take action to
avoid that threat.
Social Cognitive Theory (SCT)
Bandura’s (1989, 1992) Social Cognitive Theory (SCT) is a model that considers
attitudes, beliefs, and environmental influences as factors that shape individual behaviour.
Specifically, the model aims to consider the dynamic relationships between behaviour, personal
factors such as cognitions, and environmental influences (Bandura, 1989). The central variable in
SCT is self-efficacy, which is defined as confidence in one’s ability to successfully execute a
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behaviour to achieve a desired outcome (Godin & Kok, 1996). Bandura (1989, 1992) suggests
that the greater one’s self-efficacy, the more likely it is that he or she will successfully carry out
that behaviour. In terms of preventative health behaviours, SCT suggests that individuals will
develop a more self-efficacious attitude concerning prevention if they are provided with certain
skills and sufficient information.
Theory o f Reasoned Action (TRA)
The Theory of Reasoned Action (TRA) asserts that the likelihood of engaging in a risk
reduction behaviour (e.g. being vaccinated) can be predicted by the individual’s intention to
engage in that particular behaviour. Behavioural intention, according to this theory, consists of
three elements: (a) evaluation of the consequences of the action; (b), estimation of the judgement
of significant others regarding the action; and (c) willingness to conform to the wishes of those
significant others (Ajzen & Fishbein, 1980). According to the TRA, an individual’s subjective
norms are ultimately produced through his or her motivation to comply with salient others, and
by normative beliefs ascribed to these salient others in the context of the target behaviour
(Fishbein & Ajzen, 1975). The model suggests that the more positive one’s attitudes and
subjective norms, the more likely it is that an individual will form intentions to perform the
health behaviour, and then actually engage in the health behaviour (Janz & Becker, 1984).
Theory of Planned Behaviour (TPB)
The Theory of Planned Behaviour (TPB) was developed from the Social Cognitive
Theory and the Theory of Reasoned Action (Ajzen, 1988) in an effort to understand why
attitudes do not always predict actual behaviour. Like the TRA, this theory asserts that the
likelihood of engaging in risk reduction behaviours is due to intentions, and that intention is
derived from both individual attitudes and social norms. What makes the TPB unique is that it
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highlights a third determinant of intention, namely the degree of perceived behavioural control,
defined as the individual’s perceived amount of ease or difficulty in performing a particular risk
reduction behaviour. According to the TPB, engaging in a health behaviour is most likely when
the TRA criteria are met and when one has high perceived control over the behaviour (Ajzen,
1988).
HPV Research Explicitly Based on Dominant Theories of Health Behaviour
The first HPV vaccine related study to be based explicitly on theories of health behaviour
was conducted by Boehner et.al in 2003, prior to vaccine licensure. These authors used a
previously designed questionnaire to collect data from their sample of 256 male and female
college students regarding hypothetical acceptance of vaccines for genital herpes and HPV.
Although Boehner et.al (2003) do not provide specific details regarding their questionnaire, they
note that it was designed to solicit health beliefs as identified by the TRA, as well as
demographic information, sexual history, and knowledge of STI’s. These researchers found that
acceptance of a hypothetical HPV vaccine was influenced by factors such as parents’ feelings,
universal recommendation, numerous partners, and low cost. Additionally, Boehner et.al (2003)
noted that those who believed that the vaccine would be safe were more likely to accept a
hypothetical HPV vaccine.
In a second study conducted prior to vaccine licensure, Sauvageau et.al (2007) assessed
participants’ beliefs, attitudes and practices regarding immunization against HPV. In order to do
this, they conducted telephone interviews with 500 men and women between the ages of 18 and
69 years. Like Boehner et.al (2003), Sauvageau et.al (2007) do not provide specific details
regarding how survey items were developed, however they note that the questionnaire used in
their study was built using elements of the Health Belief Model (HBM). The results of this study
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indicated that only 15 percent of respondents had heard of HPV, 87 percent agreed that HPV
vaccines could prevent cervical cancer, 73 percent knew that the vaccine should be administered
before the onset of sexual activity, and 89 percent would recommend vaccination to their
daughters and nieces. Among respondents under the age of twenty-five, 91 percent said they
would agree to receive the vaccine if it was publicly funded.
In terms of studies related to actual HPV vaccine decision making, Kahn et.al (2008)
were the only researchers to approach the topic using theories of health behaviour. In their study,
sexually active females 13 to 26 years of age were asked to complete a questionnaire and
undergo DNA testing for HPV. In addition to collecting information regarding HPV vaccination
history, demographic factors, and gynaecologic history, Kahn et.al (2008) also aimed to gather
information regarding behaviours, knowledge, and beliefs related to HPV vaccination. Once
again, these authors do not provide details regarding how their questionnaire was designed,
however, they note that their study focused specifically on attitudes from two different health
behaviour theories. The first, a central construct in the Theory of Planned Behaviour, was
intention to perform the behaviour. The second, a key construct in Social Cognitive Theory, was
the belief about one’s capability (self-efficacy) to perform the behaviour. According to Kahn
et.al (2008), 66% of respondents intended to receive the HPV vaccine, 65% were confident they
could find the time to be vaccinated, 54% believed that they could receive all three shots, and
42% believed that they could afford vaccination. Factors associated with a high belief in one’s
ability to receive the vaccine included perceived severity of HPV, sexually transmitted disease
history, insurance coverage, and fewer barriers to vaccination (e.g. related to safety and practical
issues).
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In addition to these three studies, one major review of American studies also used health
behaviour theory to organize its findings. The review by Brewer and Fazekas (2007) looked
specifically at studies of HPV-related beliefs and HPV vaccine acceptability among adolescents,
young adults, and parents of adolescents and organized the findings according to constructs of
the Health Belief Model (HBM). According to Brewer and Fazekas (2007), perceived likelihood,
in the context of HPV vaccination, is the belief that HPV infection and cervical cancer are likely
to happen. Perceived severity, another dimension of perceived risk, is the belief that HPV
infection or cervical cancer would have serious negative consequences for health or wellbeing.
Perceived effectiveness (i.e., perceived benefit) is the belief that the HPV vaccine will reduce the
likelihood or severity of HPV infection or cervical cancer. Perceived barriers to being vaccinated
against HPV included perceived impediments to vaccination such as side effects and cost. Cues
to action are situational factors that trigger one to be vaccinated.
Overall, Brewer and Fazekas (2007) reported that most parents reacted positively to the
possibility of vaccinating their daughters against HPV, particularly parents with lower levels of
education. They also found that vaccination acceptability was higher when people believed that
the vaccine was effective, that a physician would recommend it, and that HPV infection was
likely. Cost and concerns that vaccination would promote adolescent sexual behaviour were also
noted as barriers to vaccination. African American, Hispanic, and white respondents were
equally accepting of the HPV vaccine. It is important to note that all of the studies reviewed by
Brewer and Fazekas (2007) were conducted prior to vaccine licensure and that none examined
decision-making in the context of an actual HPV vaccine. Furthermore, this review focused
exclusively on studies conducted in the United States. Although awareness and knowledge are
not formally part of the health belief model, Brewer and Fazekas (2007) also reviewed awareness
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of HPV and knowledge about HPV infection, cervical cancer, and the HPV vaccine, noting that
“awareness and knowledge appear in other conceptual approaches to studying health behaviours”
and are often considered “prerequisites for making informed decisions” (p.108).
As demonstrated above, research regarding young women’s decision-making about the
HPV vaccine has relied on health behaviour theories. For the most part, these theories have
informed the conceptualization of HPV research implicitly, though some studies are explicit.
Although these theories are applied widely in health promotion research and can provide useful
frameworks from which to begin examining decision-making, they have many limitations in
terms of their ability to help us fully understand the decision-making experiences of young
women. In the following section, I draw attention to some of the major limitations of existing
HPV vaccine decision-making research, while paying particular attention to the specific
limitations of research based on the four health behaviour theories described above.
Limitations of Existing Research on Decision-Making about HPV Vaccination
Research Design
As noted previously, the majority of studies conducted to date have been quantitative in
design and have focused primarily on the acceptability of either a hypothetical or an actual HPV
vaccine for parents and young women. While these studies have generated insights into decision
making, they are limited by their research design. In many studies, researchers created self-report
questionnaires or surveys in order to gather data regarding decision-making attitudes,
preferences, and processes. The fundamental problem with this approach is that it limits
participants to answering a range of structured questions, often guided by preselected scales or
multiple-choice responses. In choosing to ask specific questions, assumptions are made by
researchers regarding what influences may affect vaccine acceptance. As a result, the data
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collected may not fully convey the experiences of the participants and does not allow for detailed
descriptions of contextual factors that may lead to greater understandings of participants’
decision-making experiences. In studies based on health behaviour theories, for example, health
behaviour theory indicators are developed to reflect the perceptions and belief structures that are
presumed by the theory to be most important to decision-making. The participant responses
elicited using structured surveys based on these indicators are thus removed from the real
contexts in which decisions are made.
Furthermore, in studies guided by specific theories of health behaviour, certain factors
(e.g. attitudes, self-efficacy, and knowledge) introduced via pre-structured data collection
instruments may not have otherwise been identified by the participants themselves. In the study
by Sauvageau et.al (2007), for example, researchers gave participants basic information
regarding HPV and its link to cervical cancer before asking related questions. In doing so, the
researchers foreclosed the opportunity to leam about what participants actually knew or did not
know about HPV, and failed to consider the possibility that participants may have associated
HPV with genital warts or other types of cancers (e.g. anal, vulvar).
Another limitation of studies based on theories of health behaviour is that constructs
derived from a particular theory are often used and measured inconsistently. For example,
Stretcher, Champion, and Rosenstock (1997) report that the HBM has often been “misused” in
research endeavours because of a “lack of specification of the relationships among the content,
importance, and measurement of health beliefs” (p.71). According to these authors, although
various studies have attempted to construct measurements of HBM variables, there have been
multiple “interpretations” of these constructs throughout the literature (p.71). Many studies based
on the HBM are also limited in that rather than looking at the complex ways in which model
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variables interact, they tend to isolate model variables (e.g. perceived severity or susceptibility)
to determine which one variable is most predictive of health care seeking behaviour (Becker &
Maiman, 1975; Harrison, Mullen, & Green, 1992; Stretcher et.al., 1997).
Lack of Explicit Conceptual Framework
Although not all researchers explicitly described the theoretical frameworks guiding their
studies, it is clear that many were implicitly guided by the kinds of assumptions present in
dominant theories of health behaviour and were approached from similar standpoints. For
example, by focusing research efforts largely on HPV vaccine acceptance as opposed to
decision-making, the implicit assumption is that decisions to accept vaccination are correct and
desirable. This assumption carries inherent moral undertones which position the decision maker
as either rational or irrational depending on whether or not their decision is consistent with the
implied “right” choice.
Since HPV vaccination studies have been primarily concerned with examining why girls
and young women accept or do not accept the vaccine, another limitation of these studies is that
they often exclude those who are still undecided or ambivalent about vaccination. As a result,
little is known about how people actively negotiate decisions about the vaccine. In order to come
to a greater understanding of what influences young women’s decision-making experiences, it is
thus necessary to shift our attention from examining why people do or do not accept vaccination,
to how they decide about vaccination. To do this, interpretive methodological approaches are
needed to allow young women to describe their experiences of HPV vaccine decision-making in
their own ways.
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Assumptions about Decision-making and Decision Makers
Perhaps the most striking limitation of previous research is its focus on a particular view
of individual rationality in decision-making. In general, research related to decision-making in
health has been guided by the assumption that people are rational beings whose ultimate goals
include maintaining or enhancing their health (Vahabi & Gastaldo, 2003). This underlying focus
on individual rationality is central to each of the theories of health behaviour presented above.
The Theory of Reasoned Action, for example, emphasizes that individual beliefs are central to
the formation of attitudes and subjective norms. Assuming that all humans have the ability to
reason, and that there is one “correct” way to reason (i.e. by engaging in risk avoidance), the
theory asserts that individuals systematically identify and weigh outcomes to form attitudes.
Similarly, the Health Belief Model assumes that individuals are rational actors who go through a
process of weighing costs versus benefits in order to determine the severity, susceptibility,
barriers, and benefits related to engaging or not engaging in particular health behaviours
(Mattson, 1999).
According to these models, individuals make decisions only after engaging in a series of
cost-benefit calculations. These calculations allow the decision maker to compare possible
outcomes and evaluate the likelihood that each may or may not occur (Janis & Gentry, 1984).
This emphasis on rational choice is particularly problematic in that it fails to consider decisions
that may be made in ways that are not necessarily considered “logical” or “rational” according to
traditional models. For example, decisions that are made impulsively in a doctor’s office or in
other settings, or decisions that are influenced by broader contextual factors such as parental or
peer influences. As Fazio (1990) notes, decision-making is not always a deliberate, linear process
and thus may not always lead to what others deem as the most “rational” decision. Although
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theories of health behaviour may provide a normative conceptualization of how decisions are, or
should be made, research shows that people often do not operate in the way that these theories or
models envision (McCaul, Peters, Nelson, & Stefanek, 2005).
The assumption of rationality in decision-making is fundamentally rooted in realist
perspectives that consider unfavourable events as both predictable and avoidable (Lupton, 1999).
As Vahabi and Gastaldo (2003) note, this view assumes that risk is an objective construct that
can be measured. Ultimately, rational models of decision-making fail to consider how people
evaluate risks and make decisions on the basis of their own interpretations of what they are told
(Eiser, 1998). The context in which health-related messages are circulated, received, understood,
and internalized, for example, is often ignored in models that focus solely on an individual’s
decision-making response.
Women in particular are especially subject to judgements of rationality in health-related
decision-making. In their study of women’s decisions concerning mammographic screening,
Vahabi and Gastaldo (2003) describe how “gender bias in health care and the expectation of a
compliant role for women lead to the assumption that women’s health related decisions coincide
with experts’ recommendations; when that does not occur, women may be labelled as either
uninformed or irrational” (p. 245). In the context of HPV vaccination, decisions to vaccinate are
framed as the ‘rational’ choice for young women. Thus, it is often assumed (and expected) that
once women are provided with information about HPV and its link to cervical cancer, they
should readily accept vaccination as the appropriate preventative action. If a woman refuses to be
vaccinated, she may be seen as uninformed or irrational. In the context of cancer control,
McCaul et. al (2005) assert that, “normative decision models were not intended to describe how
decision-making actually occurs but rather to describe how decisions ought to be made” (p.107).
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Ultimately, although women’s decisions regarding vaccination may not appear to be rational
when judged according to criteria stipulated by these models, they may in fact be quite sensible
when examined in the context of each woman’s life circumstances. As Vahabi and Gastaldo
(2003) note,
A behaviour that is labelled irrational under the realist framework can be quite a rational
and intelligible action when other lenses are used. It is important to realize that people’s
health-related decisions are not only based on their desire to maximize their health, but
also on multiple factors such as their socio-cultural context, power relations, and
cognitive capacities (p.254)
As the above quote demonstrates, women do not make decisions about their health in a vacuum.
Rather, their decisions are made within social contexts that influence and possibly constrain their
decisions. For example, personal experiences, familial relationships and circumstances, and other
broader discourses on health risk and personal responsibility (i.e., ways of framing ideas about
health risk and personal responsibility) may all play a role in influencing women’s decision
making experiences. Given that most theories of health behaviour assume a deliberate, linear,
and “rational” decision-making process, it is unlikely that studies based on these models will
adequately examine the complex ways in which women approach decisions regarding HPV
vaccination. According to Vahabi and Gastaldo (2003), new ways of conceptualizing how people
make health-related decisions are required in order to better understand why individuals choose
or do not choose to follow the recommendations of health authorities.
A new approach to studying HPV vaccine decision-making is especially important
given that HPV vaccination represents a unique option for young women. While most vaccines
are offered in childhood, this vaccine has been marketed explicitly to young women between the
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ages of 9 and 26. Furthermore, not only is this the first vaccine designed to prevent infection
from a sexually transmitted infection, it is also the first vaccine associated with cancer
prevention. As a result, this vaccine in particular may elicit strong emotions from young women
who have been, or who know someone affected by cervical cancer or other types of cancers.
As noted previously, theories of health behaviour often assume one “right” or
“rational” choice. HPV vaccination is unique in that it is not the only option available to prevent
cervical cancer. Pap screening also provides a means for early detection of pre-cancerous cells in
the cervix, and other preventative measures such as abstinence and condom use may help to
prevent HPV transmission. Although theories of health behaviour often assume that individuals
will act in prescribed ways to reduce their risks for negative health outcomes, the ways in which
individuals view and respond to health risks is highly subjective (Lupton, 1999).
While current literature sheds light on our knowledge of general patterns and themes
in HPV vaccine decision-making, the real life experiences underlying these general trends
remain to be explored. Missing from the literature are first-hand accounts from young women
describing the complexity of their decision-making experiences within the context of their daily
lives. Qualitative approaches must therefore be used to step out of the rational model of decision
making and its traditional assumptions in order to understand not only why young women make
the decisions they do, but also how they make these decisions and how these decisions are
shaped within broader contexts. In speaking directly with young women who accepted, declined,
or who were undecided about HPV vaccination, one of the aims of the present study was to
challenge traditional notions of rational decision-making and explore new ways of understanding
young women’s decision-making experiences. In what follows, I describe how new insights into
the decision-making experiences of young women have the potential to be uncovered when
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participant narratives are examined in relation to critical concepts of medicalization and neomedicalization and related discourses of individual responsibility and health risk.
Critical Perspectives on Decision-Making in Health
A narrative research approach not only provides insight into how people convey their
personal experiences, it also provides insight into how narrators struggle in articulating their
stories in relation to broader discourses (Chase, 2003). In this sense, discourse refers to “a set of
common assumptions that sometimes, indeed often, may be so taken for granted as to be
invisible or assumed” (Cheek, 2004). According to Roof (1993), by allowing for an examination
of how dominant discourses manifest themselves in participants’ stories, narrative methods hold
the potential to move researchers beyond “methodological individualism” and “attention simply
to individual attributes,” and to push them to look at cultural narratives more broadly (p.304).
In light of the previously noted criticisms of dominant health behaviour theories used
(usually implicitly) in health promotion research regarding vaccination, this section presents a
critical approach to understanding young women’s decision-making experiences by considering
the broader social and discursive contexts within which these experiences are situated. Unlike the
health promotion theories presented earlier in this chapter which often deflect attention from the
influence of broader socio-political contexts and place decision-making at the individual level,
this approach aims to examine how processes of medicalization and neo-medicalization have
advanced discourses of health risk and individual responsibility for health. In looking at how
these discourses are taken up and/or resisted in different ways by the young women in this study,
this perspective enables a consideration of the broader contexts within which young women are
negotiating vaccination decisions.
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In what follows, the concepts of medicalization, healthism, and neo-medicalization are
reviewed in order to draw attention to related discourses of health risk and individual
responsibility for health. As I will argue, consideration of these discourses is especially relevant
to discussions of HPV vaccination as a preventative health measure.
Medicalization and Healthism
Medicalization can be defined as a process that organizes a broad and ever growing range
of behaviours and aspects of everyday life into categories of health and illness (Hartley & Tiefer,
2003). According to Crawford (1980), medicalization involves reconceptualizing social
problems as medical issues which invite medical, and thus individualized, solutions. For
Crawford (1980), this focus on the individual was the product of the rise of “healthist” culture in
the United States in the 1970’s during which the preservation and pursuit of health came to be
seen as a primary goal and a moral obligation. The concept of “healthism” was first introduced
by Crawford in 1980 to describe a form of medicalization in which individuals are encouraged to
take responsibility for modifying their everyday behaviours in ways that are consistent with the
preservation of good health (Crawford, 1980).
Neo-medicalization and the Medicalization of Health Risk
While medicalization has traditionally referred to a process in which existing symptoms
or problems have come to be understood in medical terms, new forms of medicalization have
emerged that convert risks forfuture disease into problems that require immediate medical and
pharmaceutical intervention. Neo-medicalization, a concept introduced by Batt and Lippman
(2009), refers to a process which "emphasizes an individual’s supposed risk of developing a
problem and the use of some drug or device to manage this risk” (p.50). In its most pervasive
form, neo-medicalization makes being “at-risk” a disease state and frames the individual as
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responsible for ensuring that the risk does not become reality. For Batt and Lippman (2009), neomedicalization and its endorsement of personal responsibility for the management of risks to
health “fits seamlessly into neo-liberal economic policies that put the emphasis on economic
growth and free market forces, and minimize the government’s role in social programs” (p.50).
In general, neoliberalism has come to describe a prevailing ideological paradigm that encourages
commodification and shifts responsibility away from governments and onto individuals (Batt &
Lippman, 2009). From this perspective, the emergence of new vaccines that claim to help
individuals manage their risks for future illness, can be seen as symptomatic of broader neo
liberal discourses that aim to both stimulate the economy, and position individuals as morally
responsible for their own health.
Healthism and Moral Responsibility
Ideas about morality are inherently tied to discussions of medicalization and healthism
and related discourses of personal responsibility for health risk. For example, Crawford (1980)
points out that healthism is necessarily moral in that it focuses exclusively on behaviour,
motivation and emotional state. In his discussion, he argues that healthism perpetuates an
ideology of self-improvement that insists that health is derived from individual choices, and that
poor health is most likely to result from individual failings. Similarly, Rail and Beausoleil (2003)
observe that, "the desire to achieve health has become a new form of corporeal [self] control and
guilt has become intimately tied to an individual’s failure to achieve it” (p.5). While some might
suggest that the medical model has lifted moral condemnation from the individual, Zola (1972)
argues that this condemnation is merely displaced- that is, having a disease is no longer viewed
as immoral, but what the person does about it has become the focus for moral judgement. For
Zola (1972):
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Health and illness are remarkable ‘depoliticizers’ of an issue. By locating the source and
the treatment of problems in an individual, other levels of intervention are effectively
closed. By the very acceptance of a specific behaviour as an ‘illness’ and the definition of
ill as an undesirable state, the issue becomes not whether to deal with a particular
problem, but how and when, (p.400)
Within Canada’s distinctly neo-liberal context, individuals are increasingly framed by
risk discourse as having a moral obligation to preserve their health not only for their own benefit,
but for the benefit of family members, and society as a whole (Petersen & Lupton, 1996).
According to Lupton (1999), risk discourses position social actors in specific ways by identifying
them as either responsive to risks (actively making choices in relation to risk prevention), or as
risk makers (the causes of risk, requiring regulation and discipline). In the context of women’s
health, Robertson (2000) argues that women who are responsive to their risks for breast cancer
literally embody prevailing discourses on risk which are expressed in terms of a
phenomenological experience of being ‘at-risk’” (p.230). For Robertson, the consequence of this
‘at-risk’ consciousness is that “all participants, to a greater or lesser extent, engage in particular
health practices as ‘self-care’ strategies for managing their perceived risk” (p.230). Gifford
(1986), also writing in the context of risks for breast cancer, suggests that this quest for personal
control over health risk tends to lead to further medicalization because it causes women in
particular, to turn to medical experts in their efforts to prevent illness. Similarly, these studies are
consistent with Morgan’s (1998) assertion that contemporary forms of medicalization have re
constructed the female body as a site of “virtual pathology” in which medical interventions are
promoted as a means of ‘prevention’ and ‘risk management.’
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In what follows, I describe how processes of neo-medicalization have led to the
construction of HPV as a health risk—one which can (and should) be responded to, managed,
and controlled, by women through HPV vaccination.
HPV Vaccination as a Moral Imperative
Following from the above discussion, HPV vaccination can be situated as a form of neomedicalization that encourages women to be vaccinated as a way to preserve their health and
manage their risks for future disease. For example, Polzer and Knabe (2009) note that within the
Canadian context, newspaper framings of HPV vaccination have tended to “oversimplify the
relationship between HPV and cervical cancer and thereby (wrongly) conflate HPV infection
with cervical cancer disease” (p.869). Through its relationship with cervical cancer, the HPV
virus has been converted into what Lupton (1999) terms a ‘risk object’; that is, something to
which harmful consequences are conceptually attached. Although the HPV virus is not new,
public awareness of its link to cervical cancer only began to increase once a vaccine was
available for purchase. This construction of HPV as a significant risk to women’s health has
ultimately led HPV vaccination to be framed as the “right” and “responsible” choice for
managing this risk (Polzer & Knabe, 2009). For example, in television advertisements for
Gardasil™, Merck directly markets to teens and young women in their twenties with their “I’m
Smart” campaign. In the commercial, a young woman addresses the audience saying:
I could give you a million reasons why I chose the Gardasil™ vaccine but it really comes
down to just one. ‘Cuz I’m doing everything I can to take care of myself. As in wanting
what’s right for me. Looking out for number one. I figure I owe myself at least that
much- Don’t you? (Polzer, 2008)
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This approach to advertising aims to compel young women to seek vaccination as a means of
taking responsibility for, and protecting their health. The explicit moral tone of this message
communicates to young women that if they do not accept vaccination, they do not care enough
about themselves to do all they can to protect their health.
These types of messages regarding vaccination ultimately characterize a process of neomedicalization in which being ‘at-risk’ for HPV infection (and cervical cancer) is constructed as
a disease state that can be properly managed through the uptake of the vaccine. As Crawford
(1980) describes, this “potential sick-role” imposes societal expectations on the individual on
behalf of prevention. As potentially sick, individuals experience intense social pressure to act in
ways that minimize risk. In this context, preventative health interventions become seen as “.. .a
sign of social, not just individual, responsibility” (p.379).
For Petersen and Lupton (1996), and Vahabi and Gastaldo (2003), notions of health risk
inevitably raise questions regarding what is considered to be a ‘good’ or ‘bad’ citizen.
Judgements of morality are related to the idea that good citizenship not only involves caring for
the self, but also protecting others from illness. Individuals are not only just responsible for the
preservation of their own health, but also for that of others. According to Petersen and Lupton
(1996), moral demands related to caring for oneself and others are imposed in a particular way
on women. As they describe, “the meanings associated with ‘health’ and ‘protective behaviours’
are inextricably linked with the feminised discourses of ‘looking after yourself, risk avoidance
and caution, and are highly embodied” (p.82). As a result, they suggest that women feel morally
compelled to take responsibility for their health and their active participation in preventative
practices is a way to show that they are responsible citizens. As Lupton (1999) notes, this process
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involves women’s voluntary participation in self-surveillance through which they feel rewarded
for following preventative health guidelines and taking charge of their health.
Like Lupton (1999), other researchers have also explored how processes of
medicalization and neo-medicalization shape subjectivities. As Robertson (2000) describes,
subjectivity refers to “a particular way of thinking about, relating to and situating the self in
terms of the broader social and political context within which the self is embedded/located” (p.
230). According to Riessman (2003), women have not been passive victims of medicalization.
Instead, she notes that medicalization requires active participation by individuals. Morgan (1998)
refers to this as medicalized subjectivity or medicalized agency in which people experience
themselves as active medicalizing subjects. By drawing on notions of health risk and individual
responsibility for health, vaccine discourses place the onus on women to manage their potential
risks for HPV and cervical cancer by creating a moral imperative to seek vaccination.
In terms of understanding young women’s experiences of decision-making related to
HPV vaccination, the insights presented here regarding medicalization and neo-medicalization
provide a strong starting point from which to examine how dominant discourses related to health
risk and individual responsibility for health may be embodied and expressed in participant
narratives. Given the pervasiveness of these discourses in our everyday lives, careful questioning
of their role in shaping the subjective experiences of young women is necessary. How dominant
discourses are reflected and/or challenged in participant narratives is a topic that is explored
further in detail in Chapter Five of this thesis. In the next chapter, I outline specific details about
how this study was carried out and describe why a narrative methodological approach was
chosen as the most appropriate means to exploring young women’s experiences of HPV vaccine
decision-making.
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Chapter Three: Study Design and Methods
The purpose of this chapter is to orient the reader to the study’s research question and
objectives and to introduce the methodology and methods used to explore this question. In the
first part of this chapter, I provide an overview of narrative inquiry and discuss my rationale for
selecting this methodology. In particular, I describe how the approach to narrative inquiry used
in this study, aligns with my own epistemological and ontological commitments. In the second
part of the chapter, the specific methods used to conduct this study are outlined. In addition to
describing the processes of data collection and analysis, I also provide information regarding
how participants were recruited and selected, what ethical issues were considered, and how
quality criteria were addressed.
Research Question and Objectives
As demonstrated in the previous chapter, a review of the literature related to HPV
vaccine decision-making indicates that there is a significant gap in terms of qualitative research
that examines university-aged women’s decision-making experiences. In order to address this
gap, I conducted in-depth interviews with young women between the ages of 18 and 26 who had
already been vaccinated, who had declined vaccination, or who were undecided about
vaccination at the time of recruitment. Given that university-aged women have been heavily
targeted by government and industry-sponsored media advertisements about HPV and
Gardasil™, efforts to investigate how these young women engage in decision-making around the
vaccine are warranted. Examining how young women between the ages of 18 and 26 told their
stories related to HPV vaccination allowed me to gain insight into the various events and
experiences that they interpreted as having influenced their decision-making process.
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The main research question that guided this study was; “How do young women aged 18
to 26 convey their experience of making decisions about HPV vaccination in the context of their
daily lives?” Through a narrative approach, I explored how five young women constructed their
stories related to HPV vaccination and made sense of their decision-making experiences. In
eliciting and examining participants’ stories, my goal was to learn more about how these young
women understood how they had come to be or not be vaccinated against HPV. Furthermore, by
examining participant narratives according to conceptual frames of medicalization and neomedicalization and by situating participants’ stories within dominant health discourses (e.g. those
related to health risk and individual responsibility); I hoped to come to a deeper understanding of
how young women’s experiences might be linked to broader social contexts. Specifically, the
objectives of this study were to:
1. identify and explore influences on young women’s HPV vaccination decisions;
2. identify and explore challenges and/or tensions that young women encounter in making
decisions about HPV vaccination; and
3. situate these factors and challenges in relation to broader social and discursive contexts
Narrative Inquiry: An Overview
In order to address the above research question and objectives, a narrative study was
designed. As a unique form of qualitative research, narrative inquiry refers to a diverse group of
approaches that use stories to describe human action (Polkinghome, 1995). Narrative inquiry
does not have a single heritage, theoretical orientation or standard methodology (Emden, 1998;
Priest, Roberts, & Woods, 2002; Riessman, 1993). As acknowledged by Lieblich, TuvalMashiach, and Zilber (1998), “the use and application of this research method seems to have
preceded the formalization of a philosophy and methodological parallel to the practice” (p.l).
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Although narrative inquiry may take many forms, its central contention is that stories
have the potential to give meaning to people’s lives, and are a key means through which people
construct meaning from their experiences. Fundamentally, narrative inquiry is based on the
notion that storytelling is a human impulse (White, 1981) that serves as a primary way of making
sense of an experience (Mishler, 1986). Using narrative methods therefore allows one to gain
insight into how people reconstruct life stories in order to make sense of why certain events did
or did not occur. As Bickman and Rog (1998) describe, narrative methods can be considered
“real world measures” that are appropriate when “real life problems” are investigated (p.5). To
engage in narrative inquiry, stories are collected by the researcher and used as the source of data
(Emden, 1998). How participants impose order on the flow of experience to make sense of
events and actions in their lives is of particular interest.
At this point, it is important to distinguish between what is meant by “stories” versus
“narratives.” Although these terms are often used interchangeably, Polkinghome (1988) makes
an important distinction by noting that, “narrative” refers to “a kind of organizational scheme
expressed in story form” (p. 13) or “a meaning structure that organizes events and human actions
into a whole” (p. 18). Thus, although narratives necessarily involve stories, a person’s narrative is
made up of more than a single story- it is a collection of stories. For the purpose of this study, I
chose to use the terms “story” or “stories” to describe individual accounts of events and/or
experiences as narrated by the participants. Conversely, the term “narrative” was reserved to
describe the co-constructed organization of these stories into a coherent whole.
Rationale for a Narrative Approach
I chose narrative inquiry as the research method for this study because it enabled me to
address one of the key gaps in the literature; that is, the absence of first-hand accounts of
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university-aged women’s decision-making experiences. As noted previously, narrative inquiry
lends itself to uncovering how people make sense of their experiences through telling their
stories. According to Chase (2005), narrative involves retrospective meaning making as a way to
shape and order past experiences. Storytelling is part of human nature and is used by individuals
to share not only their experiences, but also to share how these experiences have affected them.
As Connelly and Clandinin (1990) argue: “Narrative and life go together and so the principal
attraction of narrative as a method is its capacity to render life experiences, both personal and
social, in relevant and meaningful ways” (p.10).
In the context of interpretive research, narratives have numerous strengths, including the
ability to convey experience, express identities, and provide insight into the unique contexts in
which stories are told. In what follows, I will discuss the particular utility of narratives in each of
these areas in order to demonstrate why a narrative approach was chosen to examine young
women’s experiences related to HPV vaccination.
Narratives and Experiences with Medication
The ability to convey experience through storytelling is a unique strength of narrative
inquiry. Specifically, in exploring how narrative approaches might be important in research
regarding medicine users, Bissell, Ryan, and Morecroft (2006) assert that “medication
narratives” have the potential to convey insights into how people understand and make decisions
about medication use. As they describe, “medication narratives may hold the key to
understanding why some people are compliant with medication instructions and others are not”
(p.56). In relation to narratives of medication use, these authors assert that “medications ‘work’
(as in exert an effect) not only on a person’s body but also ‘work’ on their lives at a specific time
and in a specific place” (p.58). In other words, medicines operate in the context of the broader
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social world of individuals (Crossley, 2000). According to Bissell et.al (2006), since very little is
known about how people incorporate (or decline to incorporate) medicines into their social
worlds, an increased focus on individual medication narratives is warranted. As they describe,
Attention to narrative has the potential to provide us with an enhanced understanding of
patients and their agency, or behaviours, intentions, reasons, rationales, and actions.
People use narrative to constantly create and recreate sense not only of their experience
of their medicines, but also of their roles in the use of medicines. If there is a connection
between narrative and self-identity, then medicines and their use feature in that
connection (p.58).
In the context of this study, the stories that participants told were related to a specific
medical intervention- the HPV vaccine. Thus, engaging with their stories and narratives not only
offered me the opportunity to gain a deeper understanding of how participants negotiated
decisions regarding this vaccine, but also allowed me to learn more about how their experiences
with the vaccine were conveyed in light of who they are as individuals.
Narratives and Identity
The notion that stories can provide insights into the identities of narrators is echoed by
authors like Polkinghome (1991) and Rosenthal (1997), among others, who advocate that
personal narratives are people’s identities. According to this view, stories represent the inner
reality of participants while at the same time shape and construct the narrators’ personalities and
realities. According to Lieblich et.al (1998), “one of the clearest channels for learning about the
inner world is through verbal accounts and stories presented by individual narrators about their
lives and their experienced reality... narratives provide us with access to people’s identity and
personality” (p.7). It is through telling stories, that individuals are able to continually construct
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and reconstruct their identities in relation to past events and actions. Narrative inquiry allows
researchers to examine not only the personal accounts of individuals’ motives and experiences, it
also allows participants to reflect on and interpret these actions through telling their stories
(Holloway & Freshwater, 2007).
According to Bissell et.al (2006), the stories we tell are often moral stories about our
connections to other people in our lives. These connections with others are inextricably linked to
our self-concept. As they describe, the stories that we tell “are often embedded within issues of
power and control as we attempt to construct our sense of self’ (p.55). Furthermore, it is
particularly at times when an individual’s sense of identity is challenged, that stories are useful in
making sense of changes in self-concept and in the individual’s relationship with their
surroundings (Bruner, 1987; Emerson & Frosh, 2004; Riessman, 1993).
The goal of this study was to explore how participants described their experiences related
to HPV vaccine decision-making in the context of their daily lives. In allowing participants to
tell their stories, I was able to gain insight into how they were constructing their identities in
relation to their vaccination decisions.
Narratives and Context
According to Anderson and Goolishian, (1988), as human beings, we communicate and
find meaning through our unique use of language that is informed by the societies within which
we are formed and developed. Thus, by studying and interpreting these individual stories,
narrative research “can access not only the individual identity and its systems of meaning but
also the teller’s culture and social world” (p.9). Although individual experiences are unique, they
are influenced and shaped by the context in which they occur. As Holloway and Freshwater
(2007) describe, the context in which stories are told becomes a filter through which individuals
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perceive and attach meaning to their experiences. For Emden (1998), contextuality is central to
the practice of narrative. As she describes, considering context in narrative is necessary in order
to fully understand how participants make sense of their experiences: “everything becomes
related to everything else in the expression of life’s meaning and to strip one’s research
procedures of their wider influences is a contradiction of intent” (p.30).
According to Lieblich et.al (1998), “each procured story is affected by the context within
which it is narrated: the aim of the interview, the nature of the ‘audience’, and the relationship
formed between the teller and the listener, the mood of the narrator, and so forth” (p.8). Although
these immediate contextual factors must always be considered, narrative also allows us to look
further to the broader socio-cultural contexts in which stories are narrated. This insight is
important because it is within these broader contexts that dominant discourses operate.
Given this particular strength, narrative as a methodological approach was particularly
valuable for this study, where one of the main research objectives was to situate participants’
stories within broader social and discursive contexts. As Roof (1993) describes, “people’s stories
are never just their stories. Stories connect us with the larger stories, with the cultural narratives
that shape our shared meanings” (p.304).
Constructivist Approach to Narrative Inquiry
The approach to narrative inquiry that was used in this study was consistent with
constructivist epistemological and ontological commitments. According to Denzin and Lincoln’s
(2003) framework, a constructivist paradigm assumes, “a relativist ontology, a subjectivist
epistemology, and a naturalistic set of methodological procedures” (p.35). Assuming a relativist
ontological position, I commit to the idea that there are multiple social realities which are
socially constructed, selected, and built by individuals from among the situations and events of
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their experience (Guba & Lincoln, 1994). Epistemologically, I contend that knowledge is
transactional and subjective. In other words, knowledge is created through the interactions
between the researcher and the researched (Guba & Lincoln, 1994) and individual realities are
influenced by the context of the situation (Ponterotto, 2005). From this position, I embrace the
notion that my research findings are a co-construction between myself and the research
participants.
The idea of co-construction is fundamental in constructivist narrative studies that assert
that narratives are a product of a narrator and listener coming together at a specific time and
place (Chase, 2005). Narrative researchers acknowledge that “the two narratives of participant
and researcher become, in part, a shared narrative construction and reconstruction through the
inquiry” (Connelly & Clandinin, 1990, p.128). As Alex and Hammarstrom (2008) describe,
“every person has many perspectives on the same event, and what is narrated depends on the
context, the listener and the intentions. The interviewer can thus be considered a co-actor in the
created narratives” (p.170).
In this study, the stories told by each participant were understood to be context specific
given that they were told at a specific time, in a specific place, and under a specific set of
circumstances. In particular, the approach to narrative inquiry used in this study was informed by
the work of constructivist authors like Riessman (1993), who asserts that narrative research is
based on the assumption that people construct their realities through narrating their stories. In
line with my ontological and epistemological commitments, I was not interested in pursuing a
single “truth” about young women’s decision-making processes around HPV vaccination, but
rather in uncovering the various constructions held by individuals about what influences have
shaped their experiences. To this end, I have taken the position endorsed by Lieblich et.al (1998),
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who maintain that “life stories are subjective, as is one’s self or identity. They contain ‘narrative
truth’ which may be closely linked, loosely similar, or far removed from ‘historical truth’” (p.8).
For Lieblich et.al (1998), the stories people tell cannot be taken at face value, as complete and
accurate descriptions of reality. Instead we must realize that, “stories are usually constructed
around a core of facts of life events, yet allow a wide periphery for the freedom of individuality
and creativity in selection, addition to, emphasis on, and interpretation of these ‘remembered
facts’” (p. 8). It is through engaging with participant narratives that the researcher is able to gain
insight into the aspects of an experience that are deemed by the narrator to be most important,
influential, and/or memorable (Connelly & Clandinin, 1990). In narrative studies, the ways in
which stories are told are as important as their content, and allowance is made for stories to
change over time and in relation to different contexts and audiences.
As I have demonstrated thus far in this chapter, a narrative methodological approach was
particularly useful in this study of HPV vaccine decision-making since it allowed me to gain a
deeper understanding of the phenomenon from the viewpoint of young women who had already
decided or who were in the process of making decisions about HPV vaccination. A constructivist
approach to narrative inquiry was especially appropriate in that it gave participants the
opportunity to define their experiences and construct their stories in their own ways rather than
have their realities be shaped by structured data collection methods (e.g. surveys, structured
interviews).
Subjectivity and Reflexivity in Narrative Research
According to Merriam (2002), in all forms of qualitative research, “the researcher is the
primary instrument for data collection and data analysis” (p.5). Because constructivist narrative
researchers acknowledge their role in collecting, analysing, and co-constructing participant
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narratives, reflexivity is a primary concern. Instead of trying to eliminate bias, qualitative
researchers working within interpretivist and constructivist worldviews take the position that it is
important to reflect on, identify, and examine their subjectivities in order to become aware of
how their beliefs, attitudes, and cultures are influencing the research process (Merriam, 2002).
Hammersley and Atkinson (1983) define reflexivity as a process by which the researcher ‘takes a
step backwards’ and examines his or her assumptions associated with personal value systems,
gender, race, socioeconomic status and political leanings. This process continues throughout the
whole of the study, requiring ongoing introspection from the researcher. Most importantly,
reflexivity considers the unequal relationship between the researcher and participant and
involves considering how each person comes to the interview with different intentions.
In terms of reflexive acceptance of researcher subjectivity, Banister, Burman, Parker,
Taylor, and Tindall (1996) assert that subjectivity should be viewed as a resource since research
is always carried out from a particular standpoint and is never truly neutral. Similarly, Peshkin
(1988) suggests that researcher subjectivity can be viewed positively, as it can be “the basis of
researchers making a distinctive contribution, one that results from the unique configuration of
their personal qualities joined to the data they have collected” (p. 18). By making explicit the
assumptions that informed the interpretation of participant data, the researcher’s subjectivity can
be used as an analytic resource to enable readers to make their own judgements about the
research product.
Throughout the course of the study, I strove to maintain a critical awareness and a
reflexive stance regarding my role in the co-construction of the data and research findings.
Cooper and Burnett (2006) argue that ongoing reflexivity makes the researcher more conscious
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of being a co-creator of the narratives and situates the researcher more firmly in the research
process.
I began the research process by explicating my own personal beliefs and biases about
women’s decision-making experiences related to HPV vaccination, both by journaling and
through discussions with my thesis supervisor and advisory committee members. Openly
disclosing my preconceptions enabled me to subject my personal assumptions and experiences to
questioning and helped me to ensure that my interpretations remained firmly grounded in the
informants’ narratives, while at the same time acknowledging my role in their co-construction
(Silverman, 2000). Continual consideration of how my personal beliefs and biases were shaping
the research process was important in order for me to maintain a critical awareness of how these
beliefs were being challenged by the data. The methods I used to incorporate reflexivity
throughout the research process are detailed in subsequent sections of this chapter. First,
however, I begin the second half of this chapter by describing the specific methods used to
conduct this study.
Participant Recruitment
Posters (Appendix A) were the main recruitment materials used to advertise for this
study. The posters served to inform potential participants of the general purpose of the study and
to invite them to contact me to learn more about what participation in the study involved. The
coloured posters were large and eye catching and featured tear-off contact slips that potential
participants could take and save until they wished to contact me.
A staggered approach to recruitment was taken in an attempt to obtain a diverse sample
of participants from more than one location. A diverse sample was sought in order to obtain the
broadest possible range of experiences and perspectives on HPV vaccine decision-making. To
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start, posters were placed in the waiting rooms of three clinics: The London Middlesex Health
Unit’s Sexual Health Clinic, The Student Health Services Clinic at the University of Western
Ontario (UWO), and The Fanshawe Medical Clinic at Fanshawe College. These locations were
chosen as primary recruitment sites since they were thought to address a diversity of locations
where university-aged women would likely go for more information about the vaccine and/or to
be vaccinated. Since nearly all of the young women who contacted me were from UWO, I
decided to expand my initial recruitment strategy to include posters in public libraries, grocery
stores, and community centres throughout London. This was done in an effort to broaden the
demographic range of my participants to include not only university students, but also other
young women between the ages of 18 and 26.
Potential participants contacted me by phone or email if they were interested in learning
more about or participating in the study. If potential participants called me, I gave them a brief
description of the study and asked for their email address so that I could send them the letter of
information (Appendix B). When potential participants emailed me, I replied by thanking them
for their interest and sending them a copy of the letter of information via email. In both cases, I
invited potential participants to contact me by phone if they had any questions about the study
and/or if they were interested in participating.
When young women contacted me by phone expressing interest in participating, I started
by asking a few general questions to establish their eligibility to participate. Specifically, they
were asked to disclose their age, current vaccination status (vaccinated /not vaccinated/
undecided about vaccination), and where they had heard about the study. If the young women
were between the ages of 18 and 26,1 asked if I could keep their contact information on file and
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advised them that they would be contacted if they were selected to participate. Details regarding
the selection process are provided in the subsequent section.
Once selected, I contacted the participants by phone or email to arrange our first
interview. The date, time, and location of the interview were decided by the participant in order
to ensure they would be comfortable. Most young women agreed to meet with me at my office
(at UWO); however, one participant opted to meet me at another location on campus.
Selection of Narrators
Overall, the aim of qualitative studies is not to generalize findings to an entire population,
but rather to explore participants’ experiences in depth and to generate information-rich data
about a specific phenomenon (Tuckett, 2004). In order to investigate young women’s
experiences related to HPV vaccination, I conducted in-depth interviews with five young women
between the ages of 18 and 26. The small sample size used in this study was consistent with the
recommendations of Lieblich et.al (1998) who note that most narrative studies recruit a small
number of participants because of the large quantity of data that tends to be generated.
Ultimately, the decision to limit the number of participants to five was made in conjunction with
my advisory committee who felt that five was an appropriate number given the diversity of
experiences and richness of the data gleaned from my first five participants.
In order to select participants, a purposeful sampling approach was used. This means that
only people meeting certain criteria were sought rather than a sample representative of the
overall population (Palys, 1997). For the purposes of this study, “young women” were defined as
females between the ages of 18 and 26 who had, or were currently making decisions about
vaccination against HPV. I was interested in speaking not only to young women who had been
vaccinated, but also to those who declined vaccination and those who were still undecided about
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it. Further inclusion criteria for this study were that participants must: (a) be able to participate in
an interview in English, and (b) be able to give informed consent. All men, as well as women
over the age of 26, were excluded from this study given that the vaccine was not recommended
or approved for these groups at the time this study was conducted.
The five participants in this study were selected from a group of 18 young women who
contacted me and met the inclusion criteria to participate in the study. To obtain diversity in the
sample, maximum variation sampling was used (Patton, 1990). Participants were selected so that
they varied maximally in terms of age and vaccination status. Of the five young women selected
to participate in this study, two had been vaccinated, two had declined vaccination, and one was
undecided about vaccination at the time of the initial interview. Participants ranged in age from
19 to 25, which was the widest range possible, given the pool of eligible participants. Although
efforts were made to recruit participants from a variety of locations, all of the young women who
participated in this study were students at the University of Western Ontario (UWO).
Ethics Procedures
In accordance with UWO’s Health Sciences Research Ethics Board, I applied for and
received ethics approval (Appendix C), and abided by the guidelines related to issues of
informed consent and confidentiality.
In particular, a letter of information (Appendix B) was used to provide participants with
detailed information about the purpose and procedures of the study. This letter also described the
possible benefits of participation and outlined potential risks. Furthermore, it described the steps
that would be taken to protect participants’ confidentiality and anonymity both during and after
the study. Once participants confirmed that they had read and understood the letter of
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information and had had their questions answered, they were asked to sign a consent form
(Appendix D).
Considerations related to the nature of face-to-face interviews were also addressed
throughout the data collection process. According to Lincoln and Guba (2003), “such highly
personal interactions create vulnerability as knower and known exchange roles, barter trust, and
reconstruct identities” (p.229). Given this vulnerability, it was vital to consider the importance of
creating a rapport with the research participants. Efforts were made to ensure that participants
felt comfortable sharing their stories and interacting with me. Throughout the data collection
process, I made a conscious effort to be aware of and manage my facial expressions and body
language and remained thoughtful about the language I used when speaking with my
participants. Prior to beginning the interviews, I established rapport with the young women by
engaging in casual conversations with them on topics like the weather, school, and current news
stories. Furthermore, since the structure of my interviews did not follow the traditional questionanswer format that is common in other types of qualitative studies, I anticipated some hesitation
and/or discomfort on the part of my interviewees. In order to avoid this issue, I took time to
explain the narrative approach of this study to participants before beginning the first interview. I
emphasized that I was interested in hearing their stories, as they chose to tell them. I explained
that, for this reason, I would not be asking direct questions until the second interview.
Participants were assured that there were no set expectations in terms of how they should tell
their stories and they were encouraged to speak freely and openly about their experiences.
Other ethical concerns related specifically to narrative research include issues of narrative
ownership and the multiplicity of narrative meaning (Smythe & Murray, 2000). Here the concern
is that participants’ stories can be interpreted by the researcher in ways that may or may not be
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consistent with how the participant experienced them. This may be problematic in that the
researcher’s analysis is inevitably taken as the most authoritative one (Smythe & Murray, 2000).
In order to address this concern I have made a commitment to ensure that in any presentation of
this data, both in this thesis and in any other publications, it is clearly stated that each narrative
was the product of a co-construction between myself and research participants. Furthermore, my
role in the interpretation of these co-constructed narratives will also be explicated.
Finally, since the topic under investigation was a vaccine for a sexually transmitted virus
associated with cervical cancer, I anticipated that participants might talk about other experiences
they have had with STIs or cancer, or that they may come to the interviews seeking information
about HPV and/or the vaccine. Given my critical point of view, my lack of counselling
experience, and my role as a researcher in this area, I did not feel that I was in a position to
provide guidance or support to participants who were seeking information or who required
professional counselling. Instead, I prepared a resource sheet (Appendix E) that could direct
interested participants to reputable online and community resources.
Data Collection Process
Each participant in this study was interviewed twice in order to collect stories about their
experiences related to HPV vaccination. Each interview was recorded with the use of a digital
recorder and interviews ranged in length from 30 to 60 minutes.
During the interviews, I engaged in minimal note taking so as to avoid distracting
participants. Immediately after each interview, I engaged in a process of self-debriefing, which
involved writing descriptive field notes about the interview both in terms of what was said and
how I felt about it. These notes had no set structure but often included descriptions of the
dynamics of the conversation, dominant phrases used by participants, new or repeating ideas, and
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comments regarding the interview as a whole. Contextual factors (e.g. time, location, setting,
moods, body language) and concepts or ideas that struck me as potentially insightful and/or in
need of further exploration were also documented. In these reflexive field notes, I also made note
of my own subjective processes such as ideas, hunches, or questions about the data. Writing field
notes not only helped me to keep track of the development of my project, but also helped me
take note of emergent themes and remain aware of how my thinking was being influenced by the
data. Ultimately, field notes written throughout the course of the study not only assisted me in
the data analysis process, but also allowed me to describe the research process in detail, and thus
strengthened the overall quality of the study.
In addition to the data collected from each interview, demographic information about
each participant was collected at the end of the first interview (Appendix F). Participants were
asked to indicate their year of birth, highest level of education attained, employment status, and
ethnic background. Because HPV is a sexually transmitted disease, participants were also asked
to indicate whether or not they were sexually active, and if so, the gender of their partner(s). This
information was used to help give context to the narratives and allowed me to create a
demographic profile of the study participants.
Between the first and second interviews, participants were asked to read and reflect on
their transcript from Interview 1. This was done so that in the second interview, participants
could clarify and/or elaborate on their stories if they felt it was necessary. At the end of the
second interview, participants received twenty dollars as a token of appreciation for sharing their
time and stories with me.
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Data Collection Method: Narrative Interviews
Narrative inquiry assumes that conversation is a fundamental aspect of human interaction
and that conversations are composed of many stories. For Owens (2007), the key feature of
narrative interviews is that the participant describes and accounts for their experiences: why they
interpret and interact with their world in a particular way and why they link past events to
present actions. In narrative research interviews, the interviewer encourages participants in the
unfolding of stories, assists them in the production of coherent stories, or asks directly for stories
(Kvale, 1996).
For the purposes of this study, I chose to follow Bertaux and Kohli’s (1984) suggestion
that narrative interviews should consist of two parts. The first part supports the interviewee in
providing an extensive narration during which time the interviewer restricts her or his comments
to brief probes that promote the flow of the narration. The second part involves purposeful
questioning (Bertaux & Kohli, 1984). Here the interviewer “actively engages” with the narrative
by seeking clarification on topics that may have been implied, and introducing topics that may
have been omitted (Rice & Ezzy, 2001, p. 124).
Interview 1.
In the first interview, my goal was to encourage participants to tell their personal stories
related to HPV vaccination. Only one, broad narrative inducing question was used to prompt the
participant’s storytelling. This question was phrased as follows to emphasize the unstructured
nature of the interview:
Can you, in as much detail as possible, tell me your story of how you came to be (or not
be) vaccinated against HPV? Feel free to start wherever you want and end wherever you
want- it’s completely up to you.
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The reader should note that although I was interested in learning more about the decision-making
experiences of these young women, I consciously chose not to use the terms “decision” or
“decision-making” in this opening question so as to enable the participants to talk about their
experiences in whatever way made sense to them. Throughout the interview, non-directional
probes (e.g., “O.K.”, “Can you give me an example?”, “Can you say more about that?”) were
used to encourage participants to elaborate on their stories.
Transcription and creation of personalized semi-structured interview guides.
Once each interview was complete, I listened to the recording and transcribed the data
verbatim. The purpose of transcribing the interview independently was to immerse myself in the
interview data. Each transcription was checked twice to ensure accuracy and a backup of the
transcripts was saved onto a password protected external hard drive.
During the process of transcribing each participant’s first interview, I wrote additional
reflexive field notes to document my thoughts, observations, and questions. These field notes, as
well as those written directly after the first interview, later guided me in the development of a
semi-structured interview guide for each participant, which was used in Interview 2.
To encourage participants to clarify and amplify stories that had been told in the first
interview, I developed open-ended questions that focused specifically on the stories that they
shared in Interview 1. By using my field notes and the transcripts from Interview 1 as guides, I
was able to ensure that the questions stayed as close as possible to the participants’ stories. For
example, a question I commonly used to encourage participants to elaborate on their stories was;
“You mentioned___when we last talked, can you tell me more about that?” The interview
guides were different for each participant with the exception of six questions at the end
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(specified under Interview 2). These more general questions were introduced at the end of the
second interview only after participants indicated that they had nothing more to add.
Sharing the data.
After the first interview was transcribed and annonymized, participants were given a
copy of the interview, and were asked read and reflect on it before they came in for the second
interview. Depending on the preference of the participant, the interview transcript was either
hand delivered or sent via e-mail. If the participant chose to have her transcript sent via e-mail,
she was asked to provide me with a password at the end of the first interview. This password was
used to password-protect the file and ensure confidentiality.
Consistent with a narrative approach, sharing the interview transcript with the participant
facilitated co-construction of the narrative product. By reading their transcripts, participants had
the opportunity to reflect on their stories and offer further insights or anecdotes during Interview
2. After having read their transcripts, some participants also chose to clarify parts of their stories
and/or add details that they felt were not articulated fully in Interview 1.
Interview 2.
The goal of the second interview was to pursue further participants’ stories about HPV
vaccination. These stories continued to be elicited using three approaches. First, since
participants had the opportunity to read and reflect on their transcripts from Interview 1, the
second interview began by my asking participants if they wanted to discuss any part of their
transcript in further detail. Once participants had the opportunity to comment on their transcripts,
I continued the interview by asking specific questions based on my multiple readings of their
transcripts. Although I used a semi-structured interview guide, I remained open to the directions
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suggested by the interviewee (Kvale, 1996). Once again probing questions were used for clarity
and depth.
As noted previously, six general questions were also asked at the end of the second
interview in order to learn more about how young women were conceptualizing their decision
making experiences around HPV vaccination. These questions were not necessarily related to the
content of their first interviews and resembled what McCracken (1988) calls planned prompts,
which are used to address topics of interest that may not have emerged through the interview
process. These questions were:
1. Since the last time we talked, have you talked to anyone or sought out information
about HPV or HPV vaccination? If so, from who/where? What did you think of the
information?
2. Has there ever been a time where you have had second thoughts about (not) being
vaccinated?
3. In thinking about the way in which you came to be/not be vaccinated, was your
experience the same or different compared to other times where you have had to
consider a health intervention?
4. Based on your experience, what would you tell someone who asked you for advice
about vaccination?
5. What do you think makes your experience unique compared to other women your
age?
6. In general, how easy or difficult would you say your experience has been?
Planned prompts were placed purposefully at the end of the second interview in order to
ensure that both interviews were directed primarily by the research participants.
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Approach to Reflexivity
According to Holloway and Freshwater (2007), reflexivity is a necessary element of
quality and assists in establishing the trustworthiness of the study. As Lieblich et.al (1998)
describe,
Working with narrative material requires dialogical listening (Bakhtin, 1981) to three
voices: The voice of narrator, as represented by the tape or the text; the theoretical
framework, which provides the concepts and tools for interpretation; and a reflexive
monitoring of the act of reading and interpretation, that is, self-awareness of the decision
process of drawing conclusions from the material (p.10).
As previously noted, in order to document my feelings and thoughts about the data, I kept a
reflexive field journal. These reflections were openly discussed with both my supervisor and
members of my advisory committee who questioned my assumptions, interpretations, and
analytic directions throughout the course of the study.
Overall, I found it easier to relate to the young women who chose to decline vaccination
because I could identify with elements of their stories that resonated with my own experience.
Conversely, the stories told by those who chose to be vaccinated were often very different from
my own experience and introduced me to new ways of thinking about the vaccine that I had not
previously considered.
Throughout the course of the study, I was conscious of the need to keep an open mind
and overall attitude of curiosity in order to avoid having my own assumptions and attitudes
dominate the research process. I endeavoured to keep the voice of the narrator central in the
interview process while at the same time acknowledging my own involvement in the co
construction of the narrative product. As a master’s student and researcher, my perspective and
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approach has not only been influenced by my own experiences and understandings, but also by
my educational background and interactions with my supervisor and other members of my
advisory committee.
As a young woman who has already declined vaccination, I was concerned that my own
experiences and attitudes may influence the structure and/or content of my participants’ stories.
As a researcher, I was particularly concerned with having my participants see me as either “pro
vaccine” or “anti-vaccine.” Specifically, I worried that if my participants knew that I do not
support the vaccine, some might feel pressured to defend their choices rather than tell me their
stories. For this reason, I chose not to disclose my own vaccination status to my research
participants unless I was asked directly. In order to keep the focus on the participants’ stories
rather than on my own, I actively worked towards having the interviews be guided by the
participants. By consciously keeping my focus on the narrator, I successfully avoided having to
describe my own decision-making experiences with any of my participants.
In terms of the analysis, while many narrative researchers advocate relatively naive, non
judgemental reading, and refrain from extensive theoretical interpretation, Lieblich et.al. (1998)
assert that “every reader is inevitably bringing her culture, language, experience and expectations
into her interactions with others or with texts” (p.76). As they describe, for this reason narrative
reading, “is not proposed as a “true” reading but as one possibility” (p. 77). The inevitable
involvement of the researcher at all levels of reading and analysis led Lieblich et.al (1998) to
introduce the concept of the “interpretive level” which speaks to how reading and interpreting
stories may vary in the extent to which theoretical understanding plays a role in interpretation.
As they describe,
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At one extreme is the phenomenological stand, which takes the report of the teller at face
value as a presentation of his or her life and world, and reads or listens to it naively, respecting
the explicit narrative as is. At the other extreme, we may come to understand a story armed with
a variety of theoretical assumptions (unknown to the interviewee of course). Such reading
suspects the teller’s presentation and is searching for silences, gaps, contradictions, symbols, and
other clues to the underlying or implicit contents that the interviewer is concealing often also
from him- or herself.. ..Various shades of interpretive levels can be characterized between these
two extreme poles (p.76)
Although I endeavoured to respect the subjectivity of my interviewees by keeping their voices
central throughout the data collection process, I understand and accept that my critical view,
educational background, and personal experiences inevitably influenced my reading of the
transcripts as well as my approach to co-creating and analyzing the narratives.
Analysis
Scholars from various disciplines have influenced the development of data analysis
procedures for narrative inquiry. Therefore, no set method for analyzing narrative interview data
has been established. Although McLeod and Balamoutsou (2001), advocate the view that
researchers should come up with their own data analysis methods, Priest et.al (2002) propose that
novice researchers should follow a set procedure. Given my interest in examining participants’
stories in relation to broader social contexts and discourses, I chose to adopt Lieblich et.al’s
(1998) holistic content approach which makes provisions for analyzing full stories holistically
and within their context. As Lieblich et.al (1998) describe, “the holistic approach is preferred
when the person as a whole, that is, his or her development to the current position is what the
study aims to explore” (p.12).
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Lieblich etal’s (1998) holistic content approach to examining participant data involves
analyzing the meaning of specific parts of the interview in light of content that emerges from the
rest of the interview. For Lieblich et.al (1998), the term ‘content’ refers to “the explicit content
of an account, namely what happened, or why, who participated in the event, and so on, all from
the standpoint of the teller” (p.12). This content oriented approach is also concerned with
exploring the implicit content of stories to examine the meaning that the story or parts of it
convey. By analyzing the stories people choose to tell and how they choose to tell them,
researchers are able to gain insight into what individual traits or motives are displayed, or what
certain aspects of the story symbolize for the narrator (Lieblich et.al., 1998).
The five step process for reading for content in a holistic manner includes: (a) reading the
raw data several times until a pattern emerges; (b) noting exceptions to the general pattern; (c)
deciding on and highlighting key themes; (d) reading separately for each key theme; and (e)
keeping track of distinctive features (i.e. contradictions, context, and transitions) of each theme
(Lieblich et.al., 1998). While Lieblich et.al (1998) have proposed what appears to be a very
straight forward, prescriptive method for analyzing narrative data, it is important to note that
qualitative research is always interpretive and subjective. Narrative analysis, like all forms of
qualitative analysis, is inevitably messy and non-linear. As Lieblich et.al, (1998) describe,
The work that is carried out is interpretive, and an interpretation is always personal,
partial and dynamic. Therefore narrative research is suitable for scholars who are, to a
certain degree, comfortable with ambiguity. They should be able to reach interpretive
conclusions- and change and re-change them, when necessary, with further readings.
(p-10)
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Through multiple readings of the transcripts, labelling, coding, re-coding, and reorganizing the
data, I was able to move from a large amount of data to a few key themes to describe how each
of these young women negotiated decisions about HPV vaccination. The specific methods used
to analyze the data collected in this study are outlined in the following two sections.
Analysis Phase One: Constructing the Narratives
Using Lieblich et.al’s (1998) five-step process as a guide, the first phase of data analysis
involved identifying key themes from both interviews with each participant. In order to identify
important themes from across the two interviews, I also developed a set of interpretive questions
which were applied to the raw data in order to begin constructing an overall narrative for each
participant. These questions helped me to engage with the data in a new way, transforming it into
narrative form. When reading each transcript, I asked myself the following questions:
1. What and/or who was talked about?
2. How did participants begin and end the interview?
3. How did each young woman talk about vaccination?
4. Was there any tension or ambivalence in their stories? How, if at all, did they
resolve this tension?
5. How did their stories evolve/change between the interviews?
These questions assisted me in developing a thorough narrative for each participant which was
grounded in their raw interview data. As the narratives were constructed, quotations were used
frequently to highlight how participants described their own experiences. These quotations were
chosen for a number of reasons. Among them was the belief that certain words or phrases
represent language that is commonly used by those in this age group. Many of the quotations
included in the individual narratives were also chosen to highlight words or expressions that
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participants used frequently throughout the interview process. Most importantly, quotations
served to distinguish my voice from the voices of the narrators. This was particularly important
in terms of drawing attention to words or phrases that carry specific value judgments or cultural
meanings (e.g. “sleep around,” “Google-ing”).
During the process of constructing the narratives, I also engaged in what Kvale (1996)
refers to as narrative finding and narrative creating. Narrative finding was accomplished by
looking for portions of the interviews that were, in essence, intact stories. Narrative creating, by
contrast, involved weaving together the un-storied aspects of interviews into the participant’s
narrative. This process resulted in the development of an overall narrative for each participant
which aimed to represent a holistic account of her experiences related to HPV vaccine decision
making. The completed narratives of each participant are presented in the following chapter so as
to share results of this analysis phase, as well as to allow the reader to become acquainted with
the experiences of each of the study participants.
Analysis Phase Two: Cross-Narrative Analysis
The second phase of analysis involved comparing participant narratives and identifying
cross-narrative themes. These themes were identified through close, repetitive readings of the
narratives, again guided by Lieblich et.al’s (1998) holistic-content approach. Furthermore,
participant narratives were interpreted in light of concepts such as medicalization, healthism, and
neo-medicalization, and were situated within broader social discourses. In particular, my analysis
of the narratives was informed by a strong sensitivity to dominant discourses related to health
risk and individual responsibility. As a graduate student, I became sensitized to these discourses
prior to beginning my research and was interested in how the narratives I collected reflected
and/or challenged these dominant ways of thinking. By examining participant narratives in
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relation to these discourses, my goal was to gain a deeper understanding of how individual
experiences may be located in and contingent upon larger social and discursive contexts.
Although the data analysis process for this study has been presented as having occurred
in two discrete phases, the process was, in reality, non-linear and iterative in nature. As Denzin
and Lincoln describe (1994) describe; “The processes of analysis, evaluation, and interpretation
are neither terminal nor mechanical. They are always emergent, unpredictable, and unfinished”
(p.479). In what follows, the specific criteria related to ensuring quality throughout the research
process are described.
Quality Criteria
According to Connelly and Clandinin (1990), standard quality criteria specific to
narrative research remain to be established. As they describe, “like other qualitative methods,
narrative relies on criteria other than validity, reliability, and generalizability” (p.7). The purpose
of the study was not to produce findings that could be generalizable to all young women, but
rather to provide detailed information about a small group of young women whose experiences
provide new insights into how decisions about HPV vaccination are made. As Zyzanski,
McWhinney, Blake, Crabtree, and Miller (1992) describe:
The qualitative researcher is not particularly bothered by a lack of generalizability. He or
she is under no illusion that his or her observations and interpretations necessarily apply
to other persons, events, or contexts. Rather he or she endeavours to construct as thick
and detailed description as possible of his or her particular setting and circumstances so
that others who encounter his or her description can determine its possible applicability to
their settings and circumstances, (p.245)

Young W om en’s Narratives 69

According to Lieblich et.al (1998), the quality of narrative (and other qualitative studies)
should be evaluated using different criteria than those designed for consideration in quantitative
studies. As they describe, criteria such as reliability, validity, objectivity, and replicability
“contradict the very nature of the narrative approach which, starting from an interpretive
viewpoint, asserts that narrative materials- like reality itself- can be read, understood and
analyzed in extremely diverse ways” (p. 171). Given that the interpretive paradigm in which
narrative studies are based assumes that reality is “multiple and constructed rather than singular
and tangible” (Sandelowski, 1993, p.2), Lieblich et.al (1998) assert that “reaching alternative
narrative accounts is by no means an indication of inadequate scholarship but a manifestation of
the wealth of such material and the range of sensitivities of different readers” (p. 171).
In order to address the unique characteristics of narrative research, I have chosen to focus
my attention on two criteria proposed by Lieblich et.al (1998) for the evaluation of narrative
studies in particular. These criteria include width (the comprehensiveness of evidence) and
coherence (how parts fit together). In addition to these criteria, I also considered Mishler’s
(1990) criteria of trustworthiness and Clandinin and Connelly’s (2000) notion of wakefulness. In
what follows, I describe each of these criteria in further detail and discuss how each was
addressed throughout the study.
Width
The criterion of width refers to the comprehensiveness of the evidence in a narrative
study. According to Lieblich et. al (1998), width refers to both the quality of the interview data
as well as to the proposed interpretation or analysis. In this study, each interview yielded a
significant amount of data. Young women were encouraged to speak freely and openly and no
time limits were established in terms of the length of the interviews. Once the data were
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collected, analysis occurred in two stages. By analyzing the data in more than one stage, I gained
a greater understanding of participant stories and was able to report my findings in a more
comprehensive manner.
The reader should also note that all interview data were transcribed verbatim according to
pre-established transcription coding guidelines (Appendix G ) to ensure that interview transcripts
were complete and accurate. In order to enhance the quality of the narratives, members of my
advisory committee had access to de-identified transcripts from my first two interviews and were
thus able to provide me with feedback regarding both the structure and content of the first two
narratives. Advisory committee members also had access to the completed narratives of the last
three participants and provided feedback regarding their content and organization as well. As
suggested by Lieblich et.al (1998), I used numerous quotations in the construction of the
individual narratives. This approach to width allows readers to make their own judgements about
the evidence and its interpretation.
Coherence
As Lieblich et.al (1998) describe, coherence refers to “the way different parts of the
interpretation create a complete and meaningful picture” (p.173). For these authors, coherence
can be evaluated both internally, in terms of how the parts fit together, and externally, in relation
to existing theories and previous research.
In terms of this study, one of my primary concerns was ensuring that participant
narratives were coherent and reflective of the stories that participants shared with me during the
interviews. To ensure coherence in the participants’ narratives, I sought and received feedback
from my advisory committee regarding both the content and structure of the narratives. In terms
of evaluating the coherence of the data in relation to existing theories and previous research, I
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did so by conducting an extensive literature review in which previous studies related to young
women’s decision-making experiences were examined. Many of the themes that emerged from
my study were consistent with those found in previous studies while others provided new
insights.
Trustworthiness
According to Mishler (1990), trustworthiness refers to the evaluation of study findings by
a community of researchers. Mishler (1990) argues that “focusing on trustworthiness rather than
truth displaces validation from its traditional location in a presumably objective, non-reactive,
and neutral reality and moves it to the social world” (p.420). Here, the issue is whether the
relevant community of researchers can rely on a particular set of reported findings for their own
work. For Mishler (1990), central to this process is “the task of articulating and clarifying the
features and methods of our studies, of showing how the work is done and what problems
become accessible to study” (p. 423). As Lieblich et.al (1998) note, interpretive decisions
require justification; “While traditional research methods provide researchers with systematic
inferential processes, usually based on statistics, narrative work requires self-awareness and self
discipline in the ongoing examination of text against interpretation and vice versa” (p. 10)
Given the emergent nature of qualitative research designs, documentation in the form of a
written audit trail is especially important for documenting the methods used in a study. As
previously described, field notes were used throughout this study to document both
methodological decisions and data analysis procedures as well my own reflections regarding the
research process. These field notes ultimately became part of the overall data set.
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Wakefulness
Related to Mishler’s (1990) criterion of trustworthiness is Clandinin and Connelly’s
(2000) notion of “wakefulness.” For Clandinin and Connelly (2000), wakefulness refers to a
researcher’s ability to remain alert throughout the research process and aware of all of his or her
research decisions. The notion of wakefulness is similarly conveyed by Lieblich et.al (1998) who
propose that narrative quality criteria should not focus on the “truth-value” of narrative studies,
but rather on “a process of consensual validation- namely the sharing of one’s views and
conclusions and making sense in the eyes of a community of researchers, and interested,
informed individuals” (p.173). In this study, wakefulness was achieved thanks to ongoing and
candid discussions with my advisory committee during which my thoughts and decisions were
questioned and challenged throughout the research process.
Conclusion
In sum, narrative inquiry allows researchers to gain insight into the experiences of others
and present them in narrative form while preserving the richness and complexity of the
experiences as they were narrated. Using this approach allowed me to focus on the stories of five
young women who had made or who were currently making decisions regarding HPV
vaccination. Analysis of the participants’ stories allowed for unexplored contexts and factors to
be identified and examined and provided me with the opportunity to leam more about the unique
experiences of each of my participants.
In this chapter, I have provided details about the methodological approach that guided
this study and the specific methods used in the collection and analysis of participant data. In the
following chapter, I present the findings from my first level of analysis, which yielded individual
narratives for each of the study participants.
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Chapter Four: Narratives of HPV Vaccine Decision-making
At the heart of this chapter are the individual narratives of Allison, Katie, Paige, Ana, and
Kristin- the five young women who were interviewed as part of this study. Each of the narratives
presented below provides not only a description of the stories that these young women told about
their experiences with HPV vaccination, but also represents my first level of analysis which
involved moving from the raw interview data to a coherent narrative for each young woman. All
five individual narratives are presented here in order to provide readers with the necessary
background needed to appreciate the cross-narrative themes and conceptual interpretations
presented in the subsequent chapter of this thesis.
Format of the Narratives
In order to give the reader some background information about the participants, each
narrative begins by noting the participant’s age, education, ethnicity, vaccination status and
whether or not they identified as being sexually active. This information was gleaned from the
demographic survey completed by the participants at the end of the first interview. At the
beginning of each narrative, I have also included my own reflections regarding the interview in
order to provide the reader with additional information to help set the scene for the narratives.
Throughout the narratives, many words and phrases have been placed in quotation marks
to indicate material that was taken verbatim from the interview transcripts. The presence of
numerous quotations in these narratives reflects the extent to which I have endeavoured to keep
participant narratives as close to the raw data as possible. Uppercase letters have been used in the
narratives to indicate emphasis on specific words as narrated by the participants.
Finally, the order in which the narratives are presented aims to draw the reader’s attention
to the range of decision-making experiences evident across participants. The narratives illustrate
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where the participants were in their decision-making process at the time of the interviews, and
have been arranged to show a progression in decision-making certainty from the first participant
to the last. Table 1 summarizes the demographic information of each participant and the
dominant themes that characterize their narratives.
Table 1: Participant Overview
Pseudonym/
Vaccination
Status
Allison
Undecided

Katie
Vaccinated

Paige
Vaccinated

Ana
Not
Vaccinated
Kristin
Not
Vaccinated

Demographic
Information

Narrative Themes

Age: 19
Occupation:
Student
Ethnicity: White
Sexually Active?:
No
Age: 19
Occupation:
Student
Ethnicity: White
Sexually Active?:
Yes
Age: 22
Occupation:
Student
Ethnicity:
Chinese
Sexually Active?:
Yes
Age: 25
Occupation:
Student
Ethnicity: White
Sexually Active?:
Yes
Age: 24
Occupation:
Student
Ethnicity: White
Sexually Active?:
Yes

•
•
•
•

(Not) Knowing About HPV or the HPV Vaccine
Waiting for a Reason
Finding Information
Re-thinking Vaccination

•
•
•
•

Listening to ‘Dr.Mom’
Reacting to the ‘C’ Word
Spreading the Word
Accepting a Harmless (but painful) Needle

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Maintaining Silence About Sex
Overcoming the Communication Barrier
Staying Safe
Trusting in Vaccines
Trusting in Family and Friends
Doing the Right (and easy) Thing
Hearing About a Non-Essential Vaccine
Not Putting Foreign Things into her Body
Trusting Information Sources
Struggling to Claim Authority
Acknowledging the Tension
Defending her Decision
(Not) Talking About Sexual Health
Waiting for More Evidence
Protecting her Reproductive Health
Being Responsible for her Sexual Health
Weighing, Personalizing, and Accepting Risks
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Allison
Allison is a 19-year-old woman who was undecided about vaccination at the time of the
interviews. On the demographic questionnaire, she identified her ethnic background as “White”
and indicated that she is “not sexually active.” At the time of the interviews, Allison was enrolled
in her first year of a Bachelor of Arts program at UWO.
Investigator’s Reflections
Both of Allison’s interviews were very short. At our first meeting, I found out that
Allison’s main motivation for participating in the study was to gather more information about the
vaccine. Although she indicated during our phone conversation that she knew about the vaccine
and was currently considering vaccination, it was obvious in her first interview that she did not
have a clear understanding of what HPV was or what the vaccine was for. Throughout the first
interview, Allison asked questions about both the virus and the vaccine and seemed somewhat
disappointed that I was not able to give her all of the information she was seeking. I provided
only basic information regarding the virus and the vaccine, then provided her with a resource
sheet which she could use to gather more information.
Allison’s second interview was much more conversational since Allison had talked to a
friend about the vaccine and wanted to share with me what she had learned. Between the first
and the second interviews, Allison also indicated that she had looked at a few of the websites
listed on the resource sheet, but noted that talking to her friend was much more informative.
Although Allison was very friendly and seemed comfortable speaking with me, she
remained somewhat guarded in her interviews and did not provide much detail about her
experiences unless probed. At the time of the interviews, Allison indicated that she was not
sexually active; however, whether or not Allison has ever been sexually active was never
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disclosed throughout the interviews, nor were her underlying reasons for seeking information
about the vaccine.
Allison’s Narrative Themes
Allison’s narrative has been organized into four themes that reflect the evolving nature of
her narrative over the course of two interviews. These themes are presented below.
(Not) knowing about HPV or the vaccine.
At the beginning of her first interview when asked to tell her story, Allison began by
saying, “there’s not much to say.” Allison felt as though she would not be able to talk “for that
long” because she herself had not been vaccinated, nor did she “know anyone” who had been
vaccinated. According to Allison, none of her friends have had “trouble” with “STDs” or other
“really bad stuff’ so a lot of them “don’t know” much about the vaccine in terms of “how to get
vaccinated.” Personally, Allison admitted that she did not “know much about HPV in general.”
As she described during her first interview, “I don’t even really know what it is today.”
Allison also noted that, because she and her friends are uninformed, the vaccine “doesn’t
really come up in conversation too often” when they are together. According to Allison, the
reason that the vaccine is “not a common topic to talk about to friends” is because of a general
lack of “awareness” about the vaccine. As she described, “no one I know talks about it.”
According to Allison, “not a lot of people know about it” because “it's not really out there right
now.” In her experience, Allison said that she “saw maybe one or two commercials on TV- if
that. No posters, no advertisements.” For this reason, Allison asserted that “they need more
exposure for sure.”
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Waitingfor a reason.
Allison first heard about the vaccine through a “TV commercial.” As she described, she
“didn’t really understand it” but knew that it was for “some sort of disease or sickness.” At the
time, she says that she did not talk to anyone about it because she “wasn’t too curious back then”
and felt as though it did not really “affect” her life and “still doesn’t.” For Allison, this is because
she “doesn’t have a boyfriend” and therefore feels as though she does not have “a really big
chance of getting it [HPV].” In Allison’s view, the vaccine is not for “single” people like her. As
she described, “it's only pretty much if you have a boyfriend- or maybe you don’t have a
boyfriend, but if you sleep around and you’re not safe about it.” According to Allison, HPV is
“more of a risk” to those with boyfriends, so if a friend (who had a boyfriend) asked for her
advice, she said that she would tell them to “think about it or just research it.” For Allison, the
reason the vaccine has not been “on her mind” is because she does not “plan on getting a
boyfriend anytime soon” and she does not “sleep with random people.” Conversely, Allison
noted that “if’ she had a boyfriend, the vaccine would probably “apply more” to her life and she
may be more “inclined to get it.” At the time of the first interview however, Allison seemed
confident that the vaccine was not for her. As she described, “I just don’t think that it's important
in my life right now- at least not at this moment.”
In her first interview, Allison also noted that she does not usually get vaccines unless she
is “pretty much forced to.” According to Allison, vaccines are not something she is usually
interested in. As she described, “I don’t see a reason to get vaccines...like the flu-1 never got the
swine flu vaccination...! guess I take a risk that way....I don’t really see a need to go out of my
way to get one, I guess.”
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Finding information.
In her first interview, Allison noted that what “drew her to the study in the first place”
was her desire to “find out information” about the vaccine. As she described, “I’m just trying to
find more information for me and my friends so I can make an informed decision, I guess, of
whether to get it or not.” According to Allison, finding out as much information as possible is
important because “you can never be too safe!” In reference to the vaccine, Allison asserted that
“people should be more aware of it- both the cons and the pros” so that they can “get both sides
of the story” and “make an educated decision.”
Given that Allison’s goal was to obtain more information about the vaccine, I provided
her with a resource sheet of web links at the end of the first interview. During the second
interview, Allison noted that she had looked at a “few” websites and found them to be “very
informative.” As she described, “they were very professional sites-1 liked that...I could trust the
information.”
In addition to using the resource sheet, Allison also spoke to a friend about the vaccine
between the first and second interviews. In talking to her friend, Allison found out some “new
information” about the virus and about the vaccine. As she recounted, her friend “never got
Gardasil ...so she ended up getting genital warts and then had seven treatments and one
surgery...now it’s gone...she’s still planning on getting the vaccine... I guess to prevent from
other strains.” She also noted that her friends’ health insurance “covered a lot of it” but was told
that the vaccine was “very expensive.” Allison hypothesized that perhaps the high cost of the
vaccine explains why some people “don’t rush to get it first off.”
Overall, Allison said that she “learned more” from her friend than from the websites she
visited. This was because she was able to get a “first-hand experience” of “just genital warts”
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instead of cancer in general. For Allison, having a friend speak to her directly made her “more
aware of it” so that she could “spread the word” to her family and others.
Re-thinking vaccination.
After participating in the first interview, reviewing some websites, and talking to her
friend, Allison began to think differently about the vaccine. At the time of the second interview,
Allison described herself as being “more open to the vaccine.” According to Allison, this
decision to re-think the vaccine was due in large part to having spoken to her friend. As she
described, her friend “really urged” her to get the vaccine to avoid the “terrible,” “hard” and
“painful” experience she went through. According to Allison, her friend’s story “really hit home”
since she considers her friend’s “word” to be “really influential” in her life. As Allison described
at the end of the second interview, “I’m actually more swayed to get it now.” The interview itself
also seemed to have an effect on Allison’s changing views about the vaccine. As Allison
described, “If I hadn’t done the study or hadn’t heard the story [from my friend], I probably
would never even have thought about getting it [the vaccine].”
Katie
Katie is a 19-year-old woman who has been vaccinated against HPV. On the
demographic questionnaire, Katie described her ethnic background as “White” and indicated that
she is “sexually active” with “male” partner(s). At the time of the interviews, Katie was enrolled
in her first year of a Bachelor of Science program at UWO.
Investigator’s Reflections
Throughout both interviews, Katie was very open and candid with me about her
experiences. It was clear in speaking with her that she was thinking aloud through interviews. As
a result, her transcript included many of her own reflections, often in the form of half-thoughts
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and disjointed ideas. From the first to the second interviews, I noticed that Katie went from
talking about the vaccine as something routine and necessary, to something that she may not
have needed after all.
Over the course of both interviews, Katie never spoke about her specific reasons for
participating in the study so it is unclear what her motivations were for participating. However,
when I mentioned the $20 reimbursement, Katie noted that she had totally forgotten reading
about it in the information letter. Thus, I do not think the financial incentive was what prompted
her to participate. At the end of the second interview, Katie asked questions regarding how the
study results would be presented and commented that it was “fun” to be part of my study.
Katie’s Narrative Themes
Katie’s narrative has been organized according to four main themes that emerged from
her interviews. These themes are presented below.
Listening to “Dr. Mom. ”
Katie began her first interview by drawing attention to the fact that her mother “is a
doctor.” As Katie described, although both her “mom and dad” are doctors, it was her mother
who told her “you have to get this [the HPV vaccine] when it comes out.” Although Katie had
“seen commercials” about the vaccine, she described being “confused a little bit by them”
because she had “never heard of HPV before.” According to Katie, she “didn’t really pay
attention” to the commercials until her mom approached her about the vaccine. Only then, did
Katie “put two and two together” and realized that the commercials were about a new vaccine to
protect against cervical cancer. It was not long after her mom told her about the vaccine that
Katie went in to her mom’s office to be vaccinated. As she described, “there wasn’t much time to
dwell on my decision of getting it...it was like I decided to get it and I got it at the same time.”

Y oung W om en’s Narratives 81

For Katie, her experience was unique compared to others who “would have had a time period
between deciding to get it and thinking about it before they actually got it.”
In her first interview, Katie talked at length about her parents’ influence when it comes to
healthcare interventions. As she described, “if it’s important that I need to have it, then they’re
gonna want me to get it., .so basically I just follow their advice.” According to Katie, “when it
comes to vaccines” her parents often “hear about it before it hits the media” since they are in the
“medical community” so they end up informing her about anything she needs. For Katie, the fact
that her parents are doctors played a big role in how quickly she found out about the vaccine. As
she described, “if my mom wouldn’t have been a doctor or my dad would not have been...I
probably wouldn’t have known about it or gotten it as fast as I did... I would have less awareness
of any type of vaccination in general.” Other than “birth control” and “physicals” which she
takes care of and plans herself, Katie noted that it is usually “parents first” when it comes to
deciding which health interventions are necessary. According to Katie, she does not usually “ask
questions” when her parents tell her which vaccines to take. As she described, "I get all the
shots...they just tell me and I just get them.” Katie noted that the only reason she does ask
questions sometimes is because she does not like getting needles. Ultimately, Katie said she
usually only asks, “why am I getting this?” to avoid any unnecessary needles. As she described,
“if I really don’t have to get it, I’m gonna try not to get it.”
According to Katie, the reason her mom approached her was because she was the one
who would be giving her the shots. Although Katie could not remember talking to her dad about
the vaccine, she noted that her father would not “be against” talking to her about it if she ever
“had any questions.” She very clearly stated that she was not “preferencing” her mom’s advice in
any way. In her second interview, Katie noted that one reason her mom might have approached
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her about the vaccine was because it “was more so to do with HPV” and “the cervix” which she
described as a “female part.” Katie also noted that her mom is “the organizer” and the “boss
lady” in their family, the one who keeps everyone “on track with staying healthy.” Since her
mother had access to the vaccine as a physician, she told Katie “you’ll get this. I’ll order it.” As
Katie described, her mother’s description of the vaccine and what it did was very
straightforward. Essentially, her mother told her “there’s this vaccine out. It protects against
cervical cancer and you need to get it.” Katie agreed, saying, “o.k... I don’t want cervical
cancer.”
Reacting to the “c-word. ’’
Before seeing “commercials” about the HPV vaccine on television, Katie had “no idea”
what HPV was. As she described:
when I saw all those commercials I thought that meant that there was this big outbreak of
cervical cancer...it had never come up really before...I hadn’t really heard of anything
about cervical cancer, so when the vaccine came out, I thought that meant ‘oh everybody
is getting cervical cancer’...that that meant we were at-risk.
According to Katie, part of the reason she agreed to get the vaccine was “because it was
associated with the word ‘cancer’.” As she described, “to me, cancer is like the BIG
disease...I’ve had a lot of people in my family have cancer...I don’t want cancer.” Overall, Katie
said that in terms of the vaccine, she “didn’t really know that much about it” before being
vaccinated and that she found out more about it “after.” Despite her lack of knowledge about the
vaccine at the time, she said that she and her friends felt that it was important for them to be
vaccinated. As she describes, “we knew we needed to get it.”
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According to Katie, even though all of her friends “basically kind of knew” that the
vaccine protected against cervical cancer, some were not sure if they should get it. As she
described, conversations about the vaccine “started a whole little frenzy” in her social group.
When others asked for her advice about the vaccine, Katie’s response was to tell her friends that
they “should get it” since it “protects against cervical cancer.” For Katie, using the word
“cancer” was “key” because “when anyone hears the word ‘cancer’ they immediately listen.”
In her second interview, Katie realized that her assumption that there was an “epidemic”
of cervical cancer was not, in fact, reflective of the reality of the situation. As a result, she noted
that the advice she would give to her friends now has changed. As she described, “I’m not sure if
I would be as gung-ho like ‘get it!”’ ...I don’t know if I would be like before as when I thought
everybody needed it- cervical cancer is everywhere!”
Spreading the word.
As previously mentioned, a large part of Katie’s narrative centred on her ability to
“spread the word” about the vaccine and answer questions from her friends. As Katie described,
“a lot of people ask me questions [about medical issues] ‘cause my parents are doctors.”
According to Katie, one reason her friends asked her questions about this vaccine in particular
was because they knew she had already been vaccinated. As she noted, “by the time I had
already got it, they were more just finding out about it.” In terms of specific questions, Katie said
that some of her friends were concerned about taking the vaccine if they had “already had sex.”
She talked about how one of her friends thought she was “doomed for cervical cancer” since she
was already sexually active and had not been vaccinated. Katie noted that she would often refer
her friends to her mom if they had any questions about the vaccine.
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According to Katie, her friends often approached her mom about the vaccine after talking
to her. Again, Katie said that her friends did not really ask “what it did” but instead just “should I
get it?” Her mom’s response was “yes.” As Katie described, most of her friends were already
planning on getting the vaccine “before” they talked to her mom, but they just “wanted
reassurance” that it was the right choice. According to Katie, “a lot” of her friends ended up
getting the vaccine from her mom.
Having her friends consult her mom for medical advice was not new for Katie. As she
described, many of her friends often ask for her mom’s advice about “birth control” and
“different kinds of birth control.” According to Katie, the reason her friends often speak with her
mom is because she is “approachable” and “not judgemental.” As she described, “people don’t
feel uncomfortable approaching her with stuff that’s personal.” Furthermore, Katie said her
friends trust her mom’s advice because, as a doctor, she is “informed” and because she gives
them the same advice that she gives her own daughter.
Accepting a harmless (butpainful) needle.
One of the biggest challenges for Katie with regard to the vaccine was her fear of
needles. As she described, “I’m bad with needles-you have no idea...it always hurts more cause
I’m so tense so it’s just a bad experience.” When asked if her fear had ever prevented her from
being vaccinated against anything, Katie said that the only thing she tries to “prolong” is the
annual flu shot. As she described, “some years my mom will be like ‘o.k... it’s time to get the flu
shot’ and if something comes up and she kinda forgets about it, then I don’t have to get it.” Apart
from the flu shot, Katie also noted that she sometimes refuses to get blood drawn for routine tests
if she feels as though a needle is unnecessary. As she described, “when they ask if I want blood
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drawn to test for like HIV and stuff like that, I always just say no because I know I haven’t beenor I personally think I’ve never been exposed to those things.”
Despite her fear of needles, Katie agreed to be vaccinated against HPV because she “saw
no disadvantages to getting it.” For Katie, the fact that she had not heard of any “negative” side
effects from the vaccine meant that there was “no harm” in getting it. According to Katie, the
HPV vaccine is “really important for women to get” for a number of reasons. As she described:
I think it’s more men put pressure on women to have un-safe sex so I think they’re more
at risk to get something like that and I think women don’t check out ‘down there’ in the
same way that guys are aware of what’s going on down there...I think it’s important for
people who don’t stay in awareness of what’s going on with their body- to be protected in
case something happened...or in case they were exposed to something.
Katie also noted that since the vaccine was being offered “at schools” she came to see it as
“pretty generic.” Furthermore, since she was also getting a few other needles around the same
time, Katie described feeling “desensitized” when she had her first Gardasil™ shot. As she
described, “they all became unimportant” and it was just a “‘one more’ kind of thing at the
time.”
Personally, Katie said that she “didn’t have any side effects” from the vaccine and feels
as though she has “been safe” since getting it. Katie seems to trust in the vaccine and noted that
although she has not been in a “situation” where she could say that it “worked,” she is “sure” that
if she was in a “situation” that she would be “all right.” Since being vaccinated, Katie said that
the vaccine has been “outta sight, outta mind” since she does not like to think about needles.
In her second interview, Katie’s thoughts on the vaccine seemed to change slightly. As
she described, the interview itself made her “reflect” on her experience and come to the
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realization that the HPV vaccine may have been “one extra needle” that she “probably didn’t
need.” After thinking more about the vaccine through the interview process, Katie felt as though
she “coulda been fine without out it” since she “wouldn’t be having unprotected sex anyway.”
As Katie described, “I think that it’ll never have to come into play to protect me ‘cause I’ll never
get an STD.” Interestingly, Katie noted that part of the reason she felt as though an STD would
never affect her is that she has “never met anyone who had one” so to her they are “kind of like a
mythical thing!”
Paige
Paige is a 22-year-old young woman who has been vaccinated against HPV. On the
demographic questionnaire, Paige described her ethnic background as “Chinese” and indicated
that she is “sexually active” with “male” partner(s). At the time of the interviews, Paige was
enrolled in her fifth year of a Bachelor of Health Sciences program at UWO.
Investigator’s Reflections
Paige was the first participant I interviewed. Although I had conducted qualitative
interviews before, I was still very nervous about meeting her for my study. Because of this
nervousness, I did not take enough time to speak with Paige informally before starting the first
interview and this in turn affected our rapport. The first interview was very awkward in the
beginning and was characterized by many long silences. Paige seemed uneasy with the
completely open-ended structure of the interview and I found myself having to probe her
extensively for details.
In some ways, Paige used the first interview as an opportunity to ask for information
and/or confirm her understandings about the vaccine with me. Because I was very self-conscious
about not wanting to provide participants with too much information, I answered Paige’s
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questions only vaguely in order to avoid engaging in a conversation about the details of the
vaccine. Looking back, my unwillingness to engage Paige in dialogue about the vaccine may
have added to her discomfort during this first interview.
By the end of the first interview, Paige seemed more at ease with me, particularly once
the recorder was turned off. By then, she and I had established a better rapport by talking about
our common backgrounds as health sciences students. Although Paige never explicitly described
her reasons for participating in my study, I had the impression that it may have been, in part,
because she was interested in pursuing graduate studies and wanted to know more about what
was involved. At the end of the first interview, Paige asked questions not only about my
program, but also about how I chose my supervisor and whether I was enjoying graduate school.
She seemed very grateful for the information I provided her and ended our conversation by
saying that she was looking forward to talking with me again.
My second meeting with Paige was much more relaxed and the interview took on a much
more conversational tone. At this point, we had both reviewed and reflected on her first
transcript and were able to explore her stories in greater depth.
Paige’s Narrative Themes
Paige’s narrative is presented below according to six main themes that emerged from her
interviews.
Maintaining silence about sex.
Paige began her vaccination story by stating that she “started being sexually active in first
year” and that she did not really know if her parents were “aware or not.” Although she had
heard of the vaccine “partially through class” and remembered “seeing commercials about it,” it
was not until her mom “suggested it,” and told her that she should “just do it,” that she decided
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to “think about it more.” Paige assumed that her mom probably heard about the vaccine “through
the news” since she “reads the paper a lot and watches TV a lot.”
Although she did not remember all the details of her conversation with her mother, Paige
described it as being “very casual” and said that she felt that her mom had “approached it in a
good manner.” Paige noted that she was “very surprised” and “pleasantly shocked” that her mom
decided to talk to her about the vaccine since the vaccine “isn’t sexual but it has sexual
connotations.” Paige thought that it was “so odd” that her mom approached her about the vaccine
because she had never talked to her about anything “remotely sexual in nature” and had never
really had “the [sex] talk” with her before. Paige said this was because her mom is “just really
uncomfortable and would rather deny that any sort of activity like that exists” for her or her
brother. According to Paige, her parents “naively thought” that if they did not talk about “it
[sex]”, then they could “just easily assume” that she was their “little angel” and that it would not
have even crossed her mind.
Comparing herself to her peers whose parents may teach their kids about “certain kinds
of behaviours that are deemed acceptable or not acceptable at a certain age," Paige said her
parents never really gave her “those specific guidelines.” According to Paige, although her
parents did not give her specific guidelines, she knew that “BECAUSE they didn’t talk about
it...” then she “...obviously wasn’t ALLOWED to [have sex].”
Overcoming the communication barrier.
Paige described having her mom approach her about the vaccine as “interesting” because,
despite the fact that her mom is “uncomfortable with talking about that kind of stuff,” she was
“willing to discuss this.” Paige felt that being able to talk about the vaccine was important
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because it meant that her mom’s concerns for her health and well-being “helped her overcome”
the “barrier” of “it [sex]” being uncomfortable to talk about.
Although Paige said that both her parents obviously “have a vested interest” in her health,
she described her mom’s involvement in her getting the vaccine as “very crucial” and noted that
if her mom had not approached her about the vaccine, she “probably wouldn’t have gotten it.”
She also pointed out that her dad never talked to her “directly” about the vaccine even though he
is a pharmacist and she usually talks to him about “any sort of health related issue.” According to
Paige, the reason she talked to her mom this time might have been because she and her mom are
“a little bit closer” and her dad might have thought talking about the vaccine was “even more
awkward” than her mom thought it was (due to its sexual connotations).
Paige could not remember if her mom “said specifically why” she should look into
getting the vaccine but figured that she would not have said “anything to do with sexual
transmission or anything.” She described herself as “kinda curious” when it came to what her
mom’s “thoughts are on it” and wondered if “she knows” that her daughter is sexually active or
if she just sees the vaccine as an “extra precaution.”
Managing her relationship with her mother around sexuality is very important to Paige.
Since she “wasn’t really sure” if her mom knew that she was sexually active or not, she “just
didn’t feel comfortable” talking to her mom about the vaccine first. Paige felt that if she “pushed
her first” then her mom would have just “naturally assumed” that she was sexually active. For
Paige, the consequences of having her mom find out that she was sexually active were unknown“who knows what would have happened after that!” For this reason, Paige said it was “definitely
easier” that her mom had approached her about the vaccine first.
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Staying safe.
After being vaccinated, Paige said she felt “somewhat safer” in terms of her “risk” or
“chances” of getting cervical cancer. She noted that she is “already taking steps” to “ensure” her
“sexual health” and mentioned “condoms” and “birth control” as examples of how she likes to
“stay on the safer side of things.” For Paige, the “consequences” of cervical cancer can be “pretty
drastic” so when she found out it was possible to prevent it, she was “pretty intrigued.” She saw
the HPV vaccine as “just a great extra measure to take if you can” and said that it’s “better to be
safe than sorry” when it comes to vaccination.
In terms of her decision to be vaccinated, Paige said that she thought she “may as well”
get it the vaccine so that she would “not have to worry about it [cervical cancer].” For Paige, the
vaccine allowed her to have decreased anxiety about getting HPV or cervical cancer. As she
described, if she happens to “engage in sexual activity with a guy who has those viruses”, then
she would still be “kind of freaking out” but “not nearly as much” as if she had not gotten the
vaccine. In that case, Paige said that she will know that her “chances of actually contracting
cervical cancer are less.”
When asked how she would respond to a friend seeking advice on the vaccine, Paige
once again focused on the vaccine as a great safety measure. She said that she would tell her
friend that she thinks “it's great” and a “good idea” and just an extra “safety measure- an extra
barrier to keep you safe.”
Trusting in vaccines.
Ultimately, Paige explained that she felt safer because she “believes” and “trusts” in
“what the vaccine is supposed to accomplish.” Paige said that she has “always been one to trust
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in vaccines” and that she has not “really had any reason not to” since she has “never had a bad
experience with any of them or anything.”
Paige said that she was “pretty certain” that the vaccine was safe, effective and “wouldn’t
have any harmful-adverse effects or anything” because she guessed that “most vaccines” usually
“go through rigorous testing.” She also said that she did not do “much” research prior to
receiving the vaccine and instead was “relying” on the fact that she “believes” “most vaccines”
are “safe and effective.”
Interestingly, in the second interview, Paige seemed less trustful of vaccines, particularly
the new H1N1 vaccine. For Paige, thinking about the H1N1 vaccine “jogged” her thinking about
the HPV vaccine since “it was still relatively new” when she got it as well. For this reason, she
described new concerns that the HPV vaccine might not have been around “long enough to
determine what possible long-term complications may arise 10, 20, 30 years down the road.”
Despite these new concerns, Paige said that she has not “regretted” being vaccinated against
HPV.
Trusting infamily andfriends.
According to Paige, her parents have always been involved in helping her make
“informed decisions.” She described them as “pretty concerned” about her health and identified
their influence on her decision to be vaccinated as something that made her story “unique.” The
fact that her mom approached her first about the vaccine was central to Paige’s experience since
she “probably wouldn’t have gotten it [the vaccine]” otherwise.
In her first interview, Paige described how her mom usually tells her about “stuff on the
news” because she often does not hear about things since she lives in the “Western bubble” (an
expression commonly used by UWO students to connote the sheltered nature of campus life).
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Because her mom knew more than she did about the vaccine, Paige trusted her mother’s
suggestion immediately. As she described, when her mom approached her about the vaccine, her
response was “o.k... sure.”
Paige also described a conversation with a “friend” which she says “definitely pushed”
her to get the vaccine. When her friend reassured her that the vaccine was “fine” and “not a big
deal,” her response was “o.k... I believe you.” For Paige, having someone “who has gone
through something then they’re totally fine” gave her “confirmation” that the vaccine was
“reliable and safe.”
In the second interview, Paige reflected on how she “put a lot of faith” in “family and
friends as resources.” Paige found it “somewhat interesting” that she “didn’t conduct much
research on the vaccine” herself and instead “just went along with the opinions of others.” As
Paige described, she “just wanted to get it [the vaccine]” because her mom and friend had both
given her “positive evaluations of it.”
When asked if she usually relies on family and friends in her health care decision
making, Paige noted that she generally does “fall back on” her family and friends when it comes
to things that she is “not really knowledgeable about.” Paige’s approach to decision-making was
apparent in her discussion of the H1N1 vaccine. Here, Paige described her parents as “very proH1N1” and said that they really wanted her to get the vaccine. Once again, Paige sought advice
from friends in order to make her decision. While one friend (her roommate) assured her that
getting the H1N1 vaccine was “just like a regular flu shot,” another warned her that “it’s so new
that it hasn’t been tested effectively and like long enough to make sure that it’s like 100% safe.”
Since the advice from her family and friends was conflicting, it was clear that Paige was finding
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it difficult to decide whom to trust. At the time of the interviews, she said that her feelings about
the H1N1 vaccine were still “very mixed.”
Doing the right (and easy) thing.
For Paige, her decision to be vaccinated against HPV was one that did not require much
thought. According to Paige, it was “just one of those things where if it’s your health on the
line... you’re willing to go that extra measure to ensure you’re confident.” Although she
identified cost as “probably one of the major factors affecting why people don’t get it” she noted
that if someone asked her for advice, she would tell them that their health is “worth that money
that it costs to get vaccinated.” In her case, Paige was unsure if the vaccine was covered by her
parents’ health insurance but said that “either way” she ended up getting all three shots. She
noted that if it were not covered, it likely would not have affected her decision to be vaccinated
since her parents “would pay for it.”
In addition to positive evaluations of the vaccine from her mother, Paige also described
hearing positive messages about the vaccine in her university classes and on TV. For example,
Paige spoke about participating in a group discussion in her Health Promotion class in which her
work group concluded that the vaccine was a “good preventative measure” and “one of those
‘better to be safe than sorry’ kinds of issues.” According to Paige, the discussion was “pretty
uniform” in that she did not remember hearing of any “strong negative side effects” or
“drawbacks” aside from the high cost of the vaccine. In terms of the information she received
when she first heard about the vaccine on TV, Paige said that “the commercial was pretty good at
just giving you the basic facts about it.” According to Paige, the media and websites she looked
at prior to being vaccinated were effective in “just laying out the basic facts” about why being
vaccinated was important. Additionally, Paige also noted that she read an “information sheet”
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about the vaccine prior to her first shot that provided her with all of the necessary information.
Paige said that she was not confused about the information at any point and described it as
“pretty straight forward.”
Paige also described her decision in relation to ease of access and convenience. The fact
that she was able to get the vaccine on campus was important to Paige since “it would have been
more of a hassle” if she had had to go downtown to the health unit. Having the vaccine on
campus meant that it was “accessible” in a place where “privacy” and “confidentiality” would
not be an issue. As Paige described, “if I was the type of person that really cared about that kind
of thing [confidentiality] then I would have...felt fine still going to Student Health Services about
it.” Overall, she described HPV vaccination as a “health measure” that was “simple and quickrelatively pain free” and noted that she appreciated the fact that it did not “take out a lot of time”
from her day.
Ana
Ana is a 25-year-old woman who has not been vaccinated against HPV. On the
demographic questionnaire, Ana described her ethnic background as “White” and indicated that
she is “sexually active” with “male” partner(s). At the time of the interviews, Ana was enrolled
in a Master’s program at UWO.
Investigator’s Reflections
My first interview with Ana was somewhat unusual in that neither of us realized until she
came to the interview that we had already met. We did not know each other well but had spoken
a few times in group settings. Because we knew each other, we immediately began to talk about
our work as graduate students and it was during this time that I found out that Ana was currently
in the process of designing a qualitative study. Immediately, we established a friendly rapport
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and the interview felt very comfortable and open. From my perspective, Ana’s openness was
related to her collegial attitude of wanting to help a fellow graduate student. Ana had a lot to say
and was willing to share her experiences in detail. It was clear that she was thinking aloud at
times, a process that was evidenced by her often fluctuating confidence and moments of
contradiction and hesitation. Interestingly, at the end of the first interview, Ana noted that she
was also planning to do narrative interviews for her study. Although she never fully described
her motivations for participating, I suspect that Ana may have wanted to learn more about
narrative interviews by participating in my study. As a new researcher, I was somewhat uneasy
with the idea that Ana may have been judging my interviewing abilities since she was familiar
with narrative methods. However, I was thankful that I found out about Ana’s familiarity with
narrative research after the interview instead of before it.
When Ana came back for her second interview it was almost as if we just picked up
where we left off. Ana seemed very comfortable and relaxed and I was also very much at ease.
Before we started, I asked Ana if she had read her transcript and found out that she had done so
only five minutes before we met. As a result, I wondered how much reflection she was able to do
and if she noticed the contradictions and hesitations in her transcript. When I asked her to
comment on her last interview, Ana spoke mostly about how impressed she was that she
“actually” had reasons for not getting the vaccine. During the second interview, Ana continued to
think aloud and noted that being part of the study had helped her discover things about her
decision- making process that she had never thought about before.
Throughout both interviews, I found myself nodding frequently because I could identify
with many aspects of Ana’s experience. I tried to be conscious of this nodding and restrict it as
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much as possible so as not to give Ana the impression that I was finding parts of her story more
interesting or acceptable than others.
Ana’s Narrative Themes
Ana’s narrative is presented below according to five dominant themes that emerged from
her interviews.
Hearing about a non-essential vaccine.
Ana began her story by talking about the first time she heard about the HPV vaccine on
TV. She said that she “heard it in passing” and “didn’t have a lot of pull towards it.” Ana said
that although she does not really “pay much attention to drug ads in general” this one “caught her
eye” because she was eligible to take it (as a young woman under the age of 26). Her response to
the advertisements was “o.k well that COULD affect me and that might NOT affect me.” She
found nothing that “screamed” to her that she should be taking it- “nothing overwhelming” that
said that she “should get it.” In her second interview, Ana speculated that this initial response to
the vaccine might stem from a subconscious view of herself as “young and bullet proof.”
Ana “didn’t really think much” of the vaccine until she heard about it again in a “human
sexuality class” that she took in her last year of undergraduate studies. Here, Ana described how
she “learned slightly more” about the vaccine and specifically, more about the “possible
consequences of not getting it.” She described the class as “informational” and said that the
professor “wasn’t either really pro or con about it” but instead encouraged the class to “be
critical” and to be “aware” that the long-term side effects had not been researched yet. Ana felt
that her professor was not pushing the class “either way” but that she was just encouraging them
to be “smart consumers.”
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Although Ana said that she found the lecture on HPV “interesting”, it did not cross her
mind to “look into it any more” or take it “into account” in her own life because it was not “a
pressing issue” for her. Although she noted that “genital warts and cervical cancer are horrible
things”, she said she does not think of herself as “very high risk” because she is “pretty adamant
about getting physicals.” As Ana described, “as far as getting cervical cancer goes it could be
picked up during a physical rather than having to take the vaccine.” Ana seemed confident that if
she were in the “early stages of cervical cancer” that it would be “caught pretty quick.” As for
genital warts, Ana said she feels that she is “pretty low risk” because she has not had many
sexual partners and uses “protection.” For Ana, just knowing that what she is doing now (e.g.
getting physicals and using protection) is “pretty effective” makes her “not really wanna do it”
(be vaccinated).
According to Ana, the reason she has not taken “that extra step” to “do any more
research” or to “learn more about it” is because she does not feel that the vaccine is “essential”
for her, describing it as a “grey area,” “unimportant” and “ambiguous.”
Not putting foreign things into her body.
Throughout both interviews, Ana described her strong personal ethic against putting
“foreign” things into her body unless she knows “what’s gonna happen afterwards.” In
discussing the HPV vaccine, Ana said she is “wary” of the possible long-term side effects of
vaccination because there is too much “unknown.” Although Ana said that she assumed that the
vaccine would “have many trials to get through” before it was approved, she asserted that people
still “have to take everything with a grain of salt.” Ana used the example of the “drug that gave
babies no arms” (Thalidomide) to show how an approved drug still turned out to be unsafe
(Thalidomide was approved to treat morning sickness in pregnant women and was later found to
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have serious side effects on growing foetuses). In her second interview, Ana also talked about an
“alarming” news story in which a young girl had “died from the HPV vaccine.” For Ana, this
raised a “red flag” about the safety of the vaccine. Ultimately, Ana said that unless she is “100%
sure” that the vaccine is something that will protect her health, she will just continue to “go for
the cautious end of it and just not do it.”
For Ana, this personal ethic of not wanting to put foreign things into her body holds true
for other medications and vaccines as well. Even when it comes to treating headaches, Ana said
that she “doesn’t take pills or anything” and prefers to “wait it out and whine a lot” instead.
Similarly, when discussing the H1N1 vaccine, Ana said that she would not “be getting that
either” because she does not know “what it’s gonna do” to her body. Ana also described the flu
shot as something she does not feel is necessary. Overall she described her outlook as “if it’s not
broke, don’t fix it.”
In her second interview, Ana talked more about how this strong personal ethic has led her
to use more “alternative remedies” in the past year. She said that people in her life who have
“done research” have told her that “society as a whole is as unhealthy as it is because of what we
put into our bodies.” For Ana, this makes “sense” and has made her “think twice” about putting
things into her body that are “not natural.” Ana noted that her new-found interest in alternative
health practices also stems from her involvement in an academic program which is not based on
the “medical model” but which works from “different cultural ideas of what health is.” For Ana,
being in this program “tweaked” her interest in learning more about “traditional” forms of
healing.
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Trusting information sources.
Throughout her narrative, Ana drew attention to her need for trust in contexts related to
receiving information about HPV vaccination. In both interviews, Ana described how important
it is to her to have someone she “connects with” give her information about the vaccine. In
particular, Ana said that having a “strong relationship” with the person and being “comfortable”
talking to them is especially important for her. Overall, Ana said she is looking for “unbiased
information” from someone she trusts. Specifically, Ana said that she would “expect” this kind
of information to come from a “doctor,” a “researcher in the field,” or “family friends” who are
“nurses and that sort of thing.” Although she says that she would trust information from these
sources, it is clear in both interviews that Ana is very critical about where information comes
from. For example, Ana noted that pharmaceutical companies are just “trying to make money”
and said that she “wouldn’t exactly trust” information from a “commercial” because it would
depend on who was “funding it.” Similarly, Ana said that she may trust information from “a
researcher in the field” but that it would depend on “where they’re getting their funding” as well.
In her first interview, Ana talked about her human sexuality professor as a good source of
information. Ana said that her professor’s message of being cautious “really resonated” with her
because she respected her professor as someone who was “educated in health and sexual health
and all of that.” The importance of receiving information from an educated source also came up
again when Ana talked about her “friend” who had “cancerous cells in her cervix.” According to
Ana, even though her friend “has been affected by cervical cancer” she never said, “I wish this
was available” in reference to the HPV vaccine. The fact that her friend did not “think that much
about it” even though she is “fairly educated,” led Ana to believe that no one is really “latching
on” to the vaccine except grade eights and their parents.

Y oung W om en’s Narratives 100

Another source of information that Ana talked about was a “sexual health clinic doctor”
who she met for the first time when she went for a physical at her previous university’s student
clinic. Ana described the physical as the “sketchiest” physical she had ever had because it was
“SOO fast.” Ana felt as though the doctor “knew nothing” about her yet was telling her to take
the vaccine anyway just because she fell within the prescribed “[age] range.” For Ana, having
someone who knew her “history” and who could recommend the vaccine based on her
“personally” would have been better. As Ana described, if she had had a consultation with a
doctor who she thought actually “gave a shit,” she may have been more inclined to consider
being vaccinated. Ana also expressed concerns that doctors might be suggesting the HPV
vaccine just because they “have pressure from pharmaceutical companies” and may not want to
be “liable” if “something happened.” In terms of the HPV vaccine, Ana wondered if it is
something that doctors just “throw” at people in a certain age range without considering any
“risk factors.” Although Ana acknowledged that most people have an “automatic respect” for
doctors, she said that she did not follow this doctor’s advice because she felt as though it was not
directed at her for any reason other than her age. Ultimately, Ana said she was looking for
someone who could say, “these are the reasons why YOU should get it.”
In terms of online sources of information, Ana also talked about Wikipedia as “not
exactly reliable” and complained that part of the reason she did not seek out information about
the vaccine on her own was because of the “overwhelming factor” associated with searching for
“legitimate information” online.
Struggling to claim authority.
Perhaps the most striking feature of Ana’s narrative is her struggle to claim authority over
her opinions and thoughts regarding the vaccine. For Ana, this struggle resulted in two ways of
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describing herself in relation to her decision—on one hand, she described herself as “critical,”
“educated,” and “cautious” while on the other hand, she described herself as “lazy,” “ignorant”
and “passive.”
Throughout both interviews, Ana described herself as “critical.” According to Ana, her
ability to think critically has come from “six years of being in university” where in “almost every
class” she has been told that “it’s all about critical thinking.” It is in university that Ana says she
has learned the importance of asking, “where did this information come from?”
Ana described this new, critical way of thinking as a change in how she looks at things
and interacts with people in “certain situations.” According to Ana, this “revelation” came
because she is in a “feminist based” program that has taught her a lot about “social issues and
social justice.” In the program, Ana says she has learned more about looking “beyond” herself
and more to the meaning of “why things are the way they are in society.” For example, Ana
noted that since she was “younger” at the time of her physical (when her doctor told her she
should be vaccinated), she was not able to be a “self-advocate” because of the whole “authority
thing” between her and her doctor. At the time of the interviews, Ana said that she would be
“more confident” to “ask more questions about it [the vaccine]” since she has become better at
recognizing the “power differentials” between herself and doctors and would try not to be
“intimidated by them.”
In the second interview, Ana reflected on her critical comments regarding the vaccine
from our first conversation and described how she was “impressed” at what she had to say. She
realized “after seeing it all on paper” that she “actually” had a “reason” for backing up her
decision “not to do it.”
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Interestingly, later in the second interview, Ana’s critical viewpoint shifted slightly as she
described the vaccine in a new way- as possibly “really liberating” for women. For Ana, the fact
that “someone actually took the time and the effort to care for a woman’s disease” is positive in
that “it puts a lot more value on women’s health issues.” Unlike in the first interview in which
Ana talked about the unknown “side effects” of the HPV vaccine and mentioned the “drug that
gave babies no arms” (Thalidomide), this time she compared the introduction of the vaccine to
when women first got “birth control” and “had more power over their bodies.” Ana noted that
the HPV vaccine may be “empowering” for women because it means “they can take a lot better
care of their bodies.” For Ana, being able to see the vaccine “in a larger picture” has allowed her
to consider the “benefits as well as the consequences.” Despite being able to see the possible
benefits of vaccination however, Ana was still somewhat critical. As she described, “it’s
liberating in a way and also scary in another way” because “there’s nothing there” when it comes
to the “long term side effects.” Ana said she feels as though we are “jumping in all the way” by
having all grade eight girls be vaccinated. For her, this raises concerns because it implies that
young girls “should” be getting the vaccine. According to Ana, unless parents are “really
educated and real advocates against it” then young girls will probably get it.
While Ana clearly articulated her critical viewpoints, she also described feeling as though
her critique had no strong basis since she has “never done any more research into it” and has
“never sought out any opposing information” to “support” the vaccine. Although she presented
numerous reasons for not being vaccinated, Ana said that she could talk “only a certain length”
because she had not “put that much thought into it.” In describing why she did not feel the need
to look into the vaccine any further, Ana said that it was “obviously” because she did not find it
“interesting enough” to take that time- especially since her free time as a “student” is “pretty
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limited.” Ana described this failure to put in the “extra effort” and seek information as the
“laziness factor” and part of her usual “lazy way.” As Ana described, “that’s just how I roll.” In
her second interview, Ana reflected on how “it’s kinda funny” that even though she and her
classmates were encouraged to be “responsible consumers” she was just a “passive consumer”
since she did not look into vaccination any further. She also noted that although our first
interview had “peaked an interest” in learning more about the vaccine, she “still” did not go
online and “check it out” despite having had “good intentions” of “Google-ing it.”
Although Ana admitted that she is “sceptical” of the vaccine, the fact that she has not
sought out information led her to describe herself as “ignorant and sceptical.” Similarly, when
she talked about her assumption that the vaccine is covered by her mother’s health plan, she
described it as an “ignorant assumption” since she did not actually look into it herself.
Throughout both interviews, Ana seemed to struggle with explaining why she had not felt the
need to research the vaccine. At one point, Ana questioned her actions, saying that maybe it was
“stupidity” on her own part because she “should” be taking care of her own body and that
“maybe” the vaccine “is what’s best for it.” During the second interview, Ana started to re-think
her decision saying that maybe the vaccine is something she should “look into” before she is no
longer “qualified” (in terms of her age).
Although Ana seemed adamant about getting personalized advice (particularly from
doctors), she said that it was her own “fault” for “not asking questions” when the sexual health
clinic doctor told her she should be vaccinated. Ana also noted that she could have “found more
information” from her family doctor but instead just “went with the flow” instead of “questioned
it” or “stood up” for herself.
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Acknowledging the tension.
By the end of the second interview, it was clear that Ana had started to acknowledge the
tension in her narrative. This acknowledgement led her to outline two distinct types of people.
As she described, “you could be the really proactive type and really do that research and really
be educated and you know, be a good person or you could be the person who just takes
information as it’s provided to them.” For Ana, while some people might be “more motivated” to
go out and seek information for “both sides of the story”, others “just take information as they
get it and just do what people are telling them to do.” This distinction was an important one for
Ana in that she described herself as someone in the “middle of the road.”
Ultimately Ana said that she “still” does not think she would “get it [the vaccine]” since
she is “not 100% sure” that it would be “protecting” her health. Although she described her
decision as “final”, she admitted that part of her motivation for participating in the study was to
come and “leam more about it,” “how it works”, and “if it’s good for a person’s body.”
According to Ana, if new information came out that “really strongly supported” that she
“personally” should be getting the vaccine, then she might “re-consider” it.
Kristin
Kristin is a 24-year-old woman who has not been vaccinated against HPV. On the
demographic questionnaire she identified her ethnic background as “White” and indicated that
she is “sexually active” with “male” partner(s). At the time of the interviews, Kristin was
enrolled in a Master of Science program at UWO.
Investigator’s Reflections
Kristin was perhaps my most articulate participant. In her first interview, Kristin spoke
clearly and confidently, and rarely needed to be probed for more details. She spoke openly about
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her experiences and my impression was that her main goal was to defend her rationale for not
being vaccinated. Her stories seemed almost rehearsed at times and many ideas were expressed
repeatedly throughout the interviews.
What struck me most about Kristin in her first interview was that she appeared to know a
lot about the virus and the vaccine- more than- more than any of the other young women I
interviewed. Throughout the interview, she drew on this knowledge to make her case for not
wanting to be vaccinated. Because Kristin’s reasoning resonated with my own views about the
vaccine, I found myself subconsciously nodding and smiling frequently throughout the
interview.
One of Kristin’s main concerns was with the unknown effects of the vaccine on her
fertility. Although I asked her where this concern originated, Kristin never fully described why
she felt that this vaccine in particular could be harmful to her reproductive health. Kristin did
note, however, that she had chosen an IUD as her primary method of birth control. Since this
method of birth control is thought to affect fertility, it is possible that perhaps this is where her
reproductive related concerns originated.
Given the fact that she was exceptionally vocal in her first interview, I was surprised that
Kristin had nothing to say about her transcript when we sat down for the second interview. This
may have been in response to reading her transcript, which she thought showed that she talked
too much. After a bit of a slow start, Kristin began to lose this self-consciousness and became
more vocal as the second interview progressed. She answered my questions openly and seemed
to be thinking aloud at times. As a result, her transcript was replete with many half-thoughts and
asides as she struggled to express herself. At the end of the interview, Kristin and I engaged in
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some informal small talk about my study and she noted that she thought my study was “very
interesting” and “a really neat idea.”
Kristin’s Narrative Themes
Kristin’s narrative is presented below according to six major themes that emerged from
her interviews.
Defending her decision.
Kristin began her narrative by listing the main reasons why she is “not really for” the
vaccine. Within the first few minutes of her interview, Kristin had already listed at least four
reasons why she chose not to be vaccinated. In addition to not seeing “the need for it” and
viewing it as “just another tool” in addition to PAP smears and swabs, she also questioned “how
effective the vaccine would be” since she has had “multiple sexual partners” and therefore has
already likely “been exposed” to the virus. Additionally, Kristin cited “cost” as another factor,
but noted that it is not “the largest factor.” Ultimately, Kristin described that the “main reason”
she has not been vaccinated is because she still has lingering concerns about the possible
“negative effects” or “real downsides” of the vaccine in the “long term.”
Once she finished listing her reasons for not wanting to be vaccinated, Kristin went on to
describe how she has had to defend her decision not to be vaccinated on a number of occasions.
As she described, people have often labelled her as “irrational”, “stubborn” and “a pessimist”
and have accused her of “not listening to the logical arguments” about the vaccine. For example,
Kristin talked about previous conversations she has had with her boyfriend and described how he
“doesn’t understand” why she does not want to be vaccinated. According to Kristin, when she
expressed her “main fear” that the vaccine could be “like thalidomide”, her boyfriend tried to
assure her that the vaccine is “well tested” and told her that she is just being “stubborn,”
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“difficult” and “irrational.” According to Kristin, being “perceived” as “irrational or emotional”
in her “decision-making” is a “pet peeve” of hers. As she described, “it’s a nerve that’s picked
with me because I know I’m very rational in all of my choices.” Ultimately Kristin described her
boyfriend’s position as “if you can protect yourself from cervical cancer, why wouldn’t you?” In
turn, Kristin said that she defends herself by saying, “it’s not a definite ‘not getting cancer’
thing” and by citing conversations with doctors in which they have assured her that “following
all your swabs and results” is “just as effective” as the vaccine in terms of preventing cervical
cancer. Although Kristin described having to debate her boyfriend on the issue of HPV
vaccination, she noted that he “doesn’t pressure” her and that he ultimately says, “I’m not gonna
tell you what to do cause it’s your body- it’s your choice.”
In addition to discussing the vaccine with her boyfriend, Kristin also described
conversations with doctors about the vaccine. Although Kristin described the doctors at her
current university as “very nice” and “really open”, she noted that those at her previous
university were “not so good” and “quite pushy.” Kristin described an experience at her previous
university where she told doctors “no I don’t want the HPV vaccine.” In response, she said she
was “given information- but in a convincing manner.” Kristin felt as though the doctors were
“biased” in the way they spoke to her and in the way they presented the vaccine as a “be-all and
end-all” for her as a “sexually active woman.” Kristin felt as if they were “only highlighting the
pros” and that their attitude was that she should “get this for sure.” According to Kristin,
“doctors try to pressure you into taking the HPV vaccine” and some are “really forceful.” In
general, Kristin said that in the past, when doctors have asked her why she does not want to be
vaccinated, they have used “an accusatory tone,” implying that the vaccine is “a wonderful
opportunity” or “the only option.” In response, Kristin said she tells doctors that the vaccine is
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not “a be-all and end-all to stop doing the Pap smear, so if you keep on going to do the Pap
smear, I don’t understand how this vaccine is going to help me or why I need to do it.”
For Kristin, it is necessary to ask questions and “get answers” so that she can do her own
“cost-benefit analysis.” As she described, one important question that she often asks doctors is
“would getting PAP smears be sufficient enough?... would getting the HPV vaccine, aside from
protecting me from these four strains, give me that much more of a shot of not getting it [cervical
cancer]?” According to Kristin, the response from her doctors to this question was often- “no it
won’t make any difference at all”, which has led her to ask herself “well then why would I do
it?”
According to Kristin, defending her health care decisions to medical professionals is
something she is used to. For example, she recalled “birth control conversations” in which her
doctors were hesitant about replacing her IUD since they “don’t like giving young women who
haven’t had children IUDs.” As she described, the IUD was “difficult to get” so she had to make
it clear that she “wasn’t budging” and that she wanted it because other methods of birth control
were not appropriate for her and her boyfriend.
Kristin also spoke briefly about having to defend her decision not to be vaccinated to
friends. As Kristin described, one friend (who had received the vaccine) was “aghast” at her
decision and asked why she was not getting the vaccine as well. Kristin responded by saying that
she is “wary of pharmaceutical companies and wonder drugs” and that she is “not scared to wait
five years just to see how it all pans out.” Although her friend warned her that she “could be
exposed” to the virus, her response was that she is not worried since she is in a “monogamous
relationship” with her boyfriend. Kristin also noted that her male friends have also offered their
opinions saying, “it’s your body, it’s your decision, but why wouldn’t you wanna fight a cancer
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that you could?” As Kristin described, one friend encouraged her by arguing, “if they came out
with something for prostate cancer I’d do it!” to which Kristin responded, “well that’s your
decision but I just don’t think it’s right for me.”
(Not) talking about sexual health.
Interestingly, although Kristin’s narrative includes accounts of these conversations with
her boyfriend, doctors and friends, Kristin said that, generally, when it comes to the HPV
vaccine; she has “never really had a detailed discussion about it.” Specifically, Kristin noted that
when it comes the vaccine, “a lot of females are not really willing or want to talk about it” and
instead “keep their sexual health to themselves.” In her first interview, Kristin noted that this is
particularly true in the context of her “immediate family” where they “don’t really talk about
sexual reproductive health that much.” As she described, “none of the females” in her family talk
about the vaccine, or have been “advocating” it, even though “they know it’s out there.”
Specifically, she talked about her mom and sister and their unwillingness to talk about anything
sexual in nature. According to Kristin, her sister “doesn’t talk about sex or anything below the
legs” and her mom “doesn’t like to think” that she has sex since it “makes her uncomfortable.”
As a result, Kristin said that she does not talk to her mother about anything “sexual health”
related. In contrast to her mother, sister, and other family members, Kristin says that she is the
one who talks the “most” about sex and sexual health in her family.
Waitingfor more evidence.
Throughout both interviews, Kristin described wanting to “wait” until more information
about the vaccine is available. Specifically, Kristin said she is concerned about the possible
“negative effects” of the vaccine in the “long term” and feels as though five years (the length of
the Gardasil™ vaccine trials) is not “long term enough in the scale of where we are scientifically
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right now with carcinogens.” According to Kristin, “we can make guess-timates, but we’re not
really gonna know [about the side effects] for another couple years.” Until then, Kristin has
decided that she would rather “just sit and wait and not do anything till later.” As she described,
“I feel like I can just sit back to see if there are any side effects or just to see if there are any
things that I think are costs that don’t necessarily outweigh the benefit of not getting cervical
cancer.” In Kristin’s opinion, there is nothing “wrong” with waiting since she feels that 26 is an
“arbitrary age” in terms of the vaccine’s approval range. As she described, “I don’t think that
there should be a time scale, like if I wanna wait five years, I don’t see the big deal of waiting
five or even eight years.”
According to Kristin, this desire to wait is related to what type of person she is. As she
described “I’m a sit back and wait type person when it comes to anything-1 just don’t feel the
need to rush out and do something just cause it’s been released or its been discovered...that’s just
me personality-wise. I can sit back and wait and just see how the scene plays out for a bit...I feel
justified to just take the time that I need to make the decisions that I want to.”
Protecting her reproductive health.
Ultimately, Kristin’s main reason for waiting is related to her concerns regarding the
vaccine’s potential effects on her “sexual reproductive health.” As she described, “I’m waiting
because I don’t want to give up my ability to have children...I would rather have cervical cancer
and have children than have gotten the vaccine and not be able to have children.” Although she
has “no desire” to have children “right now”, she imagines that she will in the next “10 to 15
years.” For Kristin, the “bottom line” is that she is not willing to “risk” her “sexual reproductive
health” if she does not feel “100% confident” about the vaccine. For Kristin, the fact that doctors
cannot “guarantee” that the vaccine will have no effect on her ability to reproduce, has led her to
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view it as a “risk” that she is not willing to take. For Kristin, not being able to have kids due to
the vaccine is something she would “not know how to emotionally cope with.”
In order to articulate her concerns regarding the safety of the vaccine, Kristin drew on the
example of “Thalidomide” which she says, “really resonates” with her. For Kristin, the HPV
vaccine, like Thalidomide, may turn out to be “not-so-great” if it causes “more problems having
children, or if there are side effects, difficulties, or problems with pregnancies” in the long term.
Since no information is currently available regarding the potential side effects of the vaccine,
Kristin has decided that she is “willing to wait” to see if it has any effects on “fertility” in the
long term. According to Kristin, it will probably be another “15 years” before we will see any
“reproductive health issues in terms of conceiving.”
In her second interview, Kristin was asked if she is generally concerned about fertility
when it comes to other vaccines or medications as well. According to Kristin, her concerns
regarding fertility are “specific to this one [vaccine]” since it is related to HPV which is a
sexually transmitted infection.
Being responsible for her sexual health.
In her first interview, Kristin noted that she is really “on top” of her sexual health and that
she is really “aware” of her body and “what’s going on with it.” As she described, “I do my
PAPs yearly, and when there’s something wrong with them I go back and do the swabs again.”
According to Kristin, she took it upon herself to become “informed” about the HPV vaccine
because she felt it was her “responsibility” to do so. Despite seeing “commercials” about the
vaccine, reading many “news stories”, and visiting multiple “websites”, she noted that the
vaccine never really “perked” her interest because she “didn’t see the need for it.” For Kristin, its
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“role” as she saw it, was already being filled in her “health portfolio.” As she described, “I think
PAPs are sufficient because I’m on top of them and I do all my sexual health things.”
Although Kristin described herself as responsible and aware of her options, she said she
was “irritated” that her mom and sister were different from her in this way. As she described,
they “won’t take ownership of their own reproductive health” and “they don’t do anything sexual
health reproduction wise.” Instead, Kristin said they just “bury their heads in the sand” when she
tells them to “go get Pap smears.” Since her sister “hasn’t had any sexual partners yet and
doesn’t do Pap smears regularly,” Kristin said that she urges her “to get her Pap smears done
every year” and has told her to at least “consider” the HPV vaccine if she’s “not gonna go to the
doctor every year.”
According to Kristin, being “well versed” in sexual health matters is a “responsibility”
that “comes along with the privilege of being sexually active.” As she described, “I’ve always
thought that sexual health is my responsibility and that I should know what’s out there, know the
consequences and the repercussions so that I do actually know the full gamut or the weight of the
decisions I’m making.” For Kristin, getting an “unbiased opinion” is something that she has to
“go out there” and do herself because it requires taking “certain opinions” with “a grain of salt.”
Generally, when it comes to evaluating health information, Kristin said she is able to
“gauge” what is a “good source versus a bad source” because she has “a science background”
and is “familiar with how literature is published.” As she described:
The news is a good source for what’s new information, but in terms of health decision
making information, I find that I like information from pamphlets that are from reputable
sources., .an impartial party. For information about the facts of the vaccine and the
periods of dosage I think the news is a good source because they usually say from whom
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they were talking to...I like it better when it’s a named source that is associated with a
company that I can gauge of what their vested interest is in sharing the information.
In terms of the commercials, Kristin found them to be “irritating” because she felt as
though they were portraying the vaccine as a “cure-all” and a “wonderful drug that has no side
effects.” According to Kristin, the ads were not necessarily “saying the truth,” but instead were
“using facts and some statistics and presenting it in a way that was not completely truthful and
not completely representative of the situation.” As a result, Kristin said that the way the ads were
designed put her off the drug company “a little bit.” As she described, “I don’t necessarily trust
their literature on it 100%. I just feel like I need to stand back and take it with a grain of salt
‘cause they are a private company selling a drug.”
Similarly, Kristin was also “put off’ by what she perceived as the “political push” to get
the vaccine into the elementary school system. As she described, “there seemed to be this
political push after there was this media push.” Specifically, she was concerned with “the amount
of marketing” that was done for Gardasil™ and “how quickly it went from being on the market
to governments making it free and giving it to a larger size population than the test studies.” For
Kristin, this “raised a red flag” for her in terms of the vaccine because there was “only one major
group” that was studied. She also noted that, since the vaccine was approved, she has not seen
“anything published against it” and in particular, nothing about the “risks” associated with it.
Although Kristin said she “read a lot a news articles,” she noted that she read them “with
a grain of salt” since she knows that “news articles with studies tend to glamorize things.”
Overall, she found the news articles only provided very “vague” information about the vaccine
itself and instead, found that “a lot more of the coverage was on governments approving it.”
Apart from reading news articles and watching the news, Kristin also did some research
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“online.” Specifically, she went to the “company’s website,” to the “health unit” and “campus
health” websites, and to “Wikipedia.” According to Kristin, Wikipedia is a “good spot to go to
start because the pages are interlinked.” Although she acknowledged that Wikipedia is “not peer
reviewed” and noted that it may not be “100% true”, she described it as her “Google of
encyclopaedia” and said that she often looks at the “references section” at the bottom of the page
to “bring up” her general knowledge on a topic.
In addition to reading about the vaccine and researching it online, Kristin also described
speaking to “healthcare professionals” about it as well. According to Kristin, she not only asks
“logistical questions” like “how much does it cost?” and “would it be covered by insurance or
not?” but also asks about any “known symptoms” related to the vaccine. In seeking information,
Kristin has concluded that “different communities [medical/academic] have different opinions”
and that “information is relayed differently” depending on what that opinion is. For example,
Kristin described noticing at her previous university that “everybody” she spoke to about the
vaccine was “pushing it really hard.” As she described, “I felt like I was having a conversation
not with a medical professional, but like I was having a conversation with my mother.” This
experience was “not comfortable” for Kristin, especially since she noticed that the doctors
“weren’t saying the right things about HPV” in terms of the information they were providing her.
This resulted in Kristin feeling like the “trust was gone” between her and her doctor.
Overall, Kristin described herself as a “very analytic person” who does “a little bit more
questioning” than most people do. As she described, “I weigh out pros and cons and I become
informed...I guess I’ve grown up with the idea that being rational, logical and you know, making
good decisions not just because you want to- is important.” For Kristin, being analytical means
thinking “pro/con” and asking herself about the potential repercussions of her actions. For
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example, “what if I do this- what am I not gonna be able to do later?” When asked how she
thought her story might be unique compared to other young women, Kristin noted that she has
not heard of many people who are “making a conscious decision not to get it [the vaccine]” like
she is. As she described:
some people are afraid of making decisions- they like not necessarily to be told what the
decision is for them, but to be presented things so that its quite obvious what’s the best
for them to do...they just don’t notice that they’re not being active in their own life.
Ultimately, Kristin said that she hopes her experience “isn’t unique” and that others are
also “being conscious in their decision-making and looking at both sides of the decisions that
they make in life.” As she said in her second interview, “I hope people are thinking about it.
Whatever decision they make, that’s up to them- but I hope that they really sit down and think
about what’s best for their situation.”
Weighing, personalizing, and accepting risks.
According to Kristin, although she is “all for” people suggesting the vaccine for specific
reasons, she often feels that doctors do not know her “entire life story.” Unlike others who may
be “blindly trusting people” like doctors, Kristin says she “takes their advice” and thinks about
how it “fits” into her “little box” or her particular situation which she sees as “complicated.”
Ultimately, Kristin’s decision to “wait” for more information about the vaccine is related to her
ability to identify her risk for HPV and to accept the risks associated with not being vaccinated.
In terms of acquiring HPV, Kristin said that she feels that the vaccine would not be “effective”
for her since she “may have already been exposed” to the virus. As she described, “if you’ve
already been exposed, then the course of treatment is still the same. ..if you do get to the lesions
phase it’s still very treatable if you catch it early, and that’s what the Pap smear is there for.”
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Based on this reasoning, Kristin has decided that she will just continue with her current regimen
of regular Pap screening in order to control her risk for cervical cancer.
Kristin was careful to note however, that if she was a “virgin” her “thinking would
probably be different” and her “story would be different.” As she described, “it would be a
different decision process.” Still, however, Kristin says that she would “make the pro/con list” to
help her decide. As an “after-thought” Kristin also added that “skin cancer does run in the
family” so she assumes that that will probably “get” her “first”, “before cervical cancer does.”
With regard to the role of HPV in causing cervical cancer, Kristin was aware that
“multiple strains can cause cervical cancer.” Since the vaccine only protects against two cancercausing strains, Kristin said that she decided to take her “chances” and not be vaccinated. For
Kristin, although her decision may seem risky to others, it was in fact a “laid-back choice.” As
she described, “in my mind there is no wrong decision” no matter whether or not someone
decides to get the vaccine, they can “still prevent cervical cancer” by getting Pap tests done.
According to Kristin, “the end goals are the same; it’s just different ways of getting there.”
Perhaps one of the most notable features of Kristin’s narrative is her ability to accept and
come to terms with her decision no matter what the outcome. As she described, “I’ve come to
peace with the fact that i f ... I do get cervical cancer- o.k., well then I chose this, and I’m fine
with that...It’s the path that I took, so I’m happy with it.” According to Kristin, considering the
worst-case scenario is part of the “decision-making process.” For example, she said that she asks
herself “If I don’t get the vaccine and say I do get cervical cancer, how do I feel about that? ...or
what happens if I do regret the vaccine?” At the end of the day, Kristin ultimately decided that
she is o.k with telling herself “tough luck.”
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Conclusion
In this chapter, I have presented the narratives of each of the young women who
participated in this study. These narratives illustrate the range of decisions made in response to
HPV vaccination and the complex and fluid nature of each young woman’s unique decision
making experience. In the following chapter, I discuss the overlaps and differences between the
narratives and consider these findings in relation to previous research. Furthermore, I begin to
challenge commonly made assumptions regarding young women’s decision-making by
examining participant narratives in light of concepts of medicalization and neo-medicalization
and related discourses of health risk and individual responsibility.
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Chapter Five: Discussion and Conclusions
The primary focus of this research project was to learn more about the decision-making
experiences of university-aged women with regard to HPV vaccination. In the previous chapter,
individual narratives were presented in order to illustrate how each of the young women in this
study engaged in her own unique decision-making process. As described in Chapter Three, these
narratives were constructed through close, multiple readings of the interviews conducted with
each participant. In this chapter, my goal is to move beyond these individual narratives to draw
attention to some important cross-narrative themes. In addition to highlighting similarities and
differences across the narratives and integrating my research findings with previous literature, a
second goal of this chapter is to situate the participant’s narratives within a broader socio
political context using concepts of medicalization and neo-medicalization. In particular, these
concepts are used as a framework for understanding how young women take up (and/or resist)
related discourses on health risk and individual responsibility. At the end of the chapter, I
conclude by reflecting on how the narrative methodological approach taken in this study
effectively lent itself to gaining a deeper understanding of young women’s decision-making
experiences related to HPV vaccination. I also highlight the study’s main limitations and discuss
its significance and contribution to the field of health promotion.
Cross-Narrative Themes
According to Polkinghome (1988), a full description of a story should include “both the
elements that are unique to that particular story and those that can be found, at least in essence, in
other stories” (p. 167). In what follows, I describe six cross-narrative themes that emerged from
my interviews with Allison, Paige, Katie, Ana and Kristin. Each theme is discussed both in terms
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of its unique manifestation in each young woman’s narrative, and in relation to previous research
in the area of HPV vaccine decision-making.
Fluidity and Temporality in Decision-making
First, and perhaps most importantly, each of the narratives presented in the previous
chapter have, in their own ways, disturbed the linear model of decision-making that is presumed
in previous studies related to HPV vaccine decision-making. Through the interview process, the
young women were able to reflect on their decision-making experiences and come to new
understandings regarding how certain events and experiences led them to their vaccination
decisions. Their narratives show changes in their thinking over the course of two interviews and
point to the ways in which the interview itself became an important opportunity for reflection.
Ana, for example, noted that being part of the study had helped her discover things about her
decision-making process that she had never thought about before. In particular, her reflections
regarding how she had not sought out any information about the vaccine led her to reconsider
possibly looking into vaccination at the end of the second interview. Allison also said that if she
had not done the study or had not spoken to her friend between the interviews, she probably
would never have even thought about getting the vaccine. Conversely, in describing her fear of
an “epidemic” of cervical cancer, Katie realized that her decision to be vaccinated was based on
incomplete information from TV commercials. In retrospect, Katie noted that she likely did not
need the vaccine after all, and said that it is something she will no longer be recommending as
enthusiastically to her friends. Through the interview process, Paige was also able to reflect on
her trust in vaccines and consider how the HPV vaccine may be similar in some ways to the new
H1N1 (“swine flu”) vaccine that was introduced around the time of the interviews. Although she
described herself in her first interview as someone who trusted in vaccines in general, by the

Y oung W om en’s Narratives 120

second interview, Paige seemed less trustful of vaccines and cited new-found concerns that, like
the H1N1 vaccine, the HPV vaccine may not have been around “long enough” to determine any
possible long-term complications that may arise in the future.
These fluctuations in the participants’ stories point to the importance of temporality in
decision-making- a finding that was made apparent by the narrative methodology used in this
study. In contrast to decision-making theories, which see decision-making as a linear process that
culminates in a final decision at a specific point in time, the narratives of these young women
clearly illustrate that decision-making is not only complex and ongoing, but affected by a wide
variety of events, relationships, and experiences. The non-linear and evolving nature of decision
making in particular can be seen by examining the final theme in each of the narratives
presented. These themes point to where the young women were in terms of their decision
making at the time the interviews ended, and show that, particularly for those who had not
already been vaccinated; their decisions regarding vaccination were not necessarily final. For
example, by the time the second interview ended, Allison (who was undecided about
vaccination) described a new-found interest in possibly being vaccinated, while Ana and Kristin
(who had declined vaccination) noted that they may re-consider vaccination in the future if more
information is made available regarding the long term side effects of the vaccine. Even for Paige
and Katie, (who had already been vaccinated), new considerations regarding their decision to be
vaccinated surfaced through the interview process.
Cost as a Non-Issue
Although Gardasil™ is the most expensive vaccine proposed for mass use in Canada
(Lippman et.al, 2007), none of the young women, with the exception of Kristin, introduced the
issue of cost in their stories related to HPV vaccine decision-making. While Kristin cited cost as
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one of the factors influencing her decision to decline vaccination, she was careful to note that it
was not “the largest factor” and did not describe the issue of cost in detail in her interviews.
Allison and Paige only spoke of cost in relation to how it may affect the vaccination decisions of
unidentified “others.” Allison for example, hypothesized that perhaps the high cost of the
vaccine explains why some people “don’t rush to get it first off.” Conversely, although Paige
identified cost as “probably one of the major factors affecting why people don’t get it” she said
that if the vaccine had not been covered by her parents health insurance, it likely would not have
affected her decision to be vaccinated since her parents “would pay for it.” These findings are
interesting given that they lie in stark contrast to previous research which identifies cost as one of
the primary factors influencing both hypothetical vaccine acceptance (Boehner et.al., 2003;
Friedman & Shepeard, 2007; Kahn et.al., 2008; Sauvageau et.al., 2007; Scarinci et.al., 2007) and
actual vaccine acceptance (Mortensen, 2010; Wong, 2008).
This finding may be related to the fact that despite efforts to recruit a more varied sample,
all of the young women in this study were current university students. Since it is likely that these
young women come from socio-economic backgrounds in which the cost of the vaccine was
realizable, reduced concerns over the cost of the vaccine are not surprising.
Age and Vaccination Status
Another interesting observation that can be seen across the narratives is the relationship
between age and vaccination status. While the younger study participants (Katie and Paige) had
already accepted vaccination or were considering vaccination (Allison), the older participants
(Ana and Kristin) told stories related to their decision not to be vaccinated. In general, the
relationship between age and vaccination status found in this study is similar to findings from
previous studies that suggest that younger women are more likely to be vaccinated or to consider
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vaccination than those who are older (Caskey et.al., 2009; Lenselink et.al., 2008; Licht et.al.,
2010; Sauvageau et.al., 2007). Although age and vaccination status may appear to be related, it is
important that we as researchers do not make reductionist assumptions about age as a
chronological determinant of decision-making based on these observations. The women in this
study were different in many ways, and thus, there are a number of possible explanations that
may account for the apparent relationship between age and vaccination status. One possible
explanation is that older participants in this study were both Master’s students who spoke of the
influence of their educational programs in encouraging them to think critically. Ana for example,
described being “more confident” to ask questions and related this to her ability to recognize the
“power differentials” between herself and doctors. Ana attributed this new, critical way of
thinking to being in a feminist based program in university in which she says she learned more
about looking “beyond” herself and more to the meaning of “why things are the way they are in
society.”
Responses to Sources of Information and Advice about HPV Vaccination
The fourth cross-narrative theme was related to young women’s responses to information
and advice regarding HPV vaccination. Throughout their narratives, young women described
receiving information about vaccination from a variety of sources including friends, family,
media (e.g. TV, online, news), physicians, and professors. Looking at how the young women in
this study responded differently to information and advice from each of these sources was
particularly insightful in terms of learning more about where HPV related information comes
from, and how it influences young women’s decision-making. In what follows, young women’s
responses to different sources of information and advice are explored.
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Family.
Descriptions of family influences were present throughout the participants’ narratives.
Interestingly, and perhaps related, is the observation that both participants who had been
vaccinated had parents in health related professions. In her narrative for example, Katie
emphasized how the fact that her parents are physicians meant that she knew about the vaccine
sooner than her friends did, and was able to be vaccinated much earlier. Similarly, Paige (whose
father is a pharmacist) described how her parents have always been involved in helping her make
“informed decisions” about her health. For both of these young women, parents are their primary
source of advice in terms of deciding which health care interventions they need.
Mothers in particular were described as significant influences on decisions to be
vaccinated for both Paige and Katie. For both of these young women, their mothers were central
in their stories related to HPV vaccine decision-making since they were the ones who suggested
vaccination. According to these young women, the reason their mothers approached them about
the vaccine instead of their fathers was likely related to the belief that HPV and cervical cancer
are “women’s issues.” For Paige in particular, her mother’s suggestion was surprising given that
she and her mother had never talked about anything sexual in nature before. Her mother’s
willingness to talk to her about the vaccine was evidence for Paige that her mother’s concerns for
her health had helped her overcome the “barrier” of talking about sex and sexual health. In this
way, the conversation regarding HPV vaccination can be seen as replacing a conversation about
sex between Paige and her mother. An unwillingness to talk about issues related to sex and
sexual health was an issue that was echoed in Kristin’s narrative as well. According to Kristin,
when it comes to vaccination, “a lot of females are not really willing or want to talk about it but
instead keep their sexual health to themselves.” For Kristin, this is particularly true in the context
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of her immediate family where her mother and her sister refuse to talk about anything “below the
legs.”
These findings are consistent with those of Caskey et.al (2009) who found that
respondents who reported family members as sources of information about HPV were more
likely to be vaccinated. Studies by Hopfer and Clippard (2010) and Mortensen (2010) also found
that parental encouragement was one of the main drivers of vaccine acceptance. Furthermore, the
presence of mothers in the narratives of these young women is in line with findings from a recent
study by Roberts et.al (2010) who note that perceptions of their mother’s approval and motherdaughter communication about sex were significant predictors of vaccination among universityaged women.
Friends.
In terms of their interactions with friends, each of the young women in this study reported
being influenced in different ways. For example, both Paige and Allison reported interactions
with friends that led them to view the vaccine as beneficial. For Allison, hearing about her
friend’s “terrible” experience with genital warts really “hit home” for her since she considers her
friend’s word to be “really influential” in her life. Conversely, for Paige, discussing the vaccine
with a friend who had already been vaccinated provided her with “confirmation” that the vaccine
was reliable and safe. Unlike Paige and Allison, Ana and Kristin interpreted their minimal
interactions with friends regarding the vaccine as evidence that none of them were strongly
advocating for the vaccine.
For both Katie and Allison, the topic of friends also arose when discussing their desire to
“spread the word” about vaccination. In particular, because Katie’s parents are doctors and
because she was among the first in her social circle to be vaccinated, Katie took pride in her self
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appointed role in answering her friend’s questions and referring them to her mother when
necessary. Katie’s role in providing information to her friends is interesting in light of Allen
et.al’s (2009) finding that young women’s intentions to be vaccinated are influenced by their
perceptions that peers are planning to be vaccinated or have already been vaccinated.
Unlike other participant narratives, Kristin’s narrative points to different ways in which
friends may figure into the decision-making experiences of some young women. Friends, in
Kristin’s narrative, were introduced through her accounts of having to defend her decision not to
be vaccinated. Although her friends encouraged vaccination by drawing attention to its role in
cancer prevention, Kristin describes not being affected by their arguments. In doing so, Kristin
uses the differences in decision-making between her and her friends as a way to position herself
as an independent thinker, a finding that has not been highlighted in previous HPV studies.
Physicians.
Although physicians did not figure prominently in all of the participants’ narratives, they
were identified in stories told by Ana and Kristin as important influences on their decision
making concerning vaccination. Kristin’s narrative, for example, included accounts of her
interactions with physicians at student health clinics. Although Kristin described doctors at her
current university as “very nice” and “really open”, she noted that those at her previous
university were “not so good” and “quite pushy” in terms of their efforts to persuade her to be
vaccinated. Based on her experience, Kristin concluded that “different communities
[medical/academic] have different opinions” and that, “information is relayed differently”
depending on what that opinion is. Although Kristin says she is “all for” people suggesting the
vaccine for specific reasons, she often feels that doctors do not know her “entire life story.” For
this reason, she notes that unlike others who may be “blindly trusting people” like doctors, she
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“takes their advice” and thinks about how it fits into her “little box” or her particular situation
which she sees as “complicated.”
The importance of receiving information and advice from unbiased medical professionals
who could recommend the vaccine on personalized risk assessments was echoed in Ana’s
narrative as well. According to Ana, if someone knew her “history” and could recommend the
vaccine for her “personally,” then she may be “more inclined” to consider being vaccinated. Like
Kristin, Ana acknowledged that while most people have an “automatic respect for doctors,” she
did not follow her physician’s advice because she felt as though it was not directed at her for any
reason other than her age. Kristin and Ana’s experiences with physicians and their desire to trust
personalized, accurate, information from this source, relates to previous research in which trust
in health professionals was found to be a fundamental influence on parental decision-making
about vaccination (Leask et.al, 2006).
Media.
Despite the fact that all of the young women in this study cited television commercials as
one of the first places they heard about the HPV vaccine, they all noted that they were not
immediately drawn to the advertisements and many of them noted that commercials about the
vaccine were confusing and vague. Only Paige described the commercials as informative, noting
that they were “pretty good” at giving the “basic facts” about vaccination. Unlike Paige, Kristin’s
response to the commercials was much more critical. She describes the commercials as
“irritating” because they were portraying the vaccine as a “wonderful drug with no side effects.”
Kristin was concerned about the “amount of marketing” that was done for the Gardasil™ vaccine
in particular, and drew attention to what she described as a “political push” after the “media
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push.” Specifically, Kristin spoke about how quickly the vaccine went from “being on the market
to.. .making it free and giving it to a larger size population than the test studies.”
Being able to critically evaluate sources of information such as the news, printed
pamphlets, and online information, was a topic that was introduced by Ana and Kristin, both of
whom presented themselves as very savvy about how knowledge is produced. These young
women were sensitive to where information was coming from and described the need to take
information about the vaccine with “a grain of salt.” Like Kristin, Ana expressed a more political
view of knowledge production and spoke about her concerns regarding where pharmaceutical
companies and researchers get their funding. Interestingly, Ana described not having sought out
information about the vaccine on her own because of what she termed the “overwhelming factor”
associated with searching for “legitimate” information online. Like Ana, Kristin was also
concerned about where information comes from and how it is presented. In particular, Kristin
noted that news articles often tend to “glamourize things” when it comes to reporting the results
of studies. For Kristin, having a named source is important, especially in terms of knowing
where information comes from and being able to “gauge” what the author’s “vested interest” is
in sharing the information.
Overall, those who declined vaccination were more critical of vaccine information
provided through the media than were those who accepted or who were considering vaccination.
Kristin was the only young woman in my study who described seeking out information about the
vaccine on her own, while others reported receiving information more passively through
television advertisements, friends, family members, or news stories.
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University classrooms.
Two participants (Paige and Ana) also spoke about learning about the HPV vaccine in
university classes. In particular, Paige spoke about learning more about the vaccine in her health
promotion class, in which a group discussion regarding the vaccine led her to agree with her
peers in viewing the vaccine as a good preventative measure. As Paige describes, the discussion
was “pretty uniform” in that the whole group spoke of the vaccine in positive terms. Conversely,
Ana depicted a much more balanced class discussion in which both the benefits and potential
side effects of the vaccine were addressed by her professor. As Ana described, the class was
“informational” in that her professor “wasn’t either really pro or con about it” but instead just
encouraged her students to be “critical” and “aware” that the long-term side effects had not been
fully researched yet. The fact that these young women received information about the vaccine in
classroom settings was a unique finding that has not been highlighted in previous studies.
Multiple Interpretations of Risk
Comparison of the individual narratives revealed that each of the young women in this
study interpreted their risks for HPV, cervical cancer, genital warts, and vaccination itself, in
very different ways. When speaking of HPV infection, most of the young women spoke of their
risk in terms of their relationship status and/or sexual activity status. Allison, for example, was
the only participant who identified herself as “not sexually active” on the demographic
questionnaire and noted that she did not currently have a boyfriend at the time of the interviews.
According to Allison, because she does not have a boyfriend and does not “sleep around”, she
feels as though she does not have “a really big chance of getting it [HPV].” Like Allison, Katie
also framed her risk for acquiring HPV and other STIs in terms of ideas related to promiscuity,
and in particular, to having unprotected sex. According to Katie, since she “won’t be having
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unprotected sex,” she feels as though she will “never” get an STI. Conversely, Ana’s description
of herself as “pretty low risk” for acquiring HPV, stems from the fact that she has not had many
sexual partners and engages in safe sex practices. Although Kristin describes having had
“multiple sex partners” and notes that she has already likely been exposed to HPV, she does not
seem overly concerned with acquiring new strains of the virus since she is in a “monogamous”
relationship with her boyfriend.
Unlike previous research that has found that young women in committed relationships or
who were casually dating were more likely to express interest in vaccination (Gerend &
Magloire, 2008), results from this study indicate that this is not always the case. Both Ana and
Kristin reported being in committed relationships, and both had declined vaccination at the time
of the interviews. Conversely, Allison reported not having a boyfriend and not planning to get
one “anytime soon”, yet expressed interest in being vaccinated at the end of her second
interview. Furthermore, while some studies have indicated that a lack of perceived susceptibility
to HPV can be a barrier to vaccine acceptance (Dempsey et.al, 2009; Friedman & Shepeard,
2007), results from this study indicate that vaccination is sometimes sought by those who
describe themselves as being at “low-risk” for acquiring HPV.
In discussing cervical cancer, each of the young women spoke about their risks for
acquiring the disease in different ways. For example, Katie described thinking that at the time the
vaccine was introduced, there was a big “outbreak” of cervical cancer, which meant that
everyone was “at-risk.” Furthermore, Katie’s family history of cancer also influenced her ideas
about cervical cancer risk. Katie’s experience is similar to findings reported in previous studies
in which the prevention of cervical cancer and personal experience of someone with cancer were
identified as main drivers for vaccine acceptance (Mortensen, 2010).
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Unlike Katie, Kristin and Ana did not describe themselves as “at- risk” for acquiring
genital warts or cervical cancer. Although Kristin did not speak at length about her perceived risk
for acquiring cervical cancer, she noted that she is willing to “take a chance” by not getting the
vaccine since it only protects against two of the many HPV strains that can cause cervical cancer.
For both Kristin and Ana (who declined vaccination), their risks for developing cervical cancer
are diminished through their trust in Pap screening which they both described as an effective
means to detecting cervical cancer early. Alternative prevention strategies were also noted as a
theme in Hopfer and Clippard’s (2010) analysis of HPV vaccination narratives.
Interestingly, Kristin also assessed her risk for cervical cancer in relation to her perceived
risk for skin cancer. According to Kristin, cervical cancer is not as great a concern as skin cancer,
which she says, runs in her family. Also unique is that although Allison did not explicitly
describe her risk for acquiring cervical cancer, she began to consider HPV vaccination more
seriously after speaking with her friend about the “terrible,” “hard,” and “painful” experience she
had with genital warts. Both Kristin and Allison’s experiences are consistent with previous
studies that report that higher perceived severity of cervical cancer or genital warts is related to
increased likelihood for vaccination, while lower perceived severity is related to decreased
likelihood for vaccination (Kahn et.al., 2008).
Finally, in addition to talking about their risks for acquiring HPV, cervical cancer, and
genital warts, young women also spoke about how they interpreted risks associated with HPV
vaccination itself. This was most pronounced for Ana and Kristin, who declined vaccination and
who described the vaccine as potentially dangerous due to its unknown long-term side effects. In
contrast, Paige and Katie (both of whom had already been vaccinated), spoke of the vaccine
more positively, describing it as generic, safe, and effective. Interestingly, although all of the
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young women described not having heard much about the side effects of the vaccine, they each
responded to this lack of information in different ways. For Katie and Paige, not hearing about
any side effects associated with the vaccine meant that there was no harm in getting it.
Conversely, for Ana and Kristin, the lack of information regarding the long-term side effects of
the vaccine led them to view it as potentially dangerous. Both of these women drew on the
example of Thalidomide to describe their concerns that, despite vaccine approval, drastic long
term side effects were real possibilities in the future. In particular, Kristin’s main concern was
with the unknown effects of vaccination on her fertility. As she described, the fact that doctors
could not “guarantee” that the vaccine would have no effects on her fertility led her to view it as
a “risk” that she was not willing to take. These findings regarding scepticism of vaccine safety
are echoed in a recent study by Hopfer and Clippard (2010) in which college-women expressed
concerns about the lack of long-term safety information about the vaccine.
Subjectivities in Decision-making
A sixth important cross-narrative theme identified through the comparison of individual
participant narratives deals with subjectivity in decision-making. As noted previously,
subjectivity refers to “a particular way of thinking about, relating to and situating the self in
terms of the broader social and political context within which the self is embedded/located”
(Robertson, 2000, p. 230). Generally, the young women in this study described their vaccination
decisions in relation to their perceptions and understandings of themselves as decision makers
and responsible citizens.
In examining each of their narratives, it became clear that participants often made
connections between their vaccination decisions and who they are as individuals. For example,
Paige described herself as someone who “likes to stay on the safer side of things” and noted that
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she has always been one to “trust in vaccines.” For Paige, vaccination was one way for her to
decrease her anxiety related to getting HPV or cervical cancer. As she described, “it’s better to
be safe than sorry.” Like Paige, Katie also accepted vaccination. For Katie, her decision to be
vaccinated was related to her unique and privileged position as the daughter of two doctors.
Because her parents are in the “medical community”, Katie described hearing about and
accessing vaccines before others. As she described, if her parents were not doctors, she
“probably wouldn’t have known about it [the HPV vaccine] or gotten it as fast.”
Like Paige, Ana also considered herself someone who was concerned with staying safe
and being “cautious.” However, Ana’s cautious approach was linked with her self-described
tendency to be “critical” and her personal ethic of not wanting to put foreign things into her
body. For Ana, being cautious meant not getting the vaccine unless she was “100% sure” that it
that would protect her, and being critical meant questioning why physicians and others were
suggesting vaccination. Interestingly, although Ana described herself as “critical” and “cautious”
in her decision-making process, she also described herself as “lazy” when talking about how she
had not sought information about the vaccine. Specifically, Ana characterized her lack of interest
in learning more about the vaccine as part of her usual “lazy way.”
Finally, like Ana, Kristin told stories related to her decision not to be vaccinated against
HPV and talked about her desire to wait for more information about the long-term side effects of
the vaccine. For Kristin, her desire to wait is characteristic of the type of person she is. As she
described, “I’m a sit back and wait type person... that’s just me personality-wise.” Kristin also
described herself as a “very analytic person” who does “a little bit more questioning” than most
people. For Kristin, being analytic means “thinking pro/con” and asking herself about the
potential repercussions of her actions. In terms of HPV vaccination, Kristin described her
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process of weighing the pros and cons and considering what the possible outcomes would be for
her if she declined vaccination.
In what follows, I discuss the unique contribution of narrative methodology in allowing
me to explore decision-making from a new perspective- one that challenges current notions of
decision-making and considers the complex ways in which the subjective experiences of young
women are situated in broader socio-political contexts. In particular, I return to notions of
medicalization and neo-medicalization to show how young women’s decisions are related to
dominant discourses of health risk and individual responsibility for health.
Exploring Subjectivities: Discourse and Narrative
As noted previously, narratives not only give us insight into personal experience, they
also allow us to leam about the ways in which narrators reproduce larger discourses and struggle
with tensions in articulating their stories as they make sense of their experiences (Chase, 2003).
In other words, the stories collected in this study are not only stories about the unique decision
making experiences of Allison, Katie, Paige, Ana, and Kristin; they are also stories about the
kinds of broader discourses that influence how these young women come to understand
themselves and their vaccination decisions. As Weedon (1987) describes, a woman’s subjectivity
is constructed through discourses which shape her “conscious and unconscious thoughts and
emotions... her sense of herself and her ways of understanding her relation to the world” (p. 32).
By offering people ways of understanding and perceiving themselves, and by creating socially
accessible meanings and norms, discourses can have important effects on individual subjectivity
(Braun & Gavey, 1999).
In what follows, participant narratives are examined critically considering concepts such
as medicalization and neo-medicalization. In particular, I focus on how, through a process of
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neo-medicalization, discourses related to health risk and individual responsibility for health are
advanced in the context of HPV vaccination. I argue that these types of discourses construct a
new kind of citizen - one who is personally responsible for managing her health risks through
vaccination. In examining how discourses of health risk and individual responsibility for health
are manifested in the narratives of my participants, I also draw attention to how young women
respond to moral imperatives to be vaccinated in different ways.
In Allison’s narrative, for example, she describes her belief that the vaccine is not
necessary for her as a “single” young woman. Although she notes that she is not someone who
usually feels compelled to seek vaccination unless she is “forced to”, her interest in finding out
more about this vaccine in particular is especially noteworthy. In explaining why she decided to
volunteer for this study, Allison drew on discourses of personal responsibility for health in which
seeking information is the ‘right’ thing to do. As she described, “I’m just trying to find more
information for me and my friends so that I can make an informed decision.” Her desire to
become informed about the vaccine, not only for herself, but also for her friends, is reflective of
broader discourses on risk which advance ideas about morally “good citizens” who take
responsibility not only for their own health, but also for the health of others.
Similarly, Katie also draws on discourses of personal responsibility and good citizenship
as she describes her role in disseminating vaccine information to her friends. Because her parents
are doctors, Katie became a gatekeeper to medical information through her ability to refer her
friends to her mother for advice about the vaccine. As she describes, “a lot of people ask me
questions [about medical issues] ‘cause my parents are doctors.” Furthermore, in describing her
privileged position as the daughter of two doctors, Katie positions herself as a sort of elite risk
manager (Polzer, 2006) who is able to access risk- reducing medical interventions before they
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are available to others. As she describes, by the time she had already been vaccinated, her friends
were “just finding out about it.” According to Katie, if her parents were not doctors, she would
not have known about the vaccine or been vaccinated “as fast” as she was and would have “less
awareness of any type of vaccination in general.”
For Katie, finding out about the HPV vaccine from her mother as soon as it came out was
particularly important since vaccine advertisements had led her view herself as urgently “at-risk”
for cervical cancer. As she describes, “when I saw all those commercials I thought that meant
that there was this big outbreak of cervical cancer.” Katie’s response to vaccine advertisements
points to the effectiveness of marketing campaigns in constructing HPV as a risk through its
association with cervical cancer. Because risk discourses promote active participation in riskreduction by those deemed “at-risk”, Katie’s response to her “at-risk” consciousness was to
accept vaccination against HPV. In this way, Katie was able to transform herself into the
responsible risk manager expected of her in risk-related discourses.
This desire to seek vaccination as a responsible means to reducing one’s risk for cervical
cancer was echoed by Paige as well. In her narrative, Paige constructs herself as a responsible
young woman who is doing what she should to reduce her risk for disease. Specifically, she
describes how she “likes to stay on the safer side of things” and takes precautions like using
“birth control” and “condoms.” For Paige, getting the vaccine was not something that required
much thought. As she described, it was “just one of those things where if it’s your health on the
line... you’re willing to go that extra measure to ensure you’re confident.” When it comes to her
almost blind trust in vaccines, Paige’s attitude highlights the sheer power of risk discourse in
encouraging young women to just say yes to risk reduction strategies without question.
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Unlike Katie and Paige, Ana and Kristin were much more critical of the HPV vaccine as
a risk-reduction measure. Despite their critical viewpoints however, the narratives of both of
these young women show that they too were influenced by dominant discourses which promote
individual responsibility for health. Ana’s narrative in particular is insightful in that it highlights
her struggle to define who she is in relation to her vaccination decision. Specifically, Ana
struggles to make her decision not to seek vaccination or information about vaccination
commensurate with moral discourses related to taking responsibility for one’s own health.
Ultimately, Ana’s view of herself as critical and cautious and her decision not to be vaccinated
are at odds with risk discourse which says she should be doing all she can to reduce her risk for
disease.
The power of risk discourse in influencing Ana’s view of herself can be seen in how she
feels compelled to question why she has not sought out information about the vaccine. The
underlying moral imperatives that permeate notions of personal responsibility for health
ultimately lead Ana to consider the possibility that perhaps one of the reasons she has not sought
information is because of “stupidity” on her part since she “should” be taking care of her own
body. Although standing by her personal ethic and being sceptical about the long-term side
effects of the vaccine should be reason enough for her to decline vaccination, Ana struggles with
this idea and instead begins to see herself not only as “critical” and “cautious”, but also as
“lazy”, “passive” and “ignorant.” This split or bifurcated view of herself and her actions may
arise, in part because of her embodiment of dominant discourses that suggest that she should be
taking responsibility for managing her risk and preventing disease by seeking out information
about risk and being vaccinated to reduce her risk. Ultimately, although Ana is attempting to
challenge ideas about personal responsibility and question the ways in which HPV has come to
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be constructed as a risk, she struggles to do so in the face of prevailing discourses that frame the
vaccine as the appropriate and responsible choice.
Like Ana, Kristin is also very critical of the HPV vaccine and attempts to resist dominant
discourses that position the vaccine as the ideal risk-reduction tool. Because Kristin has decided
to go against the grain in terms of refusing vaccination, much of her narrative centers around her
experiences of defending her decision to others, including those in her immediate social network
(i.e., friends and boyfriend). This need to defend her decisions to others is understandable given
the moral demands placed on her through risk-related discourse. As she describes, others often
label her as “irrational” or “stubborn” when she tells them she has decided not to be vaccinated.
In particular, Kristin also noted that her male friends have offered their opinions by saying, “it’s
your body, it’s your decision, but why wouldn’t you wanna fight a cancer that you could?” This
type of questioning from Kristin’s friends arises from their understandings of HPV as a risk and
vaccination as a means of controlling this risk through medical intervention. Because Kristin’s
decision to decline vaccination is at odds with expectations communicated by risk-related
discourses and the moral imperative of taking action to reduce one’s risk for disease, she is
called upon to defend her decision to avoid being labelled “irresponsible.”
Although Kristin is critical of the HPV vaccine and attempts to resist discourses that
promote its uptake as a moral imperative, it is clear that, to some extent, Kristin, like the other
young women in this study, is also influenced by dominant discourses related to individual
responsibility for health. For example, in her first interview, Kristin constructs herself as a
responsible risk manager who, through yearly Pap tests, does everything she can to remain
“aware” of her body and “what’s going on with it.” To this end, Kristin describes how she took it
upon herself to become informed about HPV since she felt it was her “responsibility” to do so.
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According to Kristin, being “well versed” in sexual health matters is a “responsibility” which
“comes along with the privilege of being sexually active.” Furthermore, like other young women
in this study, Kristin feels responsible not only for her own health, but also for the health of her
others- namely her mother and sister. As she describes, her mother and sister are different from
her in that they “won’t take ownership of their own reproductive health” and “they don’t do
anything sexual health reproduction wise.” Instead, Kristin said they just “bury their heads in the
sand” when she tells them to “go get PAP smears.” In particular, because Kristin worries about
her sister, she said that she urges her “to get her pap smears done every year” and has told her to
at least “consider” the HPV vaccine if she’s “not gonna go to the doctor every year.”
Both Ana and Kristin draw on discourses of personal responsibility for health in their
descriptions of themselves as people who, despite not being vaccinated, protect their health in
other ways (e.g. through regular Pap screening and/or physicals). While Ana struggles to make
her decision not to be vaccinated (and not to seek information about vaccination) fit within moral
discourses of personal responsibility for health, Kristin is able to remain confident in her
construction of herself as a responsible risk manager because she takes up moral imperatives to
become informed about the vaccine and its potential benefits.
As the preceding section demonstrates, dominant discourses are taken up differently by
young women in their own ways. Generally, while those who have been vaccinated readily took
up risk related discourses of taking responsibility for, and protecting one’s health, those who
chose not to be vaccinated struggled to varying degrees to defend their decisions and support
their critical points of view. Despite having made different decisions regarding vaccination, the
young women in this study all took up moral discourses related to health risk and personal
responsibility for health in describing their vaccination decisions. The pervasiveness of these
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discourses in the narratives of these young women points to the strength of neo-medicalization in
emphasizing young women’s supposed risks for contracting HPV and developing cervical cancer
and the use of vaccination to manage this risk. In doing so, neo-medicalization advances notions
of personal responsibility, and places moral demands on young women to do all they can to
reduce their risks for future disease.
Study Limitations and Future Directions
Given that the narratives developed in this study were inevitably formed by the
characteristics and backgrounds of the sample of young women who agreed to take part in the
study, it is important to note that interpretations based on these narratives are therefore bounded.
Participants in this study were all university students at UWO who identified as heterosexual,
and with the exception of one participant, sexually active. Future research on the decision
making experiences of a more diverse population of young women may lend itself to other
interpretations, which could in turn contribute to further insights into the range and complexity
of decision-making experiences related to HPV vaccination. In particular, future research could
include insights from young women of different sexual orientations and from diverse socio
economic, ethnic, and/or educational backgrounds.
The research findings are also inevitably bound by the interpretive lens used to examine
the narratives within broader discursive contexts. While ideas related to medicalization and neomedicalization were used as conceptual frameworks for understanding how discourses related to
health risk and personal responsibility for health permeate narratives of HPV vaccine decision
making, future research efforts that approach the interpretation of participant data from other
lenses would also be insightful in terms of exploring participant narratives in new and productive
ways.
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Conclusion
The main research question that guided this study was, “How do young women aged 18
to 26 convey their experience of making decisions about HPV vaccination in the context of their
daily lives?” Using a narrative approach to inquiry, I explored how five young women
constructed their stories related to HPV vaccination and made sense of their decision-making
experiences. By examining participant narratives in relation to the conceptual frames of
medicalization and neo-medicalization, and by situating participants’ stories within dominant
health discourses (e.g. those related to health risk and individual responsibility), young women’s
experiences were linked to the broader social contexts in which their stories were narrated.
Through a narrative approach, this study allowed for new insights regarding the
complexities of young women’s decision-making to be explored. Although many of the
influences on decision-making identified in this study coincided with those found in previous
research, the findings presented here are unique in that they go beyond merely identifying
influences on decision-making, to exploring how these influences shape young women’s
decision-making experiences.
In eliciting and examining participants’ stories, this research contributes to new
understandings of how young women negotiate and make decisions regarding HPV vaccination
and challenges the linear model of decision-making that is presumed in many theories of health
behavior used in health promotion research. While the individual narratives collected in this
study show the range of decisions made in response to HPV vaccination, the cross-narrative
themes point to the similarities and differences in how young women articulated their decision
making experiences. In examining young women’s narratives in relation to concepts of
medicalization and neo-medicalization, commonly made assumptions regarding decision-making
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as a “rational” and “linear” process were challenged, and the ways in which dominant discourses
influenced participant narratives were highlighted.
In contrast to health behavior theories which see decision-making as a “rational” linear
process, the narratives of these young women clearly illustrate that decision-making is complex
and influenced by broader social and political contexts in which dominant discourses operate. As
noted in the literature review (Chapter Two), assumptions regarding individual responsibility for
health are often central to theories of health behaviour and decision-making which have
informed previous research regarding HPV vaccination. In order to move away from dominant
health behaviour theories that often deflect attention from the influence of broader contexts and
place decision-making at the level of the individual, I opted to use a narrative approach to
explore how young women were making decisions about vaccination in the context of their
everyday lives. In doing so, I was not only able to identify new influences on young women’s
decision-making, but was also able to explore how participant narratives were influenced by and
reflective of broader discursive contexts. Ultimately, a narrative approach allowed me to
contribute to existing HPV vaccination research by drawing attention to the ways in which young
women take up and/or resist dominant discourses as they respond to risk-management initiatives
in their own ways.
By showing how young women take up or resist dominant discourses related to health
risk and personal responsibility for health, this research makes a significant contribution to
understanding how processes of neo-medicalization have come to construct HPV as a risk, and
HPV vaccination as a solution to managing this risk. As the narratives demonstrate, neomedicalization occurs through various channels including family, friends, classrooms, and media
advertisements. In particular, according to Polzer and Knabe (2009), media messages regarding
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HPV vaccination often “blur the line between public health education and the marketing of
pharmaceutical companies” (p.869).
Insofar as this study highlights processes of neo-medicalization and the construction of
HPV as a health risk, it also has very practical implications for the practice of health promotion.
According to Lippman (2000), health promotion has been converted from a goal to a product. As
she describes, “rather than supporting structural changes that will lead to improved health, the
language of health promotion is [often] employed to justify the further development of more
technological and pharmaceutical options” (p. 3). In doing so, health promotion messages often
inadvertently reinforce ideas about individual responsibility for health in which individuals are
expected to seek medical interventions (such as vaccination) to control their risks for potential
illness. Since discourses related to health risk and individual responsibility continue to underlie
preventative health messages in field of health promotion (Breslow, 1999), this study draws
attention to the need to consider how health promotion initiatives may be contributing to
processes of neo-medicalization in which risks for future disease are being converted into
problems that require medical and pharmaceutical intervention.
Ultimately, by allowing participants to convey their stories related to HPV vaccination in
their own ways, and by considering the complex ways in which particular subjectivities are
constructed and made ‘real’ through discourse, this research provides new insights into how
young women are making decisions regarding vaccination in the context of their daily lives. In
particular, this study highlights how the subjective decision-making experiences of universityaged women may be situated in, and influenced by, broader social contexts in which processes of
medicalization and neo-medicalization have advanced notions of health risk and individual
responsibility.
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Posters
Text appearing on all study-related posters:
Study Participants Wanted
The HPV Vaccine: Did you get it? Did you refuse it? Are you considering it?
If you are female and between the ages of 18 to 26, you are invited to participate
in a study about young women’s experiences related to HPV vaccination.
What will I have to do?
You will be required to participate in two interviews. The information you
provide will be completely confidential.
For more information about this study, please contact:
Francesca Mancuso, MSc. Candidate, Health and Rehabilitation Sciences
(E-mail address) and (Telephone number)
Please note: By contacting the researcher, you are under no obligation to
participate in this study.
If you decide to take part in this study, you will be compensated for your time and
reimbursed for any travel costs.
Additional text for posters in clinics:
Your participation in this study is not related to any care or advice you receive at
this clinic.
Additional text for posters on campus:
Your participation in this study will have no effect on your current or future
academic status.
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Letter of Information
LETTER OF INFORMATION
Understanding Young Women’s Decision-Making Related to HPV Vaccination:
A Narrative Study
Principal Investigator:

Jessica Polzer PhD, Department of Women’s Studies and
Feminist Research and Faculty of Health Sciences,
University of Western Ontario
Tel:___________ e-mail:_______________

Research Associate:

Francesca Mancuso, MSc. Candidate, Health and
Rehabilitation Sciences, University of Western Ontario
Tel:
e-mail:

You are invited to take part in a research study that looks at young women’s decision
making experiences related to Human Papillomavirus (HPV) vaccination. In order to
leam about young women’s experiences related to HPV vaccination, we will be speaking
with young women between the ages of 18 and 26 who have been vaccinated, who have
not been vaccinated, and who are considering vaccination. This letter contains
information to help you decide whether or not you would like to participate in this study.
It is important for you to understand why the study is being conducted and what it will
involve. Please take the time to read this carefully and feel free to ask questions if
anything is unclear.
What is the purpose of the study?
The purpose of this study is to leam more about young women’s experiences related to
HPV vaccination. Since current research has focused mainly on parents and young girls
involved in the school-based immunization program for HPV, we would like to gather
more information about young women between the ages of 18 and 26 who have
considered HPV vaccination in order to gain a better understanding of the issues and
factors young women consider as they make decisions about HPV vaccination.
Am I eligible to participate?
You are eligible to take part in this study if you are:
i) a female between the ages of 18 and 26;
ii) have considered HPV vaccination;
iii) able to participate in an interview in English; and
iv) are interested in sharing your experiences related to HPV vaccination.
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If you do not fit these criteria, you are not eligible to participate.
What do I have to do?
If you choose to take part in this study, you will be asked to participate in two openended interviews. In open-ended interviews, the researcher asks open-ended questions
and allows the study participant to describe her experiences in her own words. Both
interviews will be audio-recorded to make sure that we have an accurate record of what
you say. You can request that the digital recorder be turned off at any time during the
interviews.
During the first interview you will be asked to share your story about how you came to
get, or not get, the HPV vaccination. At the end of this interview, you will be asked to
complete a short demographic survey. This information will be used to get a better
understanding of your story and context.
The researcher will type up the interview word-for-word and will provide you with a
typed copy (transcript) of your interview for you to read and reflect on before the second
interview. Any names you mention in the interview will be replaced with alternative
names (pseudonyms) to protect your identity. The transcript can be delivered to you in
person or sent via e-mail as a password protected file. If you would like the file to be sent
by e-mail, you will be asked to provide the researcher with a password at the end of the
first interview which will be used to password protect the file. If you are given a hard
copy of your transcript, you will be asked to return it to the researcher when you come in
for your second interview. If you receive a digital version, you will be asked to delete it
permanently after the second interview. In the second interview, you will be asked to
share your thoughts about the first interview. As well, the researcher will ask questions to
encourage you to expand on the information you provided in the first interview.
There is no time limit on the interviews but it is estimated that each interview will take
approximately 60 minutes to complete. The interviews will take place at a location of
your choice that is safe and comfortable for both you and the researcher. A private
interview space at the University of Western Ontario is available if you prefer this option.
You will be reimbursed for any transportation or parking expenses you pay in order to
participate in this study. At the end of the second interview, you will receive $20 as a
token of our appreciation for your time and for sharing your experiences about HPV
vaccination.
Are there any risks or discomforts?
There are no known risks associated with taking part in this study. You may find that you
experience discomfort if you disclose sensitive information related to your personal
experiences with HPV or HPV vaccination. You have the right to refuse to answer any
questions and to withdraw from the study at any time. Referrals to information sources
and counselling will be made available to you should you experience any stress or
anxiety that might arise as a result of your participation.
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What are the benefits of taking part?
The long-term benefits of this study are unknown. It is possible that you will not benefit
directly from participation in the study. A possible benefit of participation is that your
insights and personal experiences related to HPV vaccination will be used to develop
presentations and papers that will be presented to others at conferences and in academic
journals. As a result, your experiences may help to influence services, programs, and
policies related to HPV vaccination for women in your age group.
What happens to the information I share with you? How will my privacy be
protected?
Both interviews will be audio-recorded and typed out word-for-word to make sure that
we have an accurate record of what you say. The following measures will be taken to
protect your privacy by keeping your information confidential (i.e. secure) and your
identity anonymous:
• Only the Primary Investigator and the Research Associate will have access to the
original interview recordings and typed transcripts.
• All information collected from you (including interview transcripts, demographic
information, contact information, consent forms and audio recordings) will be
locked in a secure cabinet in a locked research office at The University of
Western Ontario and will be destroyed after 5 years.
• The interview transcripts will be made anonymous by replacing your real name,
and any other information that could be used to identify you (e.g. your place of
work), with a pseudonym (an alternate name). Only the pseudonym will be used
to identify recordings and transcripts.
• Your real name and pseudonym will be recorded in a master list and stored in a
locked cabinet in a secure research office for the duration of the study. This
master list will be used to match study participants with their pseudonyms if they
wish to withdraw and have their data removed from the study. This master list
will be stored separately from the signed consent forms and the raw data and will
be accessible only to the PI and the RA.
• Any data the Research Associate or Principal Investigator take off-site (e.g. to
their residences) will be made anonymous and will be transported and stored
securely in a locked case.
• You will never be identified in any future reports or publications that result from
this study. If any quotes from your interviews are used in future reports or
publications, only your pseudonym will be used, and any information in the quote
that could identify you (e.g. your place of work) will be altered or removed.
• All information transferred into digital files will be password protected and the
password will only be known to the Principal Investigator and the Research
Associate.
In the attached consent form, you will be asked if you agree to have your interview data
stored in a secure database for up to 5 years after the completion of this study so that it
may be used as part of a larger project on HPV vaccination. Whether or not you agree to
this request is entirely up to you.
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We will strive to ensure the confidentiality of your research-related records. Absolute
confidentiality cannot be guaranteed as we may have to disclose certain information
under certain laws. Representatives of The University of Western Ontario Health Science
Research Ethics Board may require access to your study-related records or may follow up
with you to monitor the conduct of the study.
Can I withdraw from the study?
Participation in this study is voluntary. You have the right to withdraw your participation
in the study at any time and may refuse to answer any interview questions. If you wish to
withdraw your participation in the study, you can contact the Research Associate,
Francesca Mancuso, and your information will be destroyed immediately. Please note
that even if your data is removed from the study, what you share in the interview may
still influence the researcher’s impressions and analyses.
Can I receive a copy of the study results?
If you would like to receive a copy of the results of this study after the analysis is
complete, you will be asked to provide your name and mailing address on a separate
piece of paper. This information will also be kept confidential in a locked cabinet.
Other information about this study:
If you are a student, your decision to participate or drop out of the study will have no
effect on your academic standing or status. If you are a patient at a clinic where you heard
about this study, your decision to participate or drop out of the study will have no effect
on the care or advice you receive at the clinic.
You will be given a copy of this letter of information and consent form once it is signed.
Please note that you do not waive any legal rights by signing this form.
If you have any other questions or concerns:
If you have any questions about this study, or would like more information, you may
contact the Principal Investigator, Jessica Polzer, at Tel:___________, E-mail:
_______________ , or the Research Associate, Francesca Mancuso, at Tel:___________,
E-mail:_______________. If you have any questions or concerns about the conduct of
this study or your rights as a research participant, you may contact the Office of Research
Ethics at (519) 661-3036 or by email at ethics@uwo.ca.
We hope that you will consider participating in this research.
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Ethics Approval

Office of Research Ethics
The University of Western Ontario
Room 4180 Support Services Building, London, ON, Canada N6A 5C1
Telephone: (519) 661-3036 Fax: (519) 850-2466 Email: ethics@uwo ca
Website: www.uwo.ca/research/ethics

Use of Human Subjects • Ethics Approval Notice
Principal Investigator: Dr. J, Polzer
Review Number. 16267E

Review Level: Expedited

Review Date: June 24, 2009
Protocol Title: Understanding Young Women's Decision-Making Regarding HPV Vaccination: A
Narrative Study

Department and Institution: W omen's Studies, University of Western Ontario
Sponsor: SSHRC-SOCIAL SCIENCE HUMANITIES RESEARCH COUNCIL
Expiry Date: September 30,2010
Ethics Approval Date: July 24, 2009
Documents Reviewed and Approved: UWO Protocol, Letters (2) of Information and Consent (Participant. Key Informant),
Advertisements (3 - Posters, Newspaper/OnBne, WebCT)

Documents Received for Information:
This is to notify you that The University o f Western Ontario Research F.thics Board for Health Sciences Research Involving Human
Subjects (HSREB) which is organized and operates according to the Tri-Council Policy Statement: Ethical Conduct o f Research
Involving Humans and the Health Canada/ICH Good Clinical Practice Practices: Consolidated Guidelines; and the applicable laws and
regulations o f Ontario has reviewed and granted approval to the above referenced study on the approval date noted above. The
membership o f this REB also complies with the membership requirements for REB's as defined in Division 5 o f the Food and Drug
Regulations.
The ethics approval for this study shall remain valid until the expiry date noted above assuming timely and acceptable responses to tile
HSREB's periodic requests for surveillance and monitoring information. If you require an updated approval notice prior to that time
you must request it using the U WO Updated Approval Request Form.
During the course o f the research, no deviations from, or changes to, the protocol or consent form may be initiated without prior
written approval from the HSREB except when necessary to eliminate immediate hazards to the subject or when the change(s) involve
only logistical or administrative aspects o f the study (e.g. change of monitor, telephone number). Expedited review o f minor
change(s) in ongoing studies will be considered. Subjects must receive a copy o f the signed information/consent documentation.
Investigators must promptly also report to the HSREB:
a) changes increasing the risk to the participant(s) and/or affecting significantly the conduct o f the study;
b) all adverse and unexpected experiences or events that are both serious and unexpected;
c) new information that may adversely affect the safely o f the subjects or the conduct o f the study.
If these changes/adverse events require a change to the information/consent documentation, and/or recruitment advertisement, the
newly revised information/consent documentation, and/or advertisement, must be submitted to this office for approval.
Members o f the HSREB who are named as investigators in research studies, or declare a conflict o f interest, do not participate in
discussion related to, nor vote on, such studies when they are presented to the HSREB.
Chair of HSREB. Dr. Joseph Gilbert

Ethics Officer to Contact for F urther InformsUon

O Janice Sutherland
(jsutherliguvm.ca)
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(ewamboltfiiuivaca)
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1 (grace, kelly@uwo.ca)
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Jenise Graton
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Consent Form
CONSENT FORM
Understanding Young Women’s Decision-Making Related to HPV Vaccination:
A Narrative Study
Primary Investigator: Jessica Polzer, PhD, Department of Women’s Studies and Feminist
Research and Faculty of Health Sciences, The University of
Western Ontario
Tel:___________ E-mail:_______________
Research Associate: Francesca Mancuso, MSc. Candidate, Health and Rehabilitation
Sciences, The University of Western Ontario
Tel:
E-mail:
_________
I have read the letter of information, I have had the nature of the study explained to me,
and I agree to participate. All questions have been answered to my satisfaction and I
understand that I do not waive any legal rights by signing this consent form.

Signature

Date

Name of Person Obtaining Consent Signature

Date

Name of Research Participant

I would like a copy of the study results sent to me once the analysis is completed (circle
one): Yes No
(If yes, please provide your contact information to the researcher on a separate piece of
paper)
I agree to have my interview data stored in a secure database for up to 5 years so that it
may be used in the future by the Primary Investigator as part of a larger project on HPV
vaccination (circle one): Yes No
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Demographic Survey
DEMOGRAPHIC SURVEY
In what year were you born?__________
What is the highest level of education you have attained?
___Some high school
___Some university
___High school diploma obtained ___ Currently enrolled in university
___Some college
___University Graduate
___Currently enrolled in college ___ Master’s/Ph.D in progress
___College Graduate
___Masters’s/Ph.D obtained
___Other; Please describe:_________________________________
What is your current employment status?
___Employed Full Time
___Employed Part Time
___Unemployed
___Student
___Stay-at-home Mom
___Self-employed
Other: Please describe:
What is your ethnic background?
___White
___Chinese
___South Asian (e.g., East Indian, Pakistani, Sri Lankan, etc.)
___Black
___Filipino
___Latin American
___Southeast Asian (e.g., Vietnamese, Cambodian, Malaysian, Laotian, etc.)
___Arab
___West Indian (e.g. Iranian, Afghan, etc.)
___Korean
___Japanese
___Indian Band/ First Nations
___Other; Please describe:_________________________________
Are you sexually active?
___Yes
___No
___Prefer not to respond

If YES, are your partners:
___Male ___ Both
___Female ___ Prefer not to respond

Where did you hear about this study?______________________________
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Transcription Coding Guidelines
Interviewer’s voice= I
Respondent’s voice= R
Interruption/Interjection
R: respondent speaking—
I: [interjects] interviewer speaking
R: —respondent continues speaking
Pauses
Short pause=...
Long pause= ... [Ip]
Laughter/Emotion
Laughter: [laughs]
Sigh: [Sigh]
Volume: [raises voice]/ [lowers voice]
Unintelligible Speech
Use [XXX] to denote unintelligible speech
Emphasis
Capitalize words for emphasis

